UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2019

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number: 001-34374

 

ARLINGTON ASSET INVESTMENT CORP.

(Exact name of Registrant as specified in its charter)

 

 

Virginia

 

54-1873198

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

6862 Elm Street, Suite 320

McLean, VA

 

22101

(Address of Principal Executive Offices)

 

(Zip Code)

 

(703) 373-0200

(Registrant’s Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Sec. 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

  

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

  

  

Small reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):Yes  No 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Class A Common Stock

 

AI

 

NYSE

7.00% Series B Cumulative Perpetual Redeemable Preferred Stock

 

AI PrB

 

NYSE

8.250% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

 

AI PrC

 

NYSE

 

Number of shares outstanding of each of the registrant’s classes of common stock, as of October 31, 2019:

 

Title

 

Outstanding

Class A Common Stock

 

36,755,387 shares

 

 


 

ARLINGTON ASSET INVESTMENT CORP.

FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2019

INDEX

 

 

 

 

 

 

 

Page

PART I — FINANCIAL INFORMATION

 

 

 

 

Item 1.

 

Consolidated Financial Statements and Notes — (unaudited)

 

1

 

 

 

 

Consolidated Balance Sheets

 

1

 

 

 

 

Consolidated Statements of Comprehensive Income

 

2

 

 

 

 

Consolidated Statements of Changes in Equity

 

3

 

 

 

 

Consolidated Statements of Cash Flows

 

5

 

 

 

 

Notes to Consolidated Financial Statements

 

6

 

 

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

24

 

 

Item 3.

 

Quantitative and Qualitative Disclosures about Market Risk

 

43

 

 

Item 4.

 

Controls and Procedures

 

47

PART II — OTHER INFORMATION

 

 

 

 

Item 1.

 

Legal Proceedings

 

48

 

 

Item 1A.

 

Risk Factors

 

48

 

 

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

48

 

 

Item 3.

 

Defaults Upon Senior Securities

 

48

 

 

Item 4.

 

Mine Safety Disclosures

 

48

 

 

Item 5.

 

Other Information

 

48

 

 

Item 6.

 

Exhibits

 

48

 

 

 

 

Signatures

 

51

 

 

 

i


 

PART I

FINANCIAL INFORMATION

Item 1. Financial Statements

ARLINGTON ASSET INVESTMENT CORP.

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

(Unaudited)

 

 

 

September 30, 2019

 

 

December 31, 2018

 

ASSETS

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

12,129

 

 

$

26,713

 

Interest receivable

 

 

11,684

 

 

 

13,349

 

Mortgage-backed securities, at fair value

 

 

 

 

 

 

 

 

Agency

 

 

4,013,161

 

 

 

3,982,106

 

Private-label

 

 

25

 

 

 

24

 

Derivative assets, at fair value

 

 

675

 

 

 

438

 

Deposits

 

 

43,298

 

 

 

61,052

 

Other assets

 

 

18,566

 

 

 

15,768

 

Total assets

 

$

4,099,538

 

 

$

4,099,450

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

Repurchase agreements

 

$

3,697,906

 

 

$

3,721,629

 

Interest payable

 

 

3,356

 

 

 

4,646

 

Accrued compensation and benefits

 

 

3,502

 

 

 

3,732

 

Dividend payable

 

 

8,397

 

 

 

11,736

 

Derivative liabilities, at fair value

 

 

724

 

 

 

6,959

 

Other liabilities

 

 

3,204

 

 

 

2,200

 

Long-term unsecured debt

 

 

74,272

 

 

 

74,104

 

Total liabilities

 

 

3,791,361

 

 

 

3,825,006

 

Commitments and contingencies

 

 

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

 

 

Series B Preferred stock, $0.01 par value, 354,039 and 350,595 shares issued and

   outstanding, respectively (liquidation preference of $8,851 and $8,765,

   respectively)

 

 

8,283

 

 

 

8,245

 

Series C Preferred stock, $0.01 par value, 1,200,000 and -0- shares issued and

   outstanding, respectively (liquidation preference of $30,000 and $-0-,

   respectively)

 

 

28,944

 

 

 

 

Class A common stock, $0.01 par value, 450,000,000 shares authorized, 36,755,387

   and 30,497,998 shares issued and outstanding, respectively

 

 

368

 

 

 

305

 

Additional paid-in capital

 

 

2,048,423

 

 

 

1,997,876

 

Accumulated deficit

 

 

(1,777,841

)

 

 

(1,731,982

)

Total stockholders’ equity

 

 

308,177

 

 

 

274,444

 

Total liabilities and stockholders’ equity

 

$

4,099,538

 

 

$

4,099,450

 

 

See notes to consolidated financial statements.

 

 

1


 

ARLINGTON ASSET INVESTMENT CORP.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Dollars in thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Interest income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency mortgage-backed securities

 

$

28,455

 

 

$

32,679

 

 

$

94,300

 

 

$

93,344

 

Private-label mortgage-backed securities

 

 

4

 

 

 

2

 

 

 

19

 

 

 

16

 

Other

 

 

215

 

 

 

183

 

 

 

904

 

 

 

419

 

Total interest income

 

 

28,674

 

 

 

32,864

 

 

 

95,223

 

 

 

93,779

 

Interest expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short-term secured debt

 

 

22,721

 

 

 

21,265

 

 

 

72,230

 

 

 

54,526

 

Long-term unsecured debt

 

 

1,261

 

 

 

1,261

 

 

 

3,802

 

 

 

3,749

 

Total interest expense

 

 

23,982

 

 

 

22,526

 

 

 

76,032

 

 

 

58,275

 

Net interest income

 

 

4,692

 

 

 

10,338

 

 

 

19,191

 

 

 

35,504

 

Investment advisory fee income

 

 

 

 

 

 

 

 

250

 

 

 

 

Investment loss, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain (loss) on trading investments, net

 

 

16,890

 

 

 

(37,878

)

 

 

128,297

 

 

 

(147,113

)

(Loss) gain from derivative instruments, net

 

 

(25,353

)

 

 

35,620

 

 

 

(149,630

)

 

 

91,826

 

Other, net

 

 

232

 

 

 

1

 

 

 

222

 

 

 

375

 

Total investment loss, net

 

 

(8,231

)

 

 

(2,257

)

 

 

(21,111

)

 

 

(54,912

)

General and administrative expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Compensation and benefits

 

 

2,833

 

 

 

2,833

 

 

 

8,182

 

 

 

7,934

 

Other general and administrative expenses

 

 

1,365

 

 

 

1,121

 

 

 

3,816

 

 

 

3,778

 

Total general and administrative expenses

 

 

4,198

 

 

 

3,954

 

 

 

11,998

 

 

 

11,712

 

(Loss) income before income taxes

 

 

(7,737

)

 

 

4,127

 

 

 

(13,668

)

 

 

(31,120

)

Income tax provision

 

 

 

 

 

9,628

 

 

 

 

 

 

34,372

 

Net loss

 

 

(7,737

)

 

 

(5,501

)

 

 

(13,668

)

 

 

(65,492

)

Dividend on preferred stock

 

 

(774

)

 

 

(151

)

 

 

(1,826

)

 

 

(437

)

Net loss attributable to common stock

 

$

(8,511

)

 

$

(5,652

)

 

$

(15,494

)

 

$

(65,929

)

Basic loss per common share

 

$

(0.23

)

 

$

(0.19

)

 

$

(0.44

)

 

$

(2.31

)

Diluted loss per common share

 

$

(0.23

)

 

$

(0.19

)

 

$

(0.44

)

 

$

(2.31

)

Weighted-average common shares outstanding

  (in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

36,572

 

 

 

29,382

 

 

 

35,399

 

 

 

28,601

 

Diluted

 

 

36,572

 

 

 

29,382

 

 

 

35,399

 

 

 

28,601

 

 

See notes to consolidated financial statements.

2


 

ARLINGTON ASSET INVESTMENT CORP.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Dollars in thousands)

(Unaudited)

 

 

 

Series B

Preferred

Stock

(#)

 

 

Series B

Preferred

Amount

($)

 

 

Series C

Preferred

Stock

(#)

 

 

Series C

Preferred

Amount

($)

 

 

Class A

Common

Stock

(#)

 

 

Class A

Amount

($)

 

 

Additional

Paid-In

Capital

 

 

Accumulated

Deficit

 

 

Total

 

Balances, December 31, 2017

 

 

303,291

 

 

$

7,108

 

 

 

 

 

$

 

 

 

28,140,721

 

 

$

281

 

 

$

1,974,941

 

 

$

(1,596,013

)

 

$

386,317

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(56,383

)

 

 

(56,383

)

Issuance of Class A common

  stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(23

)

 

 

 

 

 

(23

)

Issuance of preferred stock

 

 

19,431

 

 

 

459

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

459

 

Cumulative-effect of accounting

  change (see Note 7)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,059

 

 

 

4,059

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

451

 

 

 

 

 

 

451

 

Dividends declared

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(15,875

)

 

 

(15,875

)

Balances, March 31, 2018

 

 

322,722

 

 

$

7,567

 

 

 

 

 

$

 

 

 

28,140,721

 

 

$

281

 

 

$

1,975,369

 

 

$

(1,664,212

)

 

$

319,005

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,608

)

 

 

(3,608

)

Issuance of Class A common

  stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

66,989

 

 

 

1

 

 

 

710

 

 

 

 

 

 

711

 

Issuance of preferred stock

 

 

18,030

 

 

 

440

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

440

 

Repurchase of Class A common

  stock under stock-based

  compensation plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,011

)

 

 

 

 

 

(67

)

 

 

 

 

 

(67

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

297

 

 

 

 

 

 

297

 

Dividends declared

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(10,311

)

 

 

(10,311

)

Balances, June 30, 2018

 

 

340,752

 

 

$

8,007

 

 

 

 

 

$

 

 

 

28,201,699

 

 

$

282

 

 

$

1,976,309

 

 

$

(1,678,131

)

 

$

306,467

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,501

)

 

 

(5,501

)

Issuance of Class A common

  stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,007,216

 

 

 

20

 

 

 

20,357

 

 

 

 

 

 

20,377

 

Issuance of Class A common

  stock under stock-based

  compensation plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

164,585

 

 

 

1

 

 

 

123

 

 

 

 

 

 

124

 

Issuance of preferred stock

 

 

5,404

 

 

 

131

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

131

 

Repurchase of Class A common

  stock under stock-based

  compensation plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(27,854

)

 

 

 

 

 

(260

)

 

 

 

 

 

(260

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

752

 

 

 

 

 

 

752

 

Dividends declared

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(11,400

)

 

 

(11,400

)

Balances, September 30, 2018

 

 

346,156

 

 

$

8,138

 

 

 

 

 

$

 

 

 

30,345,646

 

 

$

303

 

 

$

1,997,281

 

 

$

(1,695,032

)

 

$

310,690

 

 

See notes to consolidated financial statements.

3


 

ARLINGTON ASSET INVESTMENT CORP.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - (continued)

(Dollars in thousands)

(Unaudited)

 

 

 

 

Series B

Preferred

Stock

(#)

 

 

Series B

Preferred

Amount

($)

 

 

Series C

Preferred

Stock

(#)

 

 

Series C

Preferred

Amount

($)

 

 

Class A

Common

Stock

(#)

 

 

Class A

Amount

($)

 

 

Additional

Paid-In

Capital

 

 

Accumulated

Deficit

 

 

Total

 

Balances, December 31, 2018

 

 

350,595

 

 

$

8,245

 

 

 

 

 

$

 

 

 

30,497,998

 

 

$

305

 

 

$

1,997,876

 

 

$

(1,731,982

)

 

$

274,444

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17,594

 

 

 

17,594

 

Issuance of Class A common

  stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,000,000

 

 

 

60

 

 

 

48,750

 

 

 

 

 

 

48,810

 

Issuance of Class A common

  stock under stock-based

  compensation plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

74,619

 

 

 

1

 

 

 

(1

)

 

 

 

 

 

 

Issuance of preferred stock

 

 

2,035

 

 

 

45

 

 

 

1,200,000

 

 

 

28,880

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

28,925

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

773

 

 

 

 

 

 

773

 

Dividends declared

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(14,135

)

 

 

(14,135

)

Balances, March 31, 2019

 

 

352,630

 

 

$

8,290

 

 

 

1,200,000

 

 

$

28,880

 

 

 

36,572,617

 

 

$

366

 

 

$

2,047,398

 

 

$

(1,728,523

)

 

$

356,411

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(23,525

)

 

 

(23,525

)

Issuance of Class A common

  stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

 

 

 

1

 

Issuance of preferred stock

 

 

1,409

 

 

 

6

 

 

 

 

 

 

64

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

70

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

217

 

 

 

 

 

 

217

 

Dividends declared

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(8,885

)

 

 

(8,885

)

Balances, June 30, 2019

 

 

354,039

 

 

$

8,296

 

 

 

1,200,000

 

 

$

28,944

 

 

 

36,572,617

 

 

$

366

 

 

$

2,047,616

 

 

$

(1,760,933

)

 

$

324,289

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(7,737

)

 

 

(7,737

)

Issuance of Class A common

  stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9

)

 

 

 

 

 

(9

)

Issuance of Class A common

  stock under stock-based

  compensation plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

219,395

 

 

 

2

 

 

 

107

 

 

 

 

 

 

109

 

Issuance of preferred stock

 

 

 

 

 

(13

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(13

)

Repurchase of Class A common

  stock under stock-based

  compensation plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(36,625

)

 

 

 

 

 

(204

)

 

 

 

 

 

(204

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

913

 

 

 

 

 

 

913

 

Dividends declared

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9,171

)

 

 

(9,171

)

Balances, September 30, 2019

 

 

354,039

 

 

$

8,283

 

 

 

1,200,000

 

 

$

28,944

 

 

 

36,755,387

 

 

$

368

 

 

$

2,048,423

 

 

$

(1,777,841

)

 

$

308,177

 

 

See notes to consolidated financial statements.

 

 

4


 

ARLINGTON ASSET INVESTMENT CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net loss

 

$

(13,668

)

 

$

(65,492

)

Adjustments to reconcile net loss to net cash provided by operating activities

 

 

 

 

 

 

 

 

Investment loss, net

 

 

21,111

 

 

 

54,912

 

Net premium amortization on mortgage-backed securities

 

 

20,500

 

 

 

24,580

 

Deferred tax provision

 

 

 

 

 

34,372

 

Other

 

 

1,991

 

 

 

1,476

 

Changes in operating assets

 

 

 

 

 

 

 

 

Interest receivable

 

 

1,665

 

 

 

(2,272

)

Other assets

 

 

(351

)

 

 

(153

)

Changes in operating liabilities

 

 

 

 

 

 

 

 

Interest payable and other liabilities

 

 

(2,223

)

 

 

84

 

Accrued compensation and benefits

 

 

(230

)

 

 

(1,350

)

Net cash provided by operating activities

 

 

28,795

 

 

 

46,157

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchases of agency mortgage-backed securities

 

 

(3,657,454

)

 

 

(2,699,857

)

Proceeds from sales of agency mortgage-backed securities

 

 

3,365,166

 

 

 

1,815,796

 

Receipt of principal payments on agency mortgage-backed securities

 

 

369,029

 

 

 

367,356

 

(Payments for) proceeds from derivatives and deposits, net

 

 

(138,792

)

 

 

76,232

 

Other

 

 

31

 

 

 

29

 

Net cash used in investing activities

 

 

(62,020

)

 

 

(440,444

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

(Repayments of) proceeds from repurchase agreements, net

 

 

(23,723

)

 

 

425,070

 

Proceeds from issuance of common stock

 

 

48,804

 

 

 

21,065

 

Proceeds from issuance of preferred stock

 

 

28,982

 

 

 

1,030

 

Dividends paid

 

 

(35,422

)

 

 

(42,293

)

Net cash provided by financing activities

 

 

18,641

 

 

 

404,872

 

Net (decrease) increase in cash and cash equivalents

 

 

(14,584

)

 

 

10,585

 

Cash and cash equivalents, beginning of period

 

 

26,713

 

 

 

21,614

 

Cash and cash equivalents, end of period

 

$

12,129

 

 

$

32,199

 

Supplemental cash flow information:

 

 

 

 

 

 

 

 

Cash payments for interest

 

$

77,154

 

 

$

58,284

 

Cash payments for taxes

 

$

 

 

$

 

 

See notes to consolidated financial statements.

 

 

 

5


 

ARLINGTON ASSET INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share data)

(Unaudited)

 

Note 1. Organization and Basis of Presentation

Arlington Asset Investment Corp. (“Arlington Asset”) and its consolidated subsidiaries (unless the context otherwise provides, collectively, the “Company”) is an investment firm that focuses on acquiring and holding a levered portfolio of residential mortgage-backed securities (“MBS”), consisting of “agency MBS” and “private-label MBS.” Agency MBS include residential mortgage pass-through certificates for which the principal and interest payments are guaranteed by either a U.S. government sponsored enterprise (“GSE”), such as the Federal National Mortgage Association (“Fannie Mae”) and the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or by a U.S. government agency, such as the Government National Mortgage Association (“Ginnie Mae”). Private-label MBS, or “non-agency MBS,” include residential MBS that are not guaranteed by a GSE or the U.S. government. Arlington Asset is a Virginia corporation that is internally managed.

For the Company’s tax years ended December 31, 2018 and earlier, the Company was taxed as a C corporation for U.S. federal tax purposes. Commencing with its taxable year ending December 31, 2019, the Company intends to elect to be taxed as a REIT under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”). As a REIT, the Company will be required to distribute annually 90% of its REIT taxable income (subject to certain adjustments). So long as the Company continues to qualify as a REIT, it will generally not be subject to U.S. Federal or state corporate income taxes on its taxable income that it distributes to its shareholders on a timely basis. At present, it is the Company’s intention to distribute 100% of its taxable income, although the Company will not be required to do so. The Company intends to make distributions of its taxable income within the time limits prescribed by the Internal Revenue Code, which may extend into the subsequent taxable year.

The unaudited interim consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Article 10 of Regulation S-X. The Company’s unaudited interim consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited annual consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

The Company’s consolidated financial statements include the accounts of Arlington Asset and all other entities in which the Company has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect amounts reported in the consolidated financial statements. Although the Company bases these estimates and assumptions on historical experience and all other reasonably available information that the Company believes to be relevant under the circumstances, such estimates frequently require management to exercise significant subjective judgment about matters that are inherently uncertain. Actual results may differ from these estimates materially.

Certain amounts in the consolidated financial statements and notes for prior periods have been reclassified to conform to the current year’s presentation. These reclassifications had no impact on the previously reported net income, total assets or total liabilities.

 

Note 2. Summary of Significant Accounting Policies

Cash Equivalents

Cash equivalents include demand deposits with banks, money market accounts and highly liquid investments with original maturities of three months or less. As of September 30, 2019 and December 31, 2018, approximately 96% and 99%, respectively, of the Company’s cash equivalents were invested in money market funds that invest primarily in U.S. Treasuries and other securities backed by the U.S. government.

Investment Security Purchases and Sales

Purchases and sales of investment securities are recorded on the settlement date of the transfer unless the trade qualifies as a “regular-way” trade and the associated commitment qualifies for an exemption from the accounting guidance applicable to derivative instruments. A regular-way trade is an investment security purchase or sale transaction that is expected to settle within the period of time following the trade date that is prevalent or traditional for that specific type of security. Any amounts payable or receivable for

6


 

unsettled security trades are recorded as “sold securities receivable” or “purchased securities payable” in the consolidated balance sheets.

Interest Income Recognition for Investments in Agency MBS

The Company recognizes interest income for its investments in agency MBS by applying the “interest method” permitted by GAAP, whereby purchase premiums and discounts are amortized and accreted, respectively, as an adjustment to contractual interest income accrued at each security’s stated coupon rate. The interest method is applied at the individual security level based upon each security’s effective interest rate. The Company calculates each security’s effective interest rate at the time of purchase by solving for the discount rate that equates the present value of that security's remaining contractual cash flows (assuming no principal prepayments) to its purchase price. Because each security’s effective interest rate does not reflect an estimate of future prepayments, the Company refers to this manner of applying the interest method as the “contractual effective interest method.” When applying the contractual effective interest method to its investments in agency MBS, as principal prepayments occur, a proportional amount of the unamortized premium or discount is recognized in interest income such that the contractual effective interest rate on the remaining security balance is unaffected.

Other Significant Accounting Policies

Certain of the Company’s other significant accounting policies are summarized in the following notes:

 

Investments in agency MBS, subsequent measurement

Note 3

Borrowings

Note 4

To-be-announced agency MBS transactions, including “dollar rolls”

Note 5

Derivative instruments

Note 5

Balance sheet offsetting

Note 6

Fair value measurements

Note 7

 

Refer to the Company’s 2018 Annual Report on Form 10-K for a complete inventory and summary of the Company’s significant accounting policies.

 

Recent Accounting Pronouncements

The following table provides a brief description of recently issued accounting pronouncements and their actual or expected effect on the Company’s consolidated financial statements:

 

Standard

Description

Date of

Adoption

Effect on the Consolidated

Financial Statements

Recently Adopted Accounting Guidance

Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842)

This amendment replaces the existing lease accounting model with a revised model.  The primary change effectuated by the revised lease accounting model is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases.

January 1, 2019

The primary impact of the adoption of ASU No. 2016-02 was the recognition of lease liabilities and associated right-of-use assets, as a component of “Other liabilities” and “Other assets,” respectively, on the Company’s consolidated balance sheets as of September 30, 2019.  The adoption of ASU No. 2016-02 did not have an effect on the timing or amount of periodic lease expense recognized in net income.  The adoption of ASU No. 2016-02 did not have a material effect on the Company’s consolidated financial statements.

 

 

 

 

7


 

Standard

Description

Date of

Adoption

Effect on the Consolidated

Financial Statements

ASU No. 2017-08, Premium Amortization of

Purchased Callable Debt Securities (Subtopic 310-20)

This amendment requires purchase premiums for investments in debt securities that are noncontingently callable by the issuer (at a fixed price and preset date) to be amortized to the earliest call date. Previously, purchase premiums for such investments were permitted to be amortized to the instrument’s maturity date.

 

January 1, 2019

 

 

Investments in prepayable financial assets, such as residential MBS, for which the embedded call options are not held by the issuer are not within the scope of ASU No. 2017-08. Accordingly, the adoption of ASU No. 2017-08 did not have an effect on the Company’s consolidated financial statements.

 

 

 

 

ASU No. 2017-12, Targeted Improvements to Accounting for Hedging Activities (Topic 815)

This update made several targeted amendments to existing GAAP with the objectives of facilitating (i) financial reporting that more closely reflects entities’ risk management strategies and (ii) greater ease of understanding and interpreting the effects of hedge accounting on an entities’ reported results.

January 1, 2019

Hedge accounting pursuant to GAAP is an elective, rather than a required, accounting model.  The Company does not elect to apply hedge accounting.  The adoption of ASU No. 2017-12 did not have an effect on the Company’s consolidated financial statements.

 

 

 

 

Recently Issued Accounting Guidance Not Yet Adopted

 

 

 

 

ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 606)

The amendments in this update require financial assets measured at amortized cost as well as available-for-sale debt securities to be measured for impairment on the basis of the net amount expected to be collected.  Credit losses are to be recognized through an allowance for credit losses, which differs from the direct write-down of the amortized cost basis currently required for other-than-temporary impairments of investments in debt securities.  This update also makes substantial changes to the manner in which interest income is to be recognized for financial assets acquired with a more-than-insignificant amount of credit deterioration since origination.

 

This update will not affect the accounting for investments in debt securities that are classified as trading securities.

January 1, 2020

As of September 30, 2019, all of the Company’s investments in debt securities are classified as trading securities. Accordingly, the Company does not expect ASU No. 2016-13 to have a material impact on its consolidated financial statements.

 

 

Note 3. Investments in Agency MBS

The Company’s investments in agency MBS are reported in the accompanying consolidated balance sheets at fair value. As of September 30, 2019 and December 31, 2018, the Company had $4,013,161 and $3,982,106, respectively, of fair value in agency MBS classified as trading securities. As of September 30, 2019, all the Company’s investments in agency MBS represent undivided (or “pass-through”) beneficial interests in specified pools of fixed-rate mortgage loans.

 

8


 

All periodic changes in the fair value of trading agency MBS that are not attributed to interest income are recognized as a component of “investment gain (loss), net” in the accompanying consolidated statements of comprehensive income. The following table provides additional information about the gains and losses recognized as a component of “investment gain (loss), net” in the Company’s consolidated statements of comprehensive income for the periods indicated with respect to investments in agency MBS classified as trading securities:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Net gains (losses) recognized in earnings for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency MBS still held at period end

 

$

12,576

 

 

$

(29,744

)

 

$

62,220

 

 

$

(103,536

)

Agency MBS sold during the period

 

 

4,315

 

 

 

(8,113

)

 

 

66,076

 

 

 

(43,547

)

Total

 

$

16,891

 

 

$

(37,857

)

 

$

128,296

 

 

$

(147,083

)

 

The Company also invests in and finances fixed-rate agency MBS on a generic pool basis through sequential series of to-be-announced security transactions commonly referred to as “dollar rolls.” Dollar rolls are accounted for as a sequential series of derivative instruments. Refer to “Note 5. Derivative Instruments” for further information about dollar rolls.

 

 

Note 4. Borrowings

Repurchase Agreements

The Company finances the purchase of MBS through repurchase agreements, which are accounted for as collateralized borrowing arrangements. In a repurchase transaction, the Company sells MBS to a counterparty under a master repurchase agreement in exchange for cash and concurrently agrees to repurchase the same security at a future date in an amount equal to the cash initially exchanged plus an agreed-upon amount of interest. MBS sold under agreements to repurchase remain on the Company’s consolidated balance sheets because the Company maintains effective control over such securities throughout the duration of the arrangement. Throughout the contractual term of a repurchase agreement, the Company recognizes a “repurchase agreement” liability on its consolidated balance sheets to reflect the obligation to repay to the counterparty the proceeds received upon the initial transfer of the MBS. The difference between the proceeds received by the Company upon the initial transfer of the MBS and the contractually agreed-upon repurchase price is recognized as interest expense ratably over the term of the repurchase arrangement.

Amounts borrowed pursuant to repurchase agreements are equal in value to a specified percentage of the fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral throughout the term of the repurchase agreement. The counterparty to the repurchase agreements may require that the Company pledge additional securities or cash as additional collateral to secure borrowings when the value of the collateral declines.

As of September 30, 2019 and December 31, 2018, the Company had no amount at risk with a single repurchase agreement counterparty or lender greater than 10% of equity. The following table provides information regarding the Company’s outstanding repurchase agreement borrowings as of the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

Pledged with agency MBS:

 

 

 

 

 

 

 

 

Repurchase agreements outstanding

 

$

3,697,906

 

 

$

3,721,629

 

Agency MBS collateral, at fair value

 

 

3,891,308

 

 

 

3,931,232

 

Net amount (1)

 

 

193,402

 

 

 

209,603

 

Weighted-average rate

 

 

2.35

%

 

 

2.72

%

Weighted-average term to maturity

 

22.2 days

 

 

17.3 days

 

 

(1)

Net amount represents the value of collateral in excess of corresponding repurchase obligation. The amount of collateral at-risk is limited to the outstanding repurchase obligation and not the entire collateral balance.

 

9


 

The following table provides information regarding the Company’s outstanding repurchase agreement borrowings during the three and nine months ended September 30, 2019 and 2018:

 

 

 

September 30, 2019

 

 

September 30, 2018

 

Weighted-average outstanding balance during the three months ended

 

$

3,609,519

 

 

$

3,841,280

 

Weighted-average rate during the three months ended

 

 

2.46

%

 

 

2.17

%

Weighted-average outstanding balance during the nine months ended

 

$

3,672,844

 

 

$

3,730,460

 

Weighted-average rate during the nine months ended

 

 

2.59

%

 

 

1.93

%

Long-Term Unsecured Debt

As of September 30, 2019 and December 31, 2018, the Company had $74,272 and $74,104, respectively, of outstanding long-term unsecured debentures, net of unamortized debt issuance costs of $1,028 and $1,196, respectively. The Company’s long-term debentures consisted of the following as of the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

 

 

Senior

Notes Due 2025

 

 

Senior

Notes Due 2023

 

 

Trust

Preferred Debt

 

 

Senior

Notes Due 2025

 

 

Senior

Notes Due 2023

 

 

Trust

Preferred Debt

 

Outstanding Principal

 

$

35,300

 

 

$

25,000

 

 

$

15,000

 

 

$

35,300

 

 

$

25,000

 

 

$

15,000

 

Annual Interest Rate

 

 

6.75

%

 

 

6.625

%

 

LIBOR+

2.25 - 3.00 %

 

 

 

6.75

%

 

 

6.625

%

 

LIBOR+

2.25 - 3.00 %

 

Interest Payment Frequency

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

Weighted-Average Interest Rate

 

 

6.75

%

 

 

6.625

%

 

 

5.05

%

 

 

6.75

%

 

 

6.625

%

 

 

5.19

%

Maturity

 

March 15, 2025

 

 

May 1, 2023

 

 

2033 - 2035

 

 

March 15, 2025

 

 

May 1, 2023

 

 

2033 - 2035

 

Early Redemption Date

 

March 15, 2018

 

 

May 1, 2016

 

 

2008 - 2010

 

 

March 15, 2018

 

 

May 1, 2016

 

 

2008 - 2010

 

 

The Senior Notes due 2023 and the Senior Notes due 2025 are publicly traded on the New York Stock Exchange under the ticker symbols “AIW” and “AIC,” respectively. The Senior Notes due 2023 and Senior Notes due 2025 may be redeemed in whole or in part at any time and from time to time at the Company’s option at a redemption price equal to the principal amount plus accrued and unpaid interest. The indenture governing these Senior Notes contains certain covenants, including limitations on the Company’s ability to merge or consolidate with other entities or sell or otherwise dispose of all or substantially all of the Company’s assets.

 

 

Note 5. Derivative Instruments

In the normal course of its operations, the Company is a party to financial instruments that are accounted for as derivative instruments. Derivative instruments are recorded at fair value as either “derivative assets” or “derivative liabilities” in the consolidated balance sheets, with all periodic changes in fair value reflected as a component of “investment gain (loss), net” in the consolidated statements of comprehensive income. Cash receipts or payments related to derivative instruments are classified as investing activities within the consolidated statements of cash flows.

Types and Uses of Derivative Instruments

Interest Rate Hedging Instruments

The Company is party to interest rate hedging instruments that are intended to economically hedge changes, attributable to changes in benchmark interest rates, in certain MBS fair values and future interest cash flows on the Company’s short-term financing arrangements. Interest rate hedging instruments include centrally cleared interest rate swaps, exchange-traded instruments, such as U.S. Treasury note futures, Eurodollar futures, interest rate swap futures and options on futures, and non-exchange-traded instruments such as options on agency MBS. While the Company uses its interest rate hedging instruments to economically hedge a portion of its interest rate risk, it has not designated such contracts as hedging instruments for financial reporting purposes.

The Company exchanges cash “variation margin” with the counterparties to its interest rate hedging instruments at least on a daily basis based upon daily changes in fair value as measured by the Chicago Mercantile Exchange (“CME”), the central clearinghouse through which those instruments are cleared. In addition, the CME requires market participants to deposit and maintain an “initial margin” amount which is determined by the CME and is generally intended to be set at a level sufficient to protect the CME from the maximum estimated single-day price movement in that market participant’s contracts. However, futures commission merchants may require “initial margin” in excess of the CME’s requirement.

10


 

Receivables recognized for the right to reclaim cash initial margin posted in respect of interest rate hedging instruments are included in the line item “deposits” in the accompanying consolidated balance sheets.

The daily exchange of variation margin associated with a centrally cleared or exchange-traded hedging instrument is legally characterized as the daily settlement of the instrument itself, as opposed to a pledge of collateral. Accordingly, the Company accounts for the daily receipt or payment of variation margin associated with its interest rate swaps and futures as a direct reduction to the carrying value of the derivative asset or liability, respectively. The carrying amount of interest rate swaps and futures reflected in the Company’s consolidated balance sheets is equal to the unsettled fair value of such instruments; because variation margin is exchanged on a one-day lag, the unsettled fair value of such instruments generally represents the change in fair value that occurred on the last day of the reporting period.

To-Be-Announced Agency MBS Transactions, Including “Dollar Rolls”

In addition to interest rate hedging instruments that are used for interest rate risk management, the Company is a party to derivative instruments that economically serve as investments, such as forward commitments to purchase fixed-rate “pass-through” agency MBS on a non-specified pool basis, which are known as to-be-announced (“TBA”) securities. A TBA security is a forward commitment for the purchase or sale of a fixed-rate agency MBS at a predetermined price, face amount, issuer, coupon, and stated maturity for settlement on an agreed upon future date. The specific agency MBS that will be delivered to satisfy the TBA trade is not known at the inception of the trade. The specific agency MBS to be delivered is determined 48 hours prior to the settlement date. The Company accounts for TBA securities as derivative instruments because the Company cannot assert that it is probable at inception and throughout the term of an individual TBA commitment that its settlement will result in physical delivery of the underlying agency MBS, or the individual TBA commitment will not settle in the shortest time period possible.

The Company’s agency MBS investment portfolio includes net purchase (or “net long”) positions in TBA securities, which are primarily the result of executing sequential series of “dollar roll” transactions. The Company executes dollar roll transactions as a means of investing in and financing non-specified fixed-rate agency MBS. Such transactions involve effectively delaying (or “rolling”) the settlement of a forward purchase of a TBA agency MBS by entering into an offsetting sale with the same counterparty prior to the settlement date, net settling the “paired-off” positions in cash, and contemporaneously entering, with the same counterparty, another forward purchase of a TBA agency MBS of the same characteristics for a later settlement date. TBA securities purchased for a forward settlement month are generally priced at a discount relative to TBA securities sold for settlement in the current month. This discount, often referred to as the dollar roll “price drop,” reflects compensation for the net interest income (interest income less financing costs) that is foregone as a result of relinquishing beneficial ownership of the MBS for the duration of the dollar roll (also known as “dollar roll income”). By executing a sequential series of dollar roll transactions, the Company is able to create the economic experience of investing in an agency MBS, financed with a repurchase agreement, over a period of time. Forward purchases and sales of TBA securities are accounted for as derivative instruments in the Company’s financial statements. Accordingly, dollar roll income is recognized as a component of “investment gain (loss), net” along with all other periodic changes in the fair value of TBA commitments.

In addition to transacting in net long positions in TBA securities for investment purposes, the Company may also, from time to time, transact in net sale (or “net short”) positions in TBA securities for the purpose of economically hedging a portion of the sensitivity of the fair value of the Company’s investments in agency MBS to changes in interest rates.

Under the terms of these forward commitments, the daily exchange of variation margin may occur based on changes in the fair value of the agency MBS commitments if a party to the transaction demands it. Receivables recognized for the right to reclaim cash collateral posted by the Company in respect of TBA transactions is included in the line item “deposits” in the accompanying consolidated balance sheets. Liabilities recognized for the obligation to return cash collateral received by the Company in respect of TBA transactions is included in the line item “other liabilities” in the accompanying consolidated balance sheets.

In addition to TBA transactions, the Company may, from time to time, enter into commitments to purchase or sell specified agency MBS that do not qualify as regular-way security trades. Such commitments are also accounted for as derivative instruments.

11


 

Derivative Instrument Population and Fair Value

The following table presents the fair value of the Company’s derivative instruments as of the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

 

 

Assets

 

 

Liabilities

 

 

Assets

 

 

Liabilities

 

Interest rate swaps

 

$

269

 

 

$

(44

)

 

$

 

 

$

(5,709

)

10-year U.S. Treasury note futures

 

 

 

 

 

 

 

 

 

 

 

(1,250

)

TBA commitments

 

 

406

 

 

 

(680

)

 

 

438

 

 

 

 

Total

 

$

675

 

 

$

(724

)

 

$

438

 

 

$

(6,959

)

 

Interest Rate Swaps

The Company’s interest rate swap agreements represent agreements to make semiannual interest payments based upon a fixed interest rate and receive quarterly variable interest payments based upon the prevailing three-month LIBOR on the date of reset.

 

The following table presents information about the Company’s interest rate swap agreements that were in effect as of September 30, 2019:

 

 

 

 

 

 

 

Weighted-average:

 

 

 

 

 

 

 

Notional Amount

 

 

Fixed Pay Rate

 

 

Variable Receive Rate

 

 

Net Receive (Pay) Rate

 

 

Remaining Life (Years)

 

 

Fair Value

 

Years to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less than 3 years

 

$

2,175,000

 

 

 

1.73

%

 

 

2.19

%

 

 

0.46

%

 

 

1.7

 

 

$

157

 

3 to less than 7 years

 

 

500,000

 

 

 

1.62

%

 

 

2.12

%

 

 

0.50

%

 

 

6.3

 

 

 

68

 

7 to less than 10 years

 

 

300,000

 

 

 

2.85

%

 

 

2.16

%

 

 

(0.69

)%

 

 

9.3

 

 

 

33

 

10 or more years

 

 

25,000

 

 

 

2.96

%

 

 

2.16

%

 

 

(0.80

)%

 

 

28.5

 

 

 

(33

)

Total / weighted-average

 

$

3,000,000

 

 

 

1.83

%

 

 

2.17

%

 

 

0.34

%

 

 

3.4

 

 

$

225

 

 

The following table presents information about the Company’s interest rate swap agreements that were in effect as of December 31, 2018:

 

 

 

 

 

 

 

Weighted-average:

 

 

 

 

 

 

 

Notional Amount

 

 

Fixed Pay Rate

 

 

Variable Receive Rate

 

 

Net Receive

(Pay) Rate

 

 

Remaining Life (Years)

 

 

Fair Value

 

Years to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less than 3 years

 

$

1,050,000

 

 

 

1.53

%

 

 

2.60

%

 

 

1.07

%

 

 

1.5

 

 

$

(152

)

3 to less than 7 years

 

 

325,000

 

 

 

2.00

%

 

 

2.73

%

 

 

0.73

%

 

 

4.4

 

 

 

(432

)

7 to less than 10 years

 

 

1,600,000

 

 

 

2.35

%

 

 

2.70

%

 

 

0.35

%

 

 

8.5

 

 

 

(4,572

)

10 or more years

 

 

125,000

 

 

 

3.02

%

 

 

2.66

%

 

 

(0.36

)%

 

 

29.6

 

 

 

(553

)

Total / weighted-average

 

$

3,100,000

 

 

 

2.07

%

 

 

2.67

%

 

 

0.60

%

 

 

6.6

 

 

$

(5,709

)

 

U.S. Treasury Note Futures

The Company may purchase or sell exchange-traded U.S. Treasury note futures with the objective of economically hedging a portion of its interest rate risk. Upon the maturity date of these futures contracts, the Company has the option to either net settle each contract in cash in an amount equal to the difference between the then-current fair value of the underlying U.S. Treasury note and the contractual sale price inherent to the futures contract, or to physically settle the contract by delivering the underlying U.S. Treasury note.

As of September 30, 2019, the Company held no U.S. Treasury note futures. As of December 31, 2018, the Company held short positions of 10-year U.S. Treasury note futures with an aggregate notional amount of $320,000 with a maturity date in March 2019.

Options on 10-year U.S. Treasury Note Futures

The Company may purchase or sell exchange-traded options on 10-year U.S. Treasury note futures contracts with the objective of economically hedging a portion of the sensitivity of its investments in agency MBS to significant changes in interest rates. The Company may purchase put options which provide the Company with the right to sell 10-year U.S. Treasury note futures to a

12


 

counterparty, and the Company may also write call options that provide a counterparty with the option to buy 10-year U.S. Treasury note futures from the Company. In order to limit its exposure on its interest rate derivative instruments from a significant decline in long-term interest rates, the Company may also purchase contracts that provide the Company with the option to buy, or call, 10-year U.S. Treasury note futures from a counterparty. The options may be exercised at any time prior to their expiry, and if exercised, may be net settled in cash or through physical receipt or delivery of the underlying futures contracts.

As of September 30, 2019 and December 31, 2018, the Company had no outstanding options on 10-year U.S. Treasury note futures contracts.

TBA Commitments

The following tables present information about the Company’s TBA commitments as of the dates indicated:

 

 

 

September 30, 2019

 

 

 

Notional Amount:

Purchase (Sale)

Commitment

 

 

Contractual Forward Price

 

 

Market Price

 

 

Fair Value

 

2.5% 30-year MBS purchase commitments

 

$

100,000

 

 

$

100,273

 

 

$

99,593

 

 

$

(680

)

3.0% 30-year MBS purchase commitments

 

 

100,000

 

 

 

101,547

 

 

 

101,563

 

 

 

16

 

3.0% 30-year MBS sale commitments

 

 

(100,000

)

 

 

(101,953

)

 

 

(101,563

)

 

 

390

 

Total TBA commitments, net

 

$

100,000

 

 

$

99,867

 

 

$

99,593

 

 

$

(274

)

 

 

 

December 31, 2018

 

 

 

Notional Amount:

Purchase (Sale)

Commitment

 

 

Contractual Forward Price

 

 

Market Price

 

 

Fair Value

 

5.0% 30-year MBS purchase commitments

 

$

100,000

 

 

$

103,750

 

 

$

104,047

 

 

$

297

 

5.0% 30-year MBS sale commitments

 

 

(100,000

)

 

 

(104,188

)

 

 

(104,047

)

 

 

141

 

Total TBA commitments, net

 

$

 

 

$

(438

)

 

$

 

 

$

438

 

 

Derivative Instrument Gains and Losses

The following tables provide information about the derivative gains and losses recognized within the periods indicated:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Interest rate derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net interest income (1)

$

4,445

 

 

$

2,295

 

 

$

12,961

 

 

$

3,962

 

Unrealized (losses) gains, net

 

(18,087

)

 

 

11,386

 

 

 

(100,337

)

 

 

66,023

 

(Losses) gains realized upon early termination, net

 

(11,992

)

 

 

17,567

 

 

 

(67,181

)

 

 

38,050

 

Total interest rate swap (losses) gains, net

 

(25,634

)

 

 

31,248

 

 

 

(154,557

)

 

 

108,035

 

U.S. Treasury note futures, net

 

(2,696

)

 

 

8,691

 

 

 

(16,421

)

 

 

27,171

 

Options on U.S. Treasury note futures, net

 

 

 

 

 

 

 

76

 

 

 

 

Total interest rate derivative (losses) gains, net

 

(28,330

)

 

 

39,939

 

 

 

(170,902

)

 

 

135,206

 

TBA and specified agency MBS commitments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TBA dollar roll income (2)

 

923

 

 

 

4,604

 

 

 

4,338

 

 

 

17,989

 

Other gains (losses) on agency MBS commitments, net

 

2,054

 

 

 

(8,923

)

 

 

16,934

 

 

 

(61,369

)

Total gains (losses) on agency MBS commitments, net

 

2,977

 

 

 

(4,319

)

 

 

21,272

 

 

 

(43,380

)

Total derivative (losses) gains, net

$

(25,353

)

 

$

35,620

 

 

$

(149,630

)

 

$

91,826

 

 

 

(1)

Represents the periodic net interest settlement incurred during the period (often referred to as “net interest carry”). Also includes “price alignment interest” income earned or expense incurred on cumulative variation margin paid or received, respectively, associated with centrally cleared interest rate swap agreements.

 

 

(2)

Represents the price discount of forward-settling TBA purchases relative to a contemporaneously executed “spot” TBA sale, which economically equates to net interest income that is earned ratably over the period beginning on the settlement date of the sale and ending on the settlement date of the forward-settling purchase.

13


 

Derivative Instrument Activity

The following tables summarize the volume of activity, in terms of notional amount, related to derivative instruments for the periods indicated:

  

 

 

For the Three Months Ended September 30, 2019

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled

Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

2,600,000

 

 

$

750,000

 

 

$

(250,000

)

 

$

(100,000

)

 

$

3,000,000

 

2-year U.S. Treasury note futures

 

 

 

 

 

139,000

 

 

 

(139,000

)

 

 

 

 

 

 

10-year U.S. Treasury note futures

 

 

155,000

 

 

 

 

 

 

(155,000

)

 

 

 

 

 

 

Commitments to purchase (sell) MBS, net

 

 

550,000

 

 

 

900,000

 

 

 

(1,350,000

)

 

 

 

 

 

100,000

 

 

 

 

For the Three Months Ended September 30, 2018

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

3,325,000

 

 

$

750,000

 

 

$

 

 

$

(600,000

)

 

$

3,475,000

 

10-year U.S. Treasury note futures

 

 

700,000

 

 

 

700,000

 

 

 

(700,000

)

 

 

 

 

 

700,000

 

Commitments to purchase (sell) MBS, net

 

 

1,100,000

 

 

 

3,050,000

 

 

 

(3,400,000

)

 

 

 

 

 

750,000

 

 

 

 

For the Nine Months Ended September 30, 2019

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled

Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

3,100,000

 

 

$

1,800,000

 

 

$

(250,000

)

 

$

(1,650,000

)

 

$

3,000,000

 

2-year U.S. Treasury note futures

 

 

 

 

 

139,000

 

 

 

(139,000

)

 

 

 

 

 

 

10-year U.S. Treasury note futures

 

 

320,000

 

 

 

826,600

 

 

 

(885,000

)

 

 

(261,600

)

 

 

 

Sold call options on 10-year U.S. Treasury note futures

 

 

 

 

 

250,000

 

 

 

(250,000

)

 

 

 

 

 

 

Purchased call options on 10-year U.S. Treasury note

  futures

 

 

 

 

 

500,000

 

 

 

(500,000

)

 

 

 

 

 

 

Commitments to purchase (sell) MBS, net

 

 

 

 

 

5,620,000

 

 

 

(5,520,000

)

 

 

 

 

 

100,000

 

 

 

 

For the Nine Months Ended September 30, 2018

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

3,600,000

 

 

$

1,300,000

 

 

$

 

 

$

(1,425,000

)

 

$

3,475,000

 

5-year U.S. Treasury note futures

 

 

21,600

 

 

 

 

 

 

(21,600

)

 

 

 

 

 

 

10-year U.S. Treasury note futures

 

 

650,000

 

 

 

2,550,000

 

 

 

(2,500,000

)

 

 

 

 

 

700,000

 

Commitments to purchase (sell) MBS, net

 

 

1,265,000

 

 

 

11,170,000

 

 

 

(11,685,000

)

 

 

 

 

 

750,000

 

 

Cash Collateral Posted and Received for Derivative and Other Financial Instruments

The following table presents information about the cash collateral posted and received by the Company in respect of its derivative and other financial instruments, which is included in the line item “deposits, net” in the accompanying consolidated balance sheets, for the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

Cash collateral posted for:

 

 

 

 

 

 

 

 

Interest rate swaps (cash initial margin)

 

$

42,506

 

 

$

54,883

 

U.S. Treasury note futures (cash initial margin)

 

 

 

 

 

6,169

 

Unsettled MBS trades and TBA commitments, net

 

 

792

 

 

 

 

Total cash collateral posted, net

 

$

43,298

 

 

$

61,052

 

 

As of December 31, 2018, the Company had received $438 of cash collateral in respect of its forward-settling TBA commitments. The Company recognized a corresponding obligation to return this cash collateral to its counterparties, which is included in the line item “other liabilities” in the accompanying consolidated balance sheets.

 

 

14


 

Note 6. Offsetting of Financial Assets and Liabilities

The agreements that govern certain of the Company’s derivative instruments and collateralized short-term financing arrangements provide for a right of setoff in the event of default or bankruptcy with respect to either party to such transactions. The Company presents derivative assets and liabilities as well as collateralized short-term financing arrangements on a gross basis.

Receivables recognized for the right to reclaim cash initial margin posted in respect of interest rate derivative instruments are included in the line item “deposits” in the accompanying consolidated balance sheets.

The daily exchange of variation margin associated with a centrally cleared or exchange-traded derivative instrument is legally characterized as the daily settlement of the derivative instrument itself, as opposed to a pledge of collateral. Accordingly, the Company accounts for the daily receipt or payment of variation margin associated with its interest rate swaps and futures as a direct reduction to the carrying value of the interest rate swap derivative asset or liability, respectively. The carrying amount of interest rate swaps and futures reflected in the Company’s consolidated balance sheets is equal to the unsettled fair value of such instruments; because variation margin is exchanged on a one-day lag, the unsettled fair value of such instruments generally represents the change in fair value that occurred on the last day of the reporting period.

The following tables present information, as of the dates indicated, about the Company’s derivative instruments, short-term borrowing arrangements, and associated collateral, including those subject to master netting (or similar) arrangements:

 

 

 

As of September 30, 2019

 

 

 

Gross Amount

Recognized

 

 

Amount Offset

in the

Consolidated

Balance Sheets

 

 

Net Amount

Presented in the

Consolidated

Balance Sheets

 

 

Gross Amount Not Offset in the

Consolidated Balance Sheets

 

 

Net

Amount

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial

Instruments (1)

 

 

Cash

Collateral (2)

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

269

 

 

$

 

 

$

269

 

 

$

(44

)

 

$

 

 

$

225

 

TBA commitments

 

 

406

 

 

 

 

 

 

406

 

 

 

 

 

 

 

 

 

406

 

Total derivative instruments

 

 

675

 

 

 

 

 

 

675

 

 

 

(44

)

 

 

 

 

 

631

 

Total assets

 

$

675

 

 

$

 

 

$

675

 

 

$

(44

)

 

$

 

 

$

631

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

44

 

 

$

 

 

$

44

 

 

$

(44

)

 

$

 

 

$

 

TBA commitments

 

 

680

 

 

 

 

 

 

680

 

 

 

 

 

 

(680

)

 

 

 

Total derivative instruments

 

 

724

 

 

 

 

 

 

724

 

 

 

(44

)

 

 

(680

)

 

 

 

Repurchase agreements

 

 

3,697,906

 

 

 

 

 

 

3,697,906

 

 

 

(3,697,906

)

 

 

 

 

 

 

Total liabilities

 

$

3,698,630

 

 

$

 

 

$

3,698,630

 

 

$

(3,697,950

)

 

$

(680

)

 

$

 

15


 

 

 

 

As of December 31, 2018

 

 

 

Gross Amount

Recognized

 

 

Amount Offset

in the

Consolidated

Balance Sheets

 

 

Net Amount

Presented in the

Consolidated

Balance Sheets

 

 

Gross Amount Not Offset in the

Consolidated Balance Sheets

 

 

Net

Amount

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial

Instruments (1)

 

 

Cash

Collateral (2)

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TBA commitments

 

$

438

 

 

$

 

 

$

438

 

 

$

 

 

$

(438

)

 

$

 

Total derivative instruments

 

 

438

 

 

 

 

 

 

438

 

 

 

 

 

 

(438

)

 

 

 

Total assets

 

$

438

 

 

$

 

 

$

438

 

 

$

 

 

$

(438

)

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

5,709

 

 

$

 

 

$

5,709

 

 

$

 

 

$

(5,709

)

 

$

 

10-year U.S. Treasury note futures

 

 

1,250

 

 

 

 

 

 

1,250

 

 

 

 

 

 

(1,250

)

 

 

 

Total derivative instruments

 

 

6,959

 

 

 

 

 

 

6,959

 

 

 

 

 

 

(6,959

)

 

 

 

Repurchase agreements

 

 

3,721,629

 

 

 

 

 

 

3,721,629

 

 

 

(3,721,629

)

 

 

 

 

 

 

Total liabilities

 

$

3,728,588

 

 

$

 

 

$

3,728,588

 

 

$

(3,721,629

)

 

$

(6,959

)

 

$

 

 

(1)

Does not include the fair value amount of financial instrument collateral pledged in respect of repurchase agreements that exceeds the associated liability presented in the consolidated balance sheets.

(2)

Does not include the amount of cash collateral pledged in respect of derivative instruments that exceeds the associated derivative liability presented in the consolidated balance sheets.

 

 

Note 7. Fair Value Measurements

Fair Value of Financial Instruments

The accounting principles related to fair value measurements define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial Accounting Standards Board Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosures, establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels, giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3) as described below:

 

 

Level 1 Inputs - 

Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible by the Company at the measurement date;

 

 

Level 2 Inputs - 

Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly; and

 

 

Level 3 Inputs - 

Unobservable inputs for the asset or liability, including significant judgments made by the Company about the assumptions that a market participant would use.

The Company measures the fair value of the following assets and liabilities:

Mortgage-backed securities

Agency MBS - The Company’s investments in agency MBS are classified within Level 2 of the fair value hierarchy. Inputs to fair value measurements of the Company’s investments in agency MBS include price estimates obtained from third-party pricing services. In determining fair value, third-party pricing services use a market approach. The inputs used in the fair value measurements performed by the third-party pricing services are based upon readily observable transactions for securities with similar characteristics (such as issuer/guarantor, coupon rate, stated maturity, and collateral pool characteristics) occurring on the measurement date. The Company makes inquiries of the third-party pricing sources to understand the significant inputs and assumptions used to determine prices. The Company reviews the various third-party fair value estimates and performs procedures to validate their reasonableness, including comparison to recent trading activity for similar securities and an overall review for consistency with market conditions observed as of the measurement date.

16


 

Derivative instruments

Exchange-traded derivative instruments - Exchange-traded derivative instruments, which include U.S. Treasury note futures, Eurodollar futures, interest rate swap futures, and options on futures, are classified within Level 1 of the fair value hierarchy as they are measured using quoted prices for identical instruments in liquid markets.

Interest rate swaps - Interest rate swaps are classified within Level 2 of the fair value hierarchy. The fair values of the Company’s centrally cleared interest rate swaps are measured using the daily valuations reported by the clearinghouse through which the instrument was cleared. In performing its end-of-day valuations, the clearinghouse constructs forward interest rate curves (for example, three-month LIBOR forward rates) from its specific observations of that day’s trading activity. The clearinghouse uses the applicable forward interest rate curve to develop a market-based forecast of future remaining contractually required cash flows for each interest rate swap. Each market-based cash flow forecast is then discounted using the overnight index swap rate curve (sourced from the Federal Reserve Bank of New York) to determine a net present value amount which represents the instrument’s fair value.

Forward-settling purchases and sales of TBA securities – Forward-settling purchases and sales of TBA securities are classified within Level 2 of the fair value hierarchy. The fair value of each forward-settling TBA contract is measured using price estimates obtained from a third-party pricing service, which are based upon readily observable transaction prices occurring on the measurement date for forward-settling contracts to buy or sell TBA securities with the same guarantor, contractual maturity, and coupon rate for delivery on the same forward settlement date as the commitment under measurement.

Other

Long-term unsecured debt - As of September 30, 2019 and December 31, 2018, the carrying value of the Company’s long-term unsecured debt was $74,272 and $74,104, respectively, net of unamortized debt issuance costs, and consists of Senior Notes and trust preferred debt issued by the Company. The Company’s estimate of the fair value of long-term unsecured debt is $69,168 and $66,562 as of September 30, 2019 and December 31, 2018, respectively. The Company’s Senior Notes, which are publicly traded on the New York Stock Exchange, are classified within Level 1 of the fair value hierarchy. Trust preferred debt is classified within Level 2 of the fair value hierarchy as the fair value is estimated based on the quoted prices of the Company’s publicly traded Senior Notes.

Investments in equity securities of non-public companies and investment funds – As of September 30, 2019 and December 31, 2018, the Company had investment in equity securities and investment funds measured at fair value of $6,239 and $6,115, respectively, which is included in the line item “other assets” in the accompanying consolidated balance sheets. ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (Subtopic 825-10), effective January 1, 2018, requires entities to measure investments in equity securities at fair value, unless fair value measurement is impractical, with changes in fair value recognized in current period earnings. Upon the adoption of ASU No. 2016-01, the Company recognized a cumulative-effect increase of $4,059 (net of taxes) in stockholders’ equity representing, as of January 1, 2018, the excess of fair value over historical cost of its investments in equity securities that were previously carried at their historical cost (net of impairments).

Investments in equity securities and investment funds are classified within Level 3 of the fair value hierarchy. The fair values of the Company’s investments in equity securities and investment funds are not readily determinable. Accordingly, for its investments in equity securities, the Company estimates fair value by estimating the enterprise value of the investee which it then allocates to the investee’s securities in the order of their preference relative to one another. To estimate the enterprise value of the investee, the Company uses traditional valuation methodologies based on income and market approaches, including the consideration of recent investments in, or tender offers for, the equity securities of the investee, a discounted cash flow analysis and a comparable guideline public company valuation. The primary unobservable inputs used in estimating the fair value of an equity security of a non-public company include (i) a stock price to net asset multiple for similar public companies that is applied to the entity’s net assets, (ii) a discount factor for lack of marketability and control, and (iii) a cost of equity discount rate, used to discount to present value the equity cash flows available for distribution and the terminal value of the entity. As of September 30, 2019, the stock price to net asset multiple for similar public companies, the discount factor for lack of marketability and control, and the cost of equity discount rate used as inputs were 95 percent, 9 percent, and 12 percent, respectively. As of December 31, 2018, the stock price to net asset multiple for similar public companies, the discount factor for lack of marketability and control, and the cost of equity discount rate used as inputs were 91 percent, 8 percent, and 12 percent, respectively. For its investments in investment funds, the Company estimates fair value based upon the investee’s net asset value per share.

Financial assets and liabilities for which carrying value approximates fair value - Cash and cash equivalents, deposits, receivables, repurchase agreements, payables, and other assets and liabilities are generally reflected in the consolidated balance sheets at their cost, which, due to the short-term nature of these instruments and their limited inherent credit risk, approximates fair value.

17


 

Fair Value Hierarchy

Financial Instruments Measured at Fair Value on a Recurring Basis

The following tables set forth financial instruments measured at fair value by level within the fair value hierarchy as of September 30, 2019 and December 31, 2018. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

 

 

September 30, 2019

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

MBS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency MBS

 

$

4,013,161

 

 

$

 

 

$

4,013,161

 

 

$

 

Private-label MBS

 

 

25

 

 

 

 

 

 

 

 

 

25

 

Total MBS

 

 

4,013,186

 

 

 

 

 

 

4,013,161

 

 

 

25

 

Derivative assets

 

 

675

 

 

 

 

 

 

675

 

 

 

 

Derivative liabilities

 

 

(724

)

 

 

 

 

 

(724

)

 

 

 

Other assets

 

 

6,239

 

 

 

 

 

 

 

 

 

6,239

 

Total

 

$

4,019,376

 

 

$

 

 

$

4,013,112

 

 

$

6,264

 

 

 

 

December 31, 2018

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

MBS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency MBS

 

$

3,982,106

 

 

$

 

 

$

3,982,106

 

 

$

 

Private-label MBS

 

 

24

 

 

 

 

 

 

 

 

 

24

 

Total MBS

 

 

3,982,130

 

 

 

 

 

 

3,982,106

 

 

 

24

 

Derivative assets

 

 

438

 

 

 

 

 

 

438

 

 

 

 

Derivative liabilities

 

 

(6,959

)

 

 

(1,250

)

 

 

(5,709

)

 

 

 

Other assets

 

 

6,115

 

 

 

 

 

 

 

 

 

6,115

 

Total

 

$

3,981,724

 

 

$

(1,250

)

 

$

3,976,835

 

 

$

6,139

 

 

Level 3 Financial Assets and Liabilities

The table below sets forth an attribution of the change in the fair value of the Company’s Level 3 investments that are measured at fair value on a recurring basis for the periods indicated:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Beginning balance

$

6,052

 

 

$

6,235

 

 

$

6,139

 

 

$

515

 

Investments in equity securities measured at fair value beginning January 1, 2018

 

 

 

 

 

 

 

 

 

 

5,362

 

Included in investment gain (loss), net

 

231

 

 

 

(21

)

 

 

224

 

 

 

343

 

Purchases

 

 

 

 

 

 

 

 

 

 

 

Sales

 

 

 

 

 

 

 

 

 

 

 

Payments, net

 

(23

)

 

 

(46

)

 

 

(118

)

 

 

(66

)

Accretion of discount

 

4

 

 

 

2

 

 

 

19

 

 

 

16

 

Ending balance

$

6,264

 

 

$

6,170

 

 

$

6,264

 

 

$

6,170

 

Net unrealized gains (losses) included in earnings for the

   period for Level 3 assets still held at the reporting date

$

231

 

 

$

(21

)

 

$

239

 

 

$

343

 

 

 

Note 8. Income Taxes

For its tax years ended December 31, 2018 and earlier, Arlington Asset was subject to taxation as a corporation under Subchapter C of the Internal Revenue Code. On December 27, 2018, the Company’s Board of Directors approved a plan for Arlington Asset to elect to be taxed and to operate in a manner that will allow it to qualify as a REIT under the Internal Revenue Code

18


 

commencing with its taxable year ending December 31, 2019. As a REIT, the Company will be required to distribute annually 90% of its REIT taxable income. So long as the Company continues to qualify as a REIT, it will generally not be subject to U.S. Federal or state corporate income taxes on its taxable income to the extent that it distributes all of its annual taxable income to its shareholders on a timely basis. At present, it is the Company’s intention to distribute 100% of its taxable income, although the Company will not be required to do so. The Company intends to make distributions of its taxable income within the time limits prescribed by the Internal Revenue Code, which may extend into the subsequent taxable year.

As of September 30, 2019, the Company had estimated net operating loss (“NOL”) carryforwards of $14,588 that can be used to offset future taxable ordinary income. The Company’s NOL carryforwards begin to expire in 2028. As of September 30, 2019, the Company had estimated net capital loss (“NCL”) carryforwards of $394,447 that can be used to offset future net capital gains. The scheduled expirations of the Company’s NCL carryforwards are $111,177 in 2019, $102,322 in 2020, $66,862 in 2021, $3,763 in 2022 and $110,323 in 2023. If the Company were to use its NOL carryforwards to offset taxable ordinary income and/or use its NCL carryforwards to offset net capital gains, the Company’s required income distribution as a REIT would be reduced accordingly.

Through December 31, 2017, the Company was subject to federal alternative minimum tax (“AMT”) on its taxable income and gains that were not offset by its NOL and NCL carryforwards with any AMT credit carryforwards available to offset future regular tax liabilities. As part of the Tax Cuts and Jobs Act, the corporate AMT was repealed for tax years beginning after December 31, 2017 with any AMT credit carryforward after that date continuing to be available to offset a taxpayer’s future regular tax liability. In addition, for tax years beginning in 2018, 2019 and 2020, to the extent that AMT credit carryforwards exceed the regular tax liability, 50% of the excess AMT credit carryforwards would be refundable in that year with any remaining AMT credit carryforwards fully refundable in 2021. As a result, the realizability of the Company’s AMT credit carryforward is certain and will be realized as either a cash refund or as an offset to future regular tax liabilities or a combination of both. For the 2018 tax year, the Company claimed $4,566 of its AMT credit carryforward as a cash tax refund, which is included as a receivable in “other assets” as of September 30, 2019 on the accompanying consolidated balance sheets.  As of September 30, 2019 and December 31, 2018, the Company had an AMT credit carryforward of $4,566 and $9,132, respectively, included as a receivable in “other assets” on the accompanying consolidated balance sheets.

The Company recognizes uncertain tax positions in the financial statements only when it is more-likely-than-not that the position will be sustained upon examination by the relevant taxing authority based on the technical merits of the position. A position that meets this standard is measured at the largest amount of benefit that will more-likely-than-not be realized upon settlement. A liability is established for differences between positions taken in a tax return and the financial statements. As of September 30, 2019 and December 31, 2018, the Company assessed the need for recording a provision for any uncertain tax position and has made the determination that such provision is not necessary.

 

On May 29, 2018, the Company received an assessment of $9,380 from Arlington County, Virginia for a business, professional and occupation license (“BPOL”) tax for 2018.  The BPOL tax is a local privilege tax on a business’ gross receipts for conducting business activities subject to licensure within Arlington County.  The Company had not been assessed or paid any such BPOL tax prior to 2018.  On June 28, 2018, the Company filed an administrative appeal with Arlington County. On August 1, 2018, the Company received a denial of its administrative appeal from Arlington County and, subsequently, the Company filed an administrative appeal with the Tax Commissioner of Virginia (the “Tax Commissioner”) on September 27, 2018.  On June 21, 2019, the Company received a determination from the Tax Commissioner stating that he believes the Company is engaged in a licensable privilege subject to the BPOL tax. However, the Tax Commissioner determined that certain of the Company’s gross receipts are exempt from BPOL taxation.  The Tax Commissioner requested that Arlington County revise its initial BPOL tax assessment to exclude these certain gross receipts from its tax calculation.  On August 21, 2019 the Company received a revised 2019 BPOL tax assessment of $471 as well as a 2018 BPOL tax assessment of $488, including interest charges, from Arlington County both of which the Company paid on September 3, 2019.  In the third quarter of 2019, the Company recognized an expense of $842 in “other general and administrative expense” which represents the 2018 BPOL tax (and associated interest) and the 2019 BPOL tax incurred through September 30, 2019.  The Company retains the right to appeal the Tax Commissioner’s determination through June of 2020. BPOL tax years 2016 and 2017 remain subject to examination by Arlington County, although the county has previously informally indicated that it did not intend to pursue assessments for those years at such time.   

 

 

19


 

Note 9. Earnings (Loss) Per Share

Basic earnings (loss) per share includes no dilution and is computed by dividing net income or loss applicable to common stock by the weighted-average number of common shares outstanding for the respective period. Diluted earnings per share includes the impact of dilutive securities such as unvested shares of restricted stock and performance share units. The following tables present the computations of basic and diluted earnings (loss) per share for the periods indicated:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(Shares in thousands)

2019

 

 

2018

 

 

2019

 

 

2018

 

Basic weighted-average common shares outstanding

 

36,572

 

 

 

29,382

 

 

 

35,399

 

 

 

28,601

 

Performance share units and unvested restricted stock

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted-average common shares outstanding

 

36,572

 

 

 

29,382

 

 

 

35,399

 

 

 

28,601

 

Net loss attributable to common stock

$

(8,511

)

 

$

(5,652

)

 

$

(15,494

)

 

$

(65,929

)

Basic loss per common share

$

(0.23

)

 

$

(0.19

)

 

$

(0.44

)

 

$

(2.31

)

Diluted loss per common share

$

(0.23

)

 

$

(0.19

)

 

$

(0.44

)

 

$

(2.31

)

 

 The diluted loss per share for the three and nine months ended September 30, 2019 did not include the antidilutive effect of 179,464 and 125,403 shares of unvested shares of restricted stock and performance share units, respectively. The diluted loss per share for the three and nine months ended September 30, 2018 did not include the antidilutive effect of 335,491 and 273,979 shares of unvested shares of restricted stock and performance share units, respectively.

 

 

Note 10. Stockholders’ Equity

Common Stock

The Company has authorized common share capital of 450,000,000 shares of Class A common stock, par value $0.01 per share, and 100,000,000 shares of Class B common stock, par value $0.01 per share. Holders of the Class A and Class B common stock are entitled to one vote and three votes per share, respectively, on all matters voted upon by the shareholders. Shares of Class B common stock are convertible into shares of Class A common stock on a one-for-one basis at the option of the Company in certain circumstances including either (i) upon sale or other transfer, or (ii) at the time the holder of such shares of Class B common stock ceases to be employed by the Company. As of September 30, 2019 and December 31, 2018, there were no outstanding shares of Class B common stock. The Class A common stock is publicly traded on the New York Stock Exchange under the ticker symbol “AI.”

Common Stock Dividends

The Board of Directors evaluates common stock dividends on a quarterly basis and, in its sole discretion, approves the payment of dividends. The Company’s common stock dividend payments, if any, may vary significantly from quarter to quarter. The Board of Directors has approved and the Company declared and paid the following dividends on its common stock to date in 2019:

 

Quarter Ended

 

Dividend

Amount

 

 

Declaration Date

 

Record Date

 

Pay Date

September 30

 

$

0.225

 

 

September 17

 

September 30

 

October 31

June 30

 

 

0.225

 

 

June 24

 

July 5

 

July 31

March 31

 

 

0.375

 

 

March 18

 

March 29

 

April 30

 

The Board of Directors approved and the Company declared and paid the following dividends for 2018:

 

Quarter Ended

 

Dividend

Amount

 

 

Declaration Date

 

Record Date

 

Pay Date

December 31

 

$

0.375

 

 

December 13

 

December 31

 

January 31, 2019

September 30

 

 

0.375

 

 

September 13

 

September 28

 

October 31

June 30

 

 

0.375

 

 

June 14

 

June 29

 

July 31

March 31

 

 

0.550

 

 

March 15

 

March 29

 

April 30

20


 

Common Equity Offerings

 

On February 22, 2019, the Company completed a public offering in which 6,000,000 shares of its Class A common stock were sold at a price of $8.16 per share for proceeds net of offering expenses of $48,827.

Common Equity Distribution Agreements

 

   On February 22, 2017, the Company entered into separate common equity distribution agreements (the “Equity Distribution Agreements”) with equity sales agents JMP Securities LLC, FBR Capital Markets & Co., JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. pursuant to which the Company may offer and sell, from time to time, up to 6,000,000 shares of the Company’s Class A common stock. On August 10, 2018, the Company entered into separate amendments to the Equity Distribution Agreements (the “Amended Equity Distribution Agreements”) with equity sales agents JMP Securities LLC, B. Riley FBR, Inc. (formerly, FBR Capital Markets & Co.), JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. pursuant to which the Company may offer and sell, from time to time, up to 12,597,423 shares of the Company’s Class A common stock.

Pursuant to the common equity distribution agreements, shares of the Company’s common stock may be offered and sold through the equity sales agents in transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange or, subject to the terms of a written notice from the Company, in privately negotiated transactions.

The following table provides information about the issuances of common stock under the common equity distribution agreements for the periods indicated:

 

Class A Common Stock Issuances

 

Year Ended

December 31, 2018

 

Shares issued

 

 

2,226,557

 

Weighted average public offering price

 

$

10.19

 

Net proceeds (1)

 

$

22,326

 

 

 

(1)

Net of selling commissions and expenses.

As of September 30, 2019, the Company had 11,302,160 shares of Class A common stock available for sale under the Amended Equity Distribution Agreements.

Common Share Repurchase Program

 

The Company’s Board of Directors authorized a share repurchase program pursuant to which the Company may repurchase up to 2,000,000 shares of Class A common stock (the “Repurchase Program”). Repurchases under the Repurchase Program may be made from time to time on the open market and in private transactions at management’s discretion in accordance with applicable federal securities laws. The timing of repurchases and the exact number of shares of Class A common stock to be repurchased will depend upon market conditions and other factors. The Repurchase Program is funded using the Company’s cash on hand and cash generated from operations. The Repurchase Program has no expiration date and may be suspended or terminated at any time without prior notice. There were no shares repurchased by the Company under the Repurchase Program during the three and nine months ended September 30, 2019 and the year ended December 31, 2018. As of September 30, 2019, there remain available for repurchase 1,951,305 shares of Class A common stock under the Repurchase Program.

21


 

Preferred Stock

The Company has authorized preferred share capital of (i) 100,000 shares designated as Series A Preferred Stock that is unissued; (ii) 2,000,000 shares designated as 7.00% Series B Cumulative Perpetual Redeemable Preferred Stock (the “Series B Preferred Stock”), par value of $0.01 per share; (iii) 2,500,000 shares designated as 8.250% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (the “Series C Preferred Stock”), par value of $0.01 per share; and (iv) 20,400,000 shares of undesignated preferred stock. The Company’s Board of Directors has the authority, without further action by the shareholders, to issue additional preferred stock in one or more series and to fix the terms and rights of the preferred stock. The Company’s preferred stock ranks senior to its common stock with respect to the payment of dividends and the distribution of assets upon a voluntary or involuntary liquidation, dissolution, or winding up of the Company. The Company’s preferred stock ranks on parity with each other.  The Series B Preferred Stock and Series C Preferred Stock are publicly traded on the New York Stock Exchange under the ticker symbols “AI PrB” and “AI PrC,” respectively.

The Series B Preferred Stock has no stated maturity, is not subject to any sinking fund and will remain outstanding indefinitely unless repurchased or redeemed by the Company. Holders of Series B Preferred Stock have no voting rights, except under limited conditions, and are entitled to receive a cumulative cash dividend at a rate of 7.00% per annum of their $25.00 per share liquidation preference (equivalent to $1.75 per annum per share). Shares of Series B Preferred Stock are redeemable at $25.00 per share, plus accumulated and unpaid dividends (whether or not authorized or declared), exclusively at the Company’s option commencing on May 12, 2022 or earlier upon the occurrence of a change in control. Dividends are payable quarterly in arrears on the 30th day of March, June, September and December of each year, when and as declared. We have declared and paid all required quarterly dividends on the Company’s Series B Preferred Stock to date in 2019.

On March 12, 2019, the Company completed an initial public offering in which 1,200,000 shares of its Series C Preferred Stock were issued to the public at a public offering price of $25.00 per share for proceeds net of underwriting discounts and commissions and expenses of $28,944.

The Series C Preferred Stock has no stated maturity, is not subject to any sinking fund and will remain outstanding indefinitely unless repurchased or redeemed by the Company. Holders of Series C Preferred Stock have no voting rights, except under limited conditions, and are entitled to receive a cumulative cash dividend (i) from and including the original issue date to, but excluding, March 30, 2024 at a fixed rate equal to 8.250% per annum of the $25.00 per share liquidation preference (equivalent to $2.0625 per annum per share) and (ii) from and including March 30, 2024, at a floating rate equal to three-month LIBOR plus a spread of 5.664% per annum of the $25.00 per share liquidation preference. Shares of Series C Preferred Stock are redeemable at $25.00 per share, plus accumulated and unpaid dividends (whether or not authorized or declared), exclusively at the Company’s option commencing on March 30, 2024 or earlier upon the occurrence of a change in control or under circumstances where it is necessary to preserve the Company’s qualification as a REIT. Under certain circumstances upon a change of control, the Series C Preferred Stock is convertible into shares of the Company’s common stock. Dividends will be payable quarterly in arrears on the 30th day of March, June, September and December of each year, when and as declared, beginning on June 30, 2019. The first dividend of $0.61875 per share, paid on July 1, 2019, was considered a long first dividend period from the original date of issuance. We have declared and paid all required quarterly dividends on the Company’s Series C Preferred Stock to date in 2019.  

 

Preferred Equity Distribution Agreements

On May 16, 2017, the Company entered into an equity distribution agreement (the “Series B Preferred Equity Distribution Agreement”) with JonesTrading Institutional Services LLC, pursuant to which the Company may offer and sell, from time to time, up to 1,865,000 shares of the Company’s Series B Preferred Stock. On March 21, 2019, the Company entered into an amended and restated equity distribution agreement (“Amended Series B Preferred Equity Distribution Agreement”) with JonesTrading Institutional Services LLC, B. Riley FBR, Inc., Compass Point Research and Trading, LLC and Ladenburg Thalmann & Co. Inc. (collectively, the “Series B Preferred Equity Agents”), pursuant to which the Company may offer and sell, from time to time, up to 1,647,370 shares of the Company’s Series B Preferred Stock.  Pursuant to the Amended Series B Preferred Equity Distribution Agreement, shares of the Company’s Series B Preferred stock may be offered and sold through the Series B Preferred Equity Sales Agents in transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange or, subject to the terms of a written notice from the Company, in privately negotiated transactions.

The following table provides information about the issuances of preferred stock under the preferred equity distribution agreements for the periods indicated:

 

22


 

Series B Preferred Stock Issuances

 

Nine Months Ended September 30, 2019

 

 

Year Ended

December 31, 2018

 

Shares issued

 

 

3,444

 

 

 

47,304

 

Weighted average public offering price

 

$

22.39

 

 

$

24.75

 

Net proceeds (1)

 

$

76

 

 

$

1,137

 

 

 

(1)

Net of selling commissions and expenses.

As of September 30, 2019, the Company had 1,645,961 shares of Series B Preferred stock available for sale under the Amended Series B Preferred Equity Distribution Agreement.

 

 

Shareholder Rights Agreement

On June 1, 2009, the Board of Directors approved a shareholder rights agreement (“Rights Plan”) and the Company’s shareholders approved the Rights Plan at its annual meeting of shareholders on June 2, 2010.  On April 9, 2018, the Board of Directors approved a first amendment to the Rights Plan (“First Amendment”) to extend the term for an additional three years and the Company’s shareholders approved the First Amendment at its annual meeting of shareholders on June 14, 2018.  

Under the terms of the Rights Plan, in general, if a person or group acquires or commences a tender or exchange offer for beneficial ownership of 4.9% or more of the outstanding shares of our Class A common stock upon a determination by our Board of Directors (an “Acquiring Person”), all of our other Class A and Class B common shareholders will have the right to purchase securities from us at a discount to such securities’ fair market value, thus causing substantial dilution to the Acquiring Person.

The Board of Directors adopted the Rights Plan in an effort to protect against a possible limitation on the Company’s ability to use its NOL carryforwards, NCL carryforwards, and built-in losses under Sections 382 and 383 of the Code. The Company’s ability to use its NOLs, NCLs and built-in losses would be limited if it experienced an “ownership change” under Section 382 of the Code. In general, an “ownership change” would occur if there is a cumulative change in the ownership of the Company’s common stock of more than 50% by one or more “5% shareholders” during a three-year period. The Rights Plan was adopted to dissuade any person or group from acquiring 4.9% or more of the Company’s outstanding Class A common stock, each, an Acquiring Person, without the approval of the Board of Directors and triggering an “ownership change” as defined by Section 382.

The Rights Plan, as amended, and any outstanding rights will expire at the earliest of (i) June 4, 2022, (ii) the time at which the rights are redeemed or exchanged pursuant to the Rights Plan, (iii) the repeal of Section 382 and 383 of the Code or any successor statute if the Board of Directors determines that the Rights Plan is no longer necessary for the preservation of the applicable tax benefits, or (iv) the beginning of a taxable year to which the Board of Directors determines that no applicable tax benefits may be carried forward.

23


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Unless the context otherwise requires or provides, references in this Quarterly Report on Form 10-Q to “we,” “us,” “our” and the “Company” refer to Arlington Asset Investment Corp. (“Arlington Asset”) and its subsidiaries. This discussion and analysis should be read in conjunction with our financial statements and accompanying notes included in Item 1 of this Quarterly Report on Form 10-Q, as well as our audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2018.

The discussion of our consolidated financial condition and results of operations below may contain forward-looking statements. These statements, which reflect management’s beliefs and expectations, are subject to risks and uncertainties that may cause actual results to differ materially. For a discussion of the risks and uncertainties that may affect our future results, please see “Cautionary Statement About Forward-Looking Information” in Item 3 of Part I of this Quarterly Report on Form 10-Q and the risk factors included in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2018.

Our Company

We are an investment firm that focuses on acquiring and holding a levered portfolio of residential mortgage-backed securities (“MBS”), consisting of agency MBS and private-label MBS. Agency MBS include residential mortgage pass-through certificates for which the principal and interest payments are guaranteed by a U.S. government agency or government sponsored enterprise (“GSE”), such as the Federal National Mortgage Association (“Fannie Mae”), the Federal Home Loan Mortgage Corporation (“Freddie Mac”) and the Government National Mortgage Association (“Ginnie Mae”). Private-label MBS, or non-agency MBS, include residential MBS that are not guaranteed by a GSE or the U.S. government. As of September 30, 2019, nearly all of our investment capital was allocated to agency MBS. 

We leverage prudently our investment portfolio so as to increase potential returns to our shareholders. We fund our investments primarily through short-term financing arrangements, principally through repurchase agreements.  We enter into various hedging transactions to mitigate the interest rate sensitivity of our cost of borrowing and the value of our MBS portfolio.

For our tax years ended December 31, 2018 and earlier, we were taxed as a C corporation for U.S. federal tax purposes. Commencing with our taxable year ending December 31, 2019, we intend to elect to be taxed as a REIT under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”).  As a REIT, we will be required to distribute annually 90% of our REIT taxable income (subject to certain adjustments).  So long as we continue to qualify as a REIT, we will generally not be subject to U.S.  Federal or state corporate income taxes on our taxable income that we distribute to our shareholders on a timely basis.  At present, it is our intention to distribute 100% of our taxable income, although we will not be required to do so. We intend to make distributions of our taxable income within the time limits prescribed by the Internal Revenue Code, which may extend into the subsequent taxable year.  

We are a Virginia corporation that is internally managed and do not have an external investment advisor.

Factors that Affect our Results of Operations and Financial Condition

Our business is materially affected by a variety of industry and economic factors, including:

 

conditions in the global financial markets and economic conditions generally;

 

changes in interest rates and prepayment rates;

 

conditions in the residential real estate and mortgage markets;

 

actions taken by the U.S. government, U.S. Federal Reserve, the U.S. Treasury and foreign central banks;

 

changes in laws and regulations and industry practices; and

 

other market developments.

Current Market Conditions and Trends

The 10-year U.S. Treasury rate was 1.66% as of September 30, 2019, a 35 basis point decrease from the prior quarter end and a 103 basis point decrease from the prior year end.  The U.S. Treasury curve flattened during the third quarter as the spread between the 2-year and 10-year U.S. Treasury rate narrowed 22 basis points resulting in a spread of only four basis points as of September 30, 2019.  In addition, the U.S. Treasury curve was inverted at the short-end of the curve as the spread between the 2-year and 5-year U.S.

24


 

Treasury rate was negative eight basis points as of September 30, 2019.  The spread between 10-year U.S. Treasury rates and interest rate swaps widened five basis points during the third quarter of 2019 with the 10-year swap rate ending at 1.56% as of September 30, 2019.  Lower mortgage rates have increased prepayment speed expectations of fixed-rate agency MBS during the third quarter of 2019 leading to higher pay-up premiums for fixed-rate agency MBS backed by specified pools of mortgage loans selected for their lower propensity for prepayment.  During the third quarter of 2019, higher market volatility, increased prepayment speed expectations and other factors led to the spread between the market yield on agency MBS and benchmark interest rates widening modestly resulting in the pricing of agency MBS underperforming interest rate hedges.  As a result of the relatively flat interest rate curve and high prepayment speed expectations, current net interest spread return opportunities available on new levered agency MBS investments are lower than historical averages.  However, to the extent that the interest rate curve or prepayment speeds revert towards historical averages, future net interest spread return opportunities on new levered agency MBS investments should improve.

During the third quarter of 2019, the Federal Open Market Committee (“FOMC”) lowered its target federal funds rate 25 basis points two times and lowered it an additional 25 basis points at its last meeting on October 30, 2019 to a current range of 1.50% to 1.75%.  At its October 30, 2019 meeting, the FOMC commented in its statement that it continues to view sustained expansion of economic activity, strong labor market conditions, and inflation near the FOMC’s symmetric 2% objective as the most likely outcomes, but uncertainties about this outlook remain.  In light of the implications of global developments for the economic outlook and muted inflation pressures, the FOMC stated that it will monitor the implications of incoming information for the economic outlook as it assesses the appropriate path of the target range for the federal funds rate.  Based on federal fund futures prices, market participants currently expect that the FOMC will lower the target federal funds rate by approximately 25 basis points over the next twelve months.  

Earlier in the year after its March 20, 2019 meeting, the FOMC also stated that it would modify its previously announced balance sheet normalization policy of gradually decreasing its reinvestment of U.S. Treasury securities and agency MBS.  More specifically, the FOMC stated that it intends to slow the pace of reduction of its holdings of U.S. Treasury securities through the end of September 2019 with the goal of generally maintaining its aggregate securities holdings thereafter;  however, the FOMC stated that it intends to continue to allow its holdings of agency MBS to decline with any principal payments from agency MBS reinvested in U.S. Treasury securities beginning in October 2019.

Starting the week of September 16, 2019, the overnight rate for repurchase agreement (“repo”) financing of U.S. Treasury securities spiked meaningfully intraday from a rate in the low two percent range to a high in the nine percent range primarily due to a scarcity of bank reserves compared with the amount of U.S. Treasury bonds in the market.  Market participants have attributed this imbalance in the amount of available bank reserves compared to U.S. Treasury bond supply to a multiple of factors, including the Federal Reserve’s reversal of its quantitative easing policy leading to a reduction in the Federal Reserve’s balance sheet, increased federal government borrowing and U.S. Treasury bond issuances to fund federal budget deficits, and large cash payments reducing the amount of available reserves such as corporate quarterly income tax payments and the monthly settlement of U.S. Treasury security auctions.  In response, the Federal Reserve immediately increased bank reserves by offering repo financing for U.S. Treasury and mortgage securities in order to keep the federal funds rate in its target range and stabilize the overnight repo rate.  On October 11, 2019, the FOMC announced further that it will continue to conduct overnight and term repo operations through at least January 2020, and that it will also purchase shorter-term U.S. Treasury bills at least into the second quarter of 2020 to maintain over time ample reserve balances at or above the level that prevailed in early September 2019.

During the third quarter of 2019, prepayment speeds in the fixed-rate 30-year residential mortgage market increased meaningfully from the prior quarter.  Prepayment speeds are expected to remain elevated in the near term in response to the decline in mortgage rates as a result of the decrease in the 10-year U.S. Treasury rate during 2019.  Housing prices continue to increase at a pace in excess of the rate of inflation as evidenced by the S&P CoreLogic Case-Shiller U.S. National Home Price NSA index reporting a 3.2% annual gain in July 2019.  Although year-over-year price gains remain positive, the recent pace of home price gains has continued a trend of broad-based price moderation toward historical long-term average home price appreciation.

The following table presents certain key market data as of the dates indicated:

 

25


 

 

 

 

September 30,

2018

 

 

December 31,

2018

 

 

March 31,

2019

 

 

June 30,

2019

 

 

September 30,

2019

 

 

Change - Third Quarter 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30-Year FNMA Fixed Rate MBS (1)

 

2.5%

 

$

92.47

 

 

$

94.30

 

 

$

97.55

 

 

$

99.27

 

 

$

99.58

 

 

$

0.31

 

3.0%

 

 

95.64

 

 

 

97.36

 

 

 

99.58

 

 

 

100.80

 

 

 

101.55

 

 

 

0.75

 

3.5%

 

 

98.39

 

 

 

99.83

 

 

 

101.39

 

 

 

102.20

 

 

 

102.64

 

 

 

0.44

 

4.0%

 

 

100.95

 

 

 

101.83

 

 

 

102.86

 

 

 

103.33

 

 

 

103.80

 

 

 

0.47

 

4.5%

 

 

103.14

 

 

 

103.45

 

 

 

104.17

 

 

 

104.48

 

 

 

105.33

 

 

 

0.85

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury Rates (UST)

 

2-year UST

 

 

2.82

%

 

 

2.49

%

 

 

2.26

%

 

 

1.75

%

 

 

1.62

%

 

 

(0.13

)

3-year UST

 

 

2.88

%

 

 

2.46

%

 

 

2.21

%

 

 

1.71

%

 

 

1.56

%

 

 

(0.15

)

5-year UST

 

 

2.95

%

 

 

2.51

%

 

 

2.23

%

 

 

1.77

%

 

 

1.54

%

 

 

(0.23

)

7-year UST

 

 

3.02

%

 

 

2.59

%

 

 

2.31

%

 

 

1.88

%

 

 

1.61

%

 

 

(0.27

)

10-year UST

 

 

3.06

%

 

 

2.69

%

 

 

2.41

%

 

 

2.01

%

 

 

1.66

%

 

 

(0.35

)

30-year UST

 

 

3.21

%

 

 

3.02

%

 

 

2.82

%

 

 

2.53

%

 

 

2.11

%

 

 

(0.42

)

2-year UST to 10-year UST spread

 

 

0.24

 

 

 

0.20

 

 

 

0.15

 

 

 

0.26

 

 

 

0.04

 

 

 

(0.22

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Rate Swap Rates

 

2-year swap

 

 

2.99

%

 

 

2.66

%

 

 

2.38

%

 

 

1.81

%

 

 

1.63

%

 

 

(0.18

)

3-year swap

 

 

3.05

%

 

 

2.59

%

 

 

2.31

%

 

 

1.74

%

 

 

1.55

%

 

 

(0.19

)

5-year swap

 

 

3.07

%

 

 

2.57

%

 

 

2.28

%

 

 

1.77

%

 

 

1.50

%

 

 

(0.27

)

7-year swap

 

 

3.09

%

 

 

2.62

%

 

 

2.32

%

 

 

1.84

%

 

 

1.51

%

 

 

(0.33

)

10-year swap

 

 

3.12

%

 

 

2.71

%

 

 

2.41

%

 

 

1.96

%

 

 

1.56

%

 

 

(0.40

)

30-year swap

 

 

3.13

%

 

 

2.84

%

 

 

2.58

%

 

 

2.21

%

 

 

1.71

%

 

 

(0.50

)

2-year swap to 2-year UST spread

 

 

0.17

 

 

 

0.17

 

 

 

0.12

 

 

 

0.06

 

 

 

0.01

 

 

 

(0.05

)

10-year swap to 10-year UST spread

 

 

0.06

 

 

 

0.02

 

 

 

-

 

 

 

(0.05

)

 

 

(0.10

)

 

 

(0.05

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

London Interbank Offered Rates (LIBOR)

 

1-month LIBOR

 

 

2.26

%

 

 

2.50

%

 

 

2.49

%

 

 

2.40

%

 

 

2.02

%

 

 

(0.38

)

3-month LIBOR

 

 

2.40

%

 

 

2.81

%

 

 

2.60

%

 

 

2.32

%

 

 

2.09

%

 

 

(0.23

)

 

(1)

Generic 30-year FNMA TBA price information, sourced from Bloomberg, provided for illustrative purposes only and is not meant to be reflective of the fair value of securities held by the Company.

Recent Regulatory Activity

Fannie Mae and Freddie Mac commenced their “Single Security Initiative” on June 3, 2019.  The Single Security Initiative is a joint initiative of Fannie Mae and Freddie Mac, under the direction of the Federal Housing Finance Committee, to develop a common MBS (referred to as a “Uniform MBS” or “UMBS”) to ultimately facilitate the combination of the separate TBA markets of each of the respective GSEs into a single, larger and more liquid market.  Existing Freddie Mac pass-through MBS have a 45-day delay remittance cycle, in which principal and interest payments are remitted to holders 45 days after such payments are due on the underlying mortgage loans, while Fannie Mae MBS have a 55-day delay remittance cycle.  As a means to conform existing Freddie Mac MBS to Fannie Mae MBS, beginning on May 7, 2019, Freddie Mac will offer holders of existing Freddie Mac MBS the option to exchange their 45-day delay MBS for a 55-day delay “mirror” MBS which is ultimately collateralized by the same pool of loans as the original 45-day delay MBS for which it was exchanged.  For each 45-day MBS that a holder elects to exchange, at the time of the exchange, Freddie Mac will provide an upfront cash payment to the holder as compensation for the prospective 10-day monthly payment delay.  We may elect to exchange some, or potentially all, of our existing Freddie Mac 45-day delay MBS for mirror 55-day delay MBS, depending upon our evaluation of the economics of the compensation payment, among other considerations.  Any exchanges of Freddie Mac MBS that we may ultimately elect to perform are not expected to materially impact our financial performance or operations.

 

In January 2014, the Consumer Financial Protection Bureau (“CFPB”) final rule became effective for a qualified mortgage as mandated by the Dodd-Frank Wall Street Reform and Consumer Protection Act, commonly referred to as the QM rule.  A qualified mortgage is a mortgage that meets certain requirements for lender protection and secondary trading.  In general, a qualified mortgage (i) contains less risky loan features, such as interest-only periods, negative amortization or balloon payments, (ii) has limits on origination points and fees, (iii) has certain legal protection for lenders, and (iv) has debt-to-income ratio limits.  However, the QM rule contained an exemption from the debt-to-income ratio limits for mortgages eligible for purchase by either Fannie Mae or Freddie Mac, commonly referred to as the “QM patch,” which is set to expire on January 10, 2021.  On July 25, 2019, the CFPB announced that it plans to allow the QM patch to expire on its scheduled expiration date.  If the QM patch were to expire, it is expected that the number of mortgage loans eligible to be purchased by Fannie Mae or Freddie Mac would decrease which could result in a decrease in the GSE’s market share while also potentially increasing the market share of private-label MBS issuers.  

26


 

 

On March 27, 2019, President Trump issued a memorandum directing the Secretary of the Treasury to develop a plan for administrative and legislative reforms to achieve the following housing reform goals: (i) ending the conservatorships of Fannie Mae and Freddie Mac upon the completion of specific reforms; (ii) facilitating competition in the housing finance market; (iii) establishing regulation of the GSEs that safeguards their safety and soundness and minimizes the risks they pose to the financial stability of the United States; and (iv) providing that the Federal government is properly compensated for any explicit or implicit support it provides the GSEs or the secondary housing finance market.  On September 5, 2019, the U.S. Department of the Treasury (“U.S. Treasury”) released its plan of recommended legislative and administrative reforms to the housing finance system to achieve the goals outlined in the Presidential memorandum.  

 

Since the release of the U.S. Treasury’s plan of recommended reforms to the housing finance system, there have been preliminary actions taken to advance the goals in the plan of recapitalizing and ending the conservatorship of the GSEs.  First, on September 27, 2019, the Federal Housing Finance Agency (“FHFA”) and U.S. Treasury entered into an agreement that permits Fannie Mae and Freddie Mac to retain up to $25 billion and $20 billion, respectively, in capital.  As part of the agreement, the liquidation preference of the U.S. Treasury’s senior preferred stock positions in Fannie Mae and Freddie Mac will be increased by a commensurate amount.  Second, on October 4, 2019, the FHFA released a solicitation for advisory services to assist in the formulation and potential implementation of a roadmap to responsibly end the conservatorships of the GSEs.

We expect vigorous debate and discussion in a number of areas, including residential housing and mortgage reform, fiscal policy, monetary policy and healthcare, to continue over the next few years; however, we cannot be certain if or when any specific proposal or policy might be announced, emerge from committee or be approved by Congress, and if so, what the effects on us may be.

 

LIBOR Transition

 

On July 27, 2017, the U.K. Financial Conduct Authority announced that it intends to stop persuading or compelling banks to submit LIBOR rates after 2021, which could either cause LIBOR to stop publication immediately or cause LIBOR’s regulator to determine that its quality had degraded to the degree that it is no longer representative of its underlying market.  The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, is considering replacing U.S. dollar LIBOR with the Secured Overnight Financing Rate (“SOFR”), a new index calculated by short-term repurchase agreements backed by U.S. Treasury securities. The Federal Reserve Bank of New York began publishing SOFR rates in April 2018. The likely market transition away from LIBOR and towards SOFR is expected to be gradual and complicated. There are significant differences between LIBOR and SOFR, such as LIBOR being an unsecured lending rate while SOFR a secured lending rate, and LIBOR reflects term rates at different maturities while SOFR is an overnight rate. These and other differences create the potential for basis risk between the two rates. The impact of any basis risk between LIBOR and SOFR may negatively affect our operating results. Any of these alternative methods may result in interest rates that are either higher or lower than if LIBOR were available in its current form, which could have a material adverse effect on our results.

 

We are party to various financial instruments which include LIBOR as a reference rate.  As of September 30, 2019, these financial instruments include interest rate swap agreements, preferred stock and unsecured notes issued by the Company.  

 

As of September 30, 2019, we had $3,000 million notional amount of interest rate swaps outstanding, including $1,225 million notional amount of interest rate swaps that expire after 2021.  Under the terms of our interest rate swap agreements, we make semiannual interest payments based upon a fixed interest rate and receive quarterly interest payments based upon the prevailing three-month LIBOR on the date of reset.  All of our existing interest rate swap agreements are centrally cleared by the Chicago Mercantile Exchange (“CME”) which acts as the calculation agent with the terms and conditions of each interest rates swap agreement defined in the CME Rulebook and supplemented by the rules published by the International Swaps and Derivative Association, Inc. (“ISDA”).  The fallback terms of our current interest rate swap agreements were not designed to cover a permanent discontinuation of LIBOR.  Under the terms of the current ISDA definitions, if the publication of LIBOR is not available, the current fallback is for the calculation agent to obtain quotations for what LIBOR should be from major banks in the interbank market.  If LIBOR is permanently discontinued, it is possible that major banks would be unwilling and/or unable to give such quotations.  Even if quotations were available in the near-term after the permanent discontinuation, it is unlikely that they will be available for each future reset date over the remaining tenor of our interest rate swap agreements.  ISDA is currently leading an effort to amend its definitions to include fallbacks for an alternative reference rate that would apply upon the permanent discontinuation of LIBOR.  It is anticipated that the amended ISDA definitions would include a statement identifying the objective triggers that would activate a fallback alternative interest rate provision and a description of the fallback alternative interest rate, which is expected to be SOFR adjusted for the fact that SOFR is an overnight rate and the various premia included within LIBOR.  It is expected that the CME Rulebook would incorporate any amendments to the ISDA definitions.  However, under the terms of the CME Rulebook, if a fallback to an alternative interest rate has not been triggered under future amended ISDA definitions, the CME as the calculation agent has the sole discretion to select an alternative interest rate if it determines that LIBOR is no longer representative of its underlying market.

27


 

 

As of September 30, 2019, we had $15.0 million of junior subordinated debt outstanding that require quarterly interest payments at three-month LIBOR plus a spread of 2.25% to 3.00% and matures between 2033 and 2035.  Under the terms of the indenture agreement for the notes, if the publication of LIBOR is not available, the current fallback is for the independent calculation agent to obtain quotations for what LIBOR should be from major banks in the interbank market.  If the calculation agent is unable to obtain such quotations, then the LIBOR in effect for future interest payments would be LIBOR in effect for the immediately preceding interest payment period.

 

As of September 30, 2019, we had 1,200,000 shares of 8.250% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series C Preferred Stock”) outstanding with a liquidation preference of $30.0 million.  The Series C Preferred Stock is entitled to receive a cumulative cash dividend (i) from and including the original issue to, but excluding, Mach 30, 2024 at a fixed rate of 8.250% per annum of the $25.00 per share liquidation preference, and (ii) from and including March 30, 2024, at a floating rate equal to three-month LIBOR plus a spread of 5.664% per annum of the $25.00 liquidation preference.  Under the terms of our Articles of Incorporation, if the publication of LIBOR is not available, the current fallback is for the Company to obtain quotations for what LIBOR should be from major banks in the interbank market. If we are unable to obtain such quotations, we are required to appoint an independent calculation agent, which will determine LIBOR based on sources it deems reasonable in its sole discretion.  If the calculation agent is unable or unwilling to determine LIBOR, then the LIBOR in effect for future dividend payments would be LIBOR in effect for the immediately preceding dividend payment period.

 

Notwithstanding the foregoing paragraph, if we determine that LIBOR has been discontinued, we will appoint an independent calculation agent to determine whether there is an industry accepted substitute or successor base rate to three-month LIBOR.   If the calculation agent determines that there is an industry accepted substitute or successor base rate, the calculation agent shall use such substitute or successor base rate.  If the calculation agent determines that there is not an accepted substitute or successor base rate, then the calculation agent will follow the original fallback language in the previous paragraph.

 

At this time, it is not possible to predict the effect of any such changes, any establishment of alternative reference rates or any other reforms to LIBOR that may be implemented in the U.K. or elsewhere. Uncertainty as to the nature of such potential changes, alternative reference rates or other reforms may adversely affect the market for or value of any securities on which the interest or dividend is determined by reference to LIBOR, loans, derivatives and other financial obligations or on our overall financial condition or results of operations. More generally, any of the above changes or any other consequential changes to LIBOR or any other “benchmark” as a result of international, national or other proposals for reform or other initiatives or investigations, or any further uncertainty in relation to the timing and manner of implementation of such changes, could have a material adverse effect on the value of and return on any securities based on or linked to a “benchmark.”

 

Executive Summary

 

The following are some key financial highlights for the quarter ended September 30, 2019:

$7.35 per common share of book value as of September 30, 2019, a decrease of 5.8% from the prior quarter end, primarily driven by a net investment loss on the Company’s hedged investment portfolio due to the underperformance of the pricing of the Company’s agency MBS investments relative to its interest rate hedges due to MBS spread widening

$0.225 per common share dividend, resulting in an economic loss of 2.9% measured as the change in book value per common share plus dividends declared during the quarter

$0.23 per diluted common share of GAAP net loss

$0.18 per diluted common share of non-GAAP core operating income (1)

Net interest income of $4.7 million compared to $6.6 million in the second quarter of 2019, driven primarily by:

 

o

lower weighted average agency MBS asset yields (2.96% versus 3.21%) due primarily to an increase in prepayment rates (12.85% versus 10.16%, annualized), partially offset by

 

o

an 18 basis point decrease in weighted average short-term secured financing costs

Economic net interest income, which includes TBA dollar roll income and net interest income earned or expense incurred from interest rate swaps, of $10.1 million compared to $12.3 million in the second quarter of 2019 (1)

 

 

28


 

(1)

For further information on the use of non-GAAP core operating income and economic net interest income, which are non-GAAP financial measures, see “Management’s Discussion and Analysis of Financial Condition and Results of Operation – Non-GAAP Core Operating Income.”

 

 

Portfolio Overview

The following table summarizes our MBS investment portfolio at fair value as of September 30, 2019 and December 31, 2018 (dollars in thousands):

 

 

 

September 30, 2019

 

 

December 31, 2018

 

Specified agency MBS

 

$

4,013,161

 

 

$

3,982,106

 

Net long agency TBA dollar roll positions (1)

 

 

99,593

 

 

 

 

Total agency investment portfolio

 

 

4,112,754

 

 

 

3,982,106

 

Private-label interest-only MBS

 

 

25

 

 

 

24

 

Total MBS investment portfolio

 

$

4,112,779

 

 

$

3,982,130

 

 

(1)

Represents the fair value of the agency MBS which underlie our TBA forward purchase and sale commitments executed as dollar roll transactions. In accordance with GAAP, our TBA forward purchase and sale commitments are reflected on the consolidated balance sheets as a component of “derivative assets, at fair value” and “derivative liabilities, at fair value,” with a collective net liability carrying value of $274 and a net asset carrying value of $438 as of September 30, 2019 and December 31, 2018, respectively.

Agency MBS Investment Portfolio

Our specified agency MBS consisted of the following as of September 30, 2019 (dollars in thousands):

 

 

 

Unpaid Principal Balance

 

 

Net Unamortized Purchase Premiums

 

 

Amortized Cost Basis

 

 

Net Unrealized Gain (Loss)

 

 

Fair Value

 

 

Market Price

 

 

Coupon

 

 

Weighted

Average

Expected

Remaining

Life

 

30-year fixed rate:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2.5%

 

$

73,009

 

 

$

798

 

 

$

73,807

 

 

$

(674

)

 

$

73,133

 

 

$

100.17

 

 

 

2.50

%

 

 

9.1

 

3.0%

 

 

808,462

 

 

 

21,109

 

 

 

829,571

 

 

 

(3,082

)

 

 

826,489

 

 

 

102.23

 

 

 

3.00

%

 

 

7.0

 

3.5%

 

 

1,293,792

 

 

 

38,904

 

 

 

1,332,696

 

 

 

8,948

 

 

 

1,341,644

 

 

 

103.70

 

 

 

3.50

%

 

 

5.0

 

4.0%

 

 

1,226,631

 

 

 

48,677

 

 

 

1,275,308

 

 

 

24,444

 

 

 

1,299,752

 

 

 

105.96

 

 

 

4.00

%

 

 

4.8

 

4.5%

 

 

439,456

 

 

 

20,573

 

 

 

460,029

 

 

 

12,100

 

 

 

472,129

 

 

 

107.43

 

 

 

4.50

%

 

 

4.3

 

5.5%

 

 

12

 

 

 

 

 

 

12

 

 

 

2

 

 

 

14

 

 

 

112.39

 

 

 

5.50

%

 

 

5.2

 

Total/weighted-average

 

$

3,841,362

 

 

$

130,061

 

 

$

3,971,423

 

 

$

41,738

 

 

$

4,013,161

 

 

$

104.47

 

 

 

3.65

%

 

 

5.4

 

 

 

 

Unpaid Principal Balance

 

 

Net Unamortized Purchase Premiums

 

 

Amortized Cost Basis

 

 

Net Unrealized Gain

 

 

Fair Value

 

 

Market

Price

 

 

Coupon

 

 

Weighted

Average

Expected

Remaining

Life

 

Fannie Mae

 

$

1,555,761

 

 

$

52,822

 

 

$

1,608,583

 

 

$

21,535

 

 

$

1,630,118

 

 

$

104.78

 

 

 

3.70

%

 

 

5.3

 

Freddie Mac

 

 

2,285,601

 

 

 

77,239

 

 

 

2,362,840

 

 

 

20,203

 

 

 

2,383,043

 

 

 

104.26

 

 

 

3.61

%

 

 

5.4

 

Total/weighted-average

 

$

3,841,362

 

 

$

130,061

 

 

$

3,971,423

 

 

$

41,738

 

 

$

4,013,161

 

 

$

104.47

 

 

 

3.65

%

 

 

5.4

 

 

The actual constant prepayment rate for the Company’s agency MBS was 12.85% for the three months ended September 30, 2019. As of September 30, 2019, the Company’s agency MBS was comprised of securities specifically selected for their relatively lower propensity for prepayment, which includes approximately 78% in specified pools of low balance loans while the remainder includes specified pools of loans originated in certain geographical areas, loans refinanced through the U.S. Government sponsored Home Affordable Refinance Program or with other characteristics selected for their relatively lower propensity for prepayment.

 

Our agency MBS investment portfolio also includes net long TBA positions, which are primarily the result of executing sequential series of “dollar roll” transactions that are settled on a net basis. In accordance with GAAP, we account for our net long

29


 

TBA positions as derivative instruments.  Information about the Company’s net long TBA positions as of September 30, 2019 is as follows (dollars in thousands):

 

 

 

Notional Amount:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Long (Short)

 

 

Implied

 

 

Implied

 

 

Net Carrying

 

 

 

Position (1)

 

 

Cost Basis (2)

 

 

Fair Value (3)

 

 

Amount (4)

 

2.5% 30-year MBS purchase commitments

 

$

100,000

 

 

$

100,273

 

 

$

99,593

 

 

$

(680

)

3.0% 30-year MBS purchase commitments

 

 

100,000

 

 

 

101,547

 

 

 

101,563

 

 

 

16

 

3.0% 30-year MBS sale commitments

 

 

(100,000

)

 

 

(101,953

)

 

 

(101,563

)

 

 

390

 

Total net long agency TBA dollar roll positions

 

$

100,000

 

 

$

99,867

 

 

$

99,593

 

 

$

(274

)

 

(1)

“Notional amount” represents the unpaid principal balance of the underlying agency MBS.

(2)

“Implied cost basis” represents the contractual forward price for the underlying agency MBS.

(3)

“Implied fair value” represents the current fair value of the underlying agency MBS.

(4)

“Net carrying amount” represents the difference between the implied cost basis and the current fair value of the underlying agency MBS. This amount is reflected on the Company’s consolidated balance sheets as a component of “derivative assets, at fair value” and “derivative liabilities, at fair value.”

Economic Hedging Instruments

The Company attempts to hedge a portion of its exposure to interest rate fluctuations associated with its agency MBS primarily through the use of interest rate hedging instruments. Specifically, these interest rate hedging instruments are intended to economically hedge changes, attributable to changes in benchmark interest rates, in agency MBS fair values and future interest cash flows on the Company’s short-term financing arrangements. As of September 30, 2019, the interest rate hedging instruments primarily used by the Company were centrally cleared interest rate swap agreements and exchange-traded 10-year U.S. Treasury note futures.

The Company’s interest rate swap agreements represent agreements to make semiannual interest payments based upon a fixed interest rate and receive quarterly variable interest payments based upon the prevailing three-month LIBOR on the date of reset. Information about the Company’s outstanding interest rate swap agreements in effect as of September 30, 2019 is as follows (dollars in thousands):

 

 

 

 

 

 

 

Weighted-average:

 

 

 

Notional Amount

 

 

Fixed Pay Rate

 

 

Variable Receive Rate

 

 

Net Receive (Pay) Rate

 

 

Remaining Life (Years)

 

Years to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less than 3 years

 

$

2,175,000

 

 

 

1.73

%

 

 

2.19

%

 

 

0.46

%

 

 

1.7

 

3 to less than 7 years

 

 

500,000

 

 

 

1.62

%

 

 

2.12

%

 

 

0.50

%

 

 

6.3

 

7 to less than 10 years

 

 

300,000

 

 

 

2.85

%

 

 

2.16

%

 

 

(0.69

)%

 

 

9.3

 

10 or more years

 

 

25,000

 

 

 

2.96

%

 

 

2.16

%

 

 

(0.80

)%

 

 

28.5

 

Total / weighted-average

 

$

3,000,000

 

 

 

1.83

%

 

 

2.17

%

 

 

0.34

%

 

 

3.4

 

 

In addition to interest rate swap agreements, the Company may also hold exchange-traded U.S. Treasury note futures that are short positions that mature on a quarterly basis. Upon the maturity date of these futures contracts, the Company has the option to either net settle each contract in cash in an amount equal to the difference between the current fair value of the underlying U.S. Treasury note and the contractual sale price inherent to the futures contract, or to physically settle the contract by delivering the underlying U.S. Treasury note. As of September 30, 2019, the Company held no U.S. Treasury note futures.

 

Results of Operations

Net Interest Income

Net interest income determined in accordance with GAAP primarily represents the interest income recognized from our investments in specified agency MBS and private-label MBS (including the amortization of purchase premiums and accretion of purchase discounts), net of the interest expense incurred from repurchase agreement financing arrangements or other short- and long-term borrowing transactions. 

Net interest income determined in accordance with GAAP does not include TBA agency MBS dollar roll income, which we believe represents the economic equivalent of net interest income generated from our investments in non-specified fixed-rate agency

30


 

MBS, nor does it include the net interest income or expense of our interest rate swap agreements, which are not designated as hedging instruments for financial reporting purposes. In our consolidated statements of comprehensive income prepared in accordance with GAAP, TBA agency MBS dollar roll income and the net interest income or expense from our interest rate swap agreements are reported as a component of the overall periodic change in the fair value of derivative instruments within the line item “gain (loss) from derivative instruments, net” of the “investment gain (loss), net” section.

Investment Gain (Loss), Net

“Investment gain (loss), net” primarily consists of periodic changes in the fair value (whether realized or unrealized) of investments in MBS classified as trading securities and periodic changes in the fair value (whether realized or unrealized) of derivative instruments.

General and Administrative Expenses

“Compensation and benefits expense” includes base salaries, annual cash incentive compensation, and non-cash stock-based compensation. Annual cash incentive compensation is based on meeting estimated annual performance measures and discretionary components. Non-cash stock-based compensation includes expenses associated with stock-based awards granted to employees, including the Company’s performance share units to executive officers that are earned only upon the attainment of Company performance measures over the relevant measurement period.

“Other general and administrative expenses” primarily consists of the following:

 

professional services expenses, including accounting, legal, and consulting fees;

 

insurance expenses, including liability and property insurance;

 

occupancy and equipment expense, including rental costs for our facilities, and depreciation and amortization of equipment and software;

 

fees and commissions related to transactions in interest rate derivative instruments;

 

Board of Director fees; and

 

other operating expenses, including information technology expenses, business development costs, public company reporting expenses, proxy solicitation expenses, corporate registration fees, local license taxes, office supplies and other miscellaneous expenses.

Three and nine months ended September 30, 2019 compared to the three and nine months ended September 30, 2018

The following table presents the net income (loss) available (attributable) to common stock reported for the three and nine months ended September 30, 2019 and 2018, respectively (dollars in thousands, except per share amounts):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Interest income

 

$

28,674

 

 

$

32,864

 

 

$

95,223

 

 

$

93,779

 

Interest expense

 

 

23,982

 

 

 

22,526

 

 

 

76,032

 

 

 

58,275

 

Net interest income

 

 

4,692

 

 

 

10,338

 

 

 

19,191

 

 

 

35,504

 

Investment advisory fee income

 

 

 

 

 

 

 

 

250

 

 

 

 

Investment loss, net

 

 

(8,231

)

 

 

(2,257

)

 

 

(21,111

)

 

 

(54,912

)

General and administrative expenses

 

 

(4,198

)

 

 

(3,954

)

 

 

(11,998

)

 

 

(11,712

)

(Loss) income before income taxes

 

 

(7,737

)

 

 

4,127

 

 

 

(13,668

)

 

 

(31,120

)

Income tax provision

 

 

 

 

 

9,628

 

 

 

 

 

 

34,372

 

Net loss

 

 

(7,737

)

 

 

(5,501

)

 

 

(13,668

)

 

 

(65,492

)

Dividend on preferred stock

 

 

(774

)

 

 

(151

)

 

 

(1,826

)

 

 

(437

)

Net loss attributable to common stock

 

$

(8,511

)

 

$

(5,652

)

 

$

(15,494

)

 

$

(65,929

)

Diluted loss per common share

 

$

(0.23

)

 

$

(0.19

)

 

$

(0.44

)

 

$

(2.31

)

Weighted-average diluted common shares

  outstanding

 

 

36,572

 

 

 

29,382

 

 

 

35,399

 

 

 

28,601

 

 

31


 

GAAP Net Interest Income

Net interest income determined in accordance with GAAP (“GAAP net interest income”) decreased $5.6 million, or 54.4%, from $10.3 million for the three months ended September 30, 2018 to $4.7 million for the three months ended September 30, 2019 and decreased $16.3 million, or 45.9%, from $35.5 million for the nine months ended September 30, 2018 to $19.2 million for the nine months ended September 30, 2019.

The decrease in GAAP net interest income for the three months ended September 30, 2019 is primarily attributable to:

 

lower average specified agency MBS investment balances,

 

a 29 basis point increase in the average interest costs of our short-term secured financing arrangements due primarily to increases in prevailing benchmark short-term interest rates, and

 

a 15 basis point decrease in the average asset yields of our specified agency MBS due to reallocating our concentration of MBS toward lower coupon securities with lower asset yields as a result of the flattening of the interest rate curve and elevated prepayment speeds during the third quarter of 2019.

 

The decrease in GAAP net interest income for the nine months ended September 30, 2019 is primarily attributable to:

 

a 66 basis point increase in the average interest costs of our short-term secured financing arrangements due primarily to increases in prevailing benchmark short-term interest rates, and

 

lower average specified agency MBS investment balances, partially offset by

 

a 15 basis point increase in the average asset yields of our specified agency MBS due to reinvestments from portfolio repositioning and monthly paydowns into higher current investment yields as a result of a rise in long-term interest rates and widening agency MBS spreads.

The components of GAAP net interest income from our MBS portfolio is summarized in the following tables for the periods indicated (dollars in thousands):

 

 

 

Three Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

 

Average

 

 

Income

 

 

Yield

 

 

Average

 

 

Income

 

 

Yield

 

 

 

Balance

 

 

(Expense)

 

 

(Cost)

 

 

Balance

 

 

(Expense)

 

 

(Cost)

 

Agency MBS

 

$

3,844,404

 

 

$

28,455

 

 

 

2.96

%

 

$

4,204,472

 

 

$

32,679

 

 

 

3.11

%

Other

 

 

 

 

 

219

 

 

 

 

 

 

 

 

 

 

185

 

 

 

 

 

 

 

$

3,844,404

 

 

 

28,674

 

 

 

2.98

%

 

$

4,204,472

 

 

 

32,864

 

 

 

3.13

%

Short-term secured debt

 

$

3,609,519

 

 

 

(22,721

)

 

 

(2.46

)%

 

$

3,841,280

 

 

 

(21,265

)

 

 

(2.17

)%

Long-term unsecured debt

 

 

74,253

 

 

 

(1,261

)

 

 

(6.79

)%

 

 

74,029

 

 

 

(1,261

)

 

 

(6.81

)%

 

 

$

3,683,772

 

 

 

(23,982

)

 

 

(2.55

)%

 

$

3,915,309

 

 

 

(22,526

)

 

 

(2.26

)%

Net interest income/spread (1)

 

 

 

 

 

$

4,692

 

 

 

0.52

%

 

 

 

 

 

$

10,338

 

 

 

0.96

%

Net interest margin (1)

 

 

 

 

 

 

 

 

 

 

0.62

%

 

 

 

 

 

 

 

 

 

 

1.10

%

 

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

 

Average

 

 

Income

 

 

Yield

 

 

Average

 

 

Income

 

 

Yield

 

 

 

Balance

 

 

(Expense)

 

 

(Cost)

 

 

Balance

 

 

(Expense)

 

 

(Cost)

 

Agency MBS

 

$

3,955,819

 

 

$

94,300

 

 

 

3.18

%

 

$

4,109,482

 

 

$

93,344

 

 

 

3.03

%

Other

 

 

 

 

 

923

 

 

 

 

 

 

 

 

 

 

435

 

 

 

 

 

 

 

$

3,955,819

 

 

 

95,223

 

 

 

3.21

%

 

$

4,109,482

 

 

 

93,779

 

 

 

3.04

%

Short-term secured debt

 

$

3,672,844

 

 

 

(72,230

)

 

 

(2.59

)%

 

$

3,730,460

 

 

 

(54,526

)

 

 

(1.93

)%

Long-term unsecured debt

 

 

74,197

 

 

 

(3,802

)

 

 

(6.83

)%

 

 

73,973

 

 

 

(3,749

)

 

 

(6.76

)%

 

 

$

3,747,041

 

 

 

(76,032

)

 

 

(2.68

)%

 

$

3,804,433

 

 

 

(58,275

)

 

 

(2.02

)%

Net interest income/spread (1)

 

 

 

 

 

$

19,191

 

 

 

0.62

%

 

 

 

 

 

$

35,504

 

 

 

1.11

%

Net interest margin (1)

 

 

 

 

 

 

 

 

 

 

0.77

%

 

 

 

 

 

 

 

 

 

 

1.27

%

 

 

(1)

Net interest income/spread and net interest margin excludes interest on long-term unsecured debt.

32


 

The effects of changes in the composition of our investments on our GAAP net interest income from our MBS investment activities are summarized below (dollars in thousands):

 

 

 

Three Months Ended September 30, 2019

 

 

Nine Months Ended September 30, 2019

 

 

 

vs.

 

 

vs.

 

 

 

Three Months Ended September 30, 2018

 

 

Nine Months Ended September 30, 2018

 

 

 

Rate

 

 

Volume

 

 

Total Change

 

 

Rate

 

 

Volume

 

 

Total Change

 

Agency MBS

 

$

(1,426

)

 

$

(2,798

)

 

$

(4,224

)

 

$

4,442

 

 

$

(3,486

)

 

$

956

 

Other

 

 

34

 

 

 

 

 

 

34

 

 

 

488

 

 

 

 

 

 

488

 

Short-term secured debt

 

 

(2,701

)

 

 

1,245

 

 

 

(1,456

)

 

 

(18,529

)

 

 

825

 

 

 

(17,704

)

Long-term unsecured debt

 

 

4

 

 

 

(4

)

 

 

 

 

 

(42

)

 

 

(11

)

 

 

(53

)

 

 

$

(4,089

)

 

$

(1,557

)

 

$

(5,646

)

 

$

(13,641

)

 

$

(2,672

)

 

$

(16,313

)

 

Economic Net Interest Income

Economic net interest income, a non-GAAP financial measure, represents the interest income earned net of the interest expense incurred from all of our interest bearing financial instruments as well as the agency MBS which underlie, and are implicitly financed through, our TBA dollar roll transactions. Economic net interest income is comprised of the following: (i) net interest income determined in accordance with GAAP, (ii) TBA agency MBS “dollar roll” income, and (iii) net interest income earned or expense incurred from interest rate swap agreements. We believe that economic net interest income assists investors in understanding and evaluating the financial performance of the Company’s long-term-focused, net interest spread-based investment strategy, prior to the deduction of core general and administrative expenses. A full description of each of the three aforementioned components of economic net interest income is included within the “Non-GAAP Core Operating Income” section of this document.

The components of our economic net interest income are summarized in the following tables for the periods indicated (dollars in thousands):

 

 

 

Three Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

 

Average

 

 

Income

 

 

Yield

 

 

Average

 

 

Income

 

 

Yield

 

 

 

Balance

 

 

(Expense)

 

 

(Cost)

 

 

Balance

 

 

(Expense)

 

 

(Cost)

 

Agency MBS

 

$

3,844,404

 

 

$

28,455

 

 

 

2.96

%

 

$

4,204,472

 

 

$

32,679

 

 

 

3.11

%

TBA dollar rolls (1)

 

 

396,857

 

 

 

923

 

 

 

0.93

%

 

 

990,231

 

 

 

4,604

 

 

 

1.86

%

Other

 

 

 

 

 

219

 

 

 

 

 

 

 

 

 

 

185

 

 

 

 

 

Short-term secured debt

 

 

3,609,519

 

 

 

(22,721

)

 

 

(2.46

)%

 

 

3,841,280

 

 

 

(21,265

)

 

 

(2.17

)%

Interest rate swaps (2)

 

 

2,888,011

 

 

 

4,445

 

 

 

0.62

%

 

 

3,372,151

 

 

 

2,295

 

 

 

0.27

%

Long-term unsecured debt

 

 

74,253

 

 

 

(1,261

)

 

 

(6.79

)%

 

 

74,029

 

 

 

(1,261

)

 

 

(6.81

)%

Economic net interest income/margin (3)

 

 

 

 

 

$

10,060

 

 

 

1.07

%

 

 

 

 

 

$

17,237

 

 

 

1.42

%

 

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

 

Average

 

 

Income

 

 

Yield

 

 

Average

 

 

Income

 

 

Yield

 

 

 

Balance

 

 

(Expense)

 

 

(Cost)

 

 

Balance

 

 

(Expense)

 

 

(Cost)

 

Agency MBS

 

$

3,955,819

 

 

$

94,300

 

 

 

3.18

%

 

$

4,109,482

 

 

$

93,344

 

 

 

3.03

%

TBA dollar rolls (1)

 

 

627,902

 

 

 

4,338

 

 

 

0.92

%

 

 

1,281,730

 

 

 

17,989

 

 

 

1.87

%

Other

 

 

 

 

 

923

 

 

 

 

 

 

 

 

 

 

435

 

 

 

 

 

Short-term secured debt

 

 

3,672,844

 

 

 

(72,230

)

 

 

(2.59

)%

 

 

3,730,460

 

 

 

(54,526

)

 

 

(1.93

)%

Interest rate swaps (2)

 

 

2,959,695

 

 

 

12,961

 

 

 

0.58

%

 

 

3,462,581

 

 

 

3,962

 

 

 

0.15

%

Long-term unsecured debt

 

 

74,197

 

 

 

(3,802

)

 

 

(6.83

)%

 

 

73,973

 

 

 

(3,749

)

 

 

(6.76

)%

Economic net interest income/margin (3)

 

 

 

 

 

$

36,490

 

 

 

1.17

%

 

 

 

 

 

$

57,455

 

 

 

1.51

%

 

 

(1)

TBA dollar roll average balance (average cost basis) is based upon the contractual price of the initial TBA purchase trade of each individual series of dollar roll transactions.  TBA dollar roll income is net of implied financing costs.

 

(2)

Interest rate swap cost represents the weighted average net receive (pay) rate in effect for the period, adjusted for price alignment interest” income earned or expense incurred on cumulative variation margin paid or received, respectively.

 

(3)

Economic net interest margin rate excludes interest on long-term unsecured debt.

 

33


 

The effects of changes in the composition of our investments on our economic net interest income from our MBS investment and related funding and hedging activities are summarized below (dollars in thousands):

 

 

 

Three Months Ended September 30, 2019

 

 

Nine Months Ended September 30, 2019

 

 

 

vs.

 

 

vs.

 

 

 

Three Months Ended September 30, 2018

 

 

Nine Months Ended September 30, 2018

 

 

 

Rate

 

 

Volume

 

 

Total Change

 

 

Rate

 

 

Volume

 

 

Total Change

 

Agency MBS

 

$

(1,426

)

 

$

(2,798

)

 

$

(4,224

)

 

$

4,442

 

 

$

(3,486

)

 

$

956

 

TBA dollar rolls

 

 

(922

)

 

 

(2,759

)

 

 

(3,681

)

 

 

(4,474

)

 

 

(9,177

)

 

 

(13,651

)

Other

 

 

34

 

 

 

 

 

 

34

 

 

 

488

 

 

 

 

 

 

488

 

Short-term secured debt

 

 

(2,701

)

 

 

1,245

 

 

 

(1,456

)

 

 

(18,529

)

 

 

825

 

 

 

(17,704

)

Interest rate swaps

 

 

2,480

 

 

 

(330

)

 

 

2,150

 

 

 

9,574

 

 

 

(575

)

 

 

8,999

 

Long-term unsecured debt

 

 

4

 

 

 

(4

)

 

 

-

 

 

 

(42

)

 

 

(11

)

 

 

(53

)

 

 

$

(2,531

)

 

$

(4,646

)

 

$

(7,177

)

 

$

(8,541

)

 

$

(12,424

)

 

$

(20,965

)

 

Economic net interest income for the three and nine months ended September 30, 2019 decreased relative to the comparative periods from the prior year due primarily to:

 

lower average leverage and portfolio volumes, and

 

higher financing costs on the unhedged portion of our short-term secured financing arrangements and implied TBA financing driven primarily by an increase in prevailing benchmark short-term interest rates, partially offset by

 

for the nine months ended September 30, 2019, an increase in the average asset yields of our specified agency MBS due to reinvestments from portfolio repositioning and monthly paydowns into higher current investment yields as a result of a rise in long-term interest rates and widening agency MBS spreads.

Investment Advisory Fee Income

We formed a wholly-owned subsidiary, Rock Creek Investment Advisors, LLC (“Rock Creek”), which was approved as a registered investment adviser and is regulated under the Investment Advisers Act of 1940, as amended (the “Advisers Act”), in the fourth quarter of 2018 and commenced operations in December 2018.  Rock Creek provides investment advisory services to institutional clients on a separate account basis by investing primarily in agency MBS. Rock Creek earns investment management fee income based upon a percentage of the capital funded by a client to its separate managed account. During the nine months ended September 30, 2019, we recognized $0.3 million in investment advisory fee income. No investment advisory fee income was recognized during the three months ended September 30, 2019.

Investment Gain (Loss), Net

As prevailing longer-term interest rates increase (decrease), the fair value of our investments in fixed rate agency MBS and TBA commitments generally decreases (increases).  Conversely, the fair value of our interest rate hedging instruments increases (decreases) in response to increases (decreases) in prevailing interest rates.  While our interest rate hedging instruments are designed to mitigate the sensitivity of the fair value of our agency MBS portfolio to fluctuations in benchmark interest rates, they are not generally designed to mitigate the sensitivity of our net book value to spread risk, which is the risk of an increase of the market spread between the yield on our agency MBS and the benchmark yield on U.S. Treasury securities or interest rate swaps.  Accordingly, irrespective of fluctuations in interest rates, an increase (decrease) in agency MBS spreads will generally result in the underperformance (outperformance) of the values of agency MBS relative to interest rate hedging instruments.

The following table presents information about the gains and losses recognized due to the changes in the fair value of our agency MBS, TBA transactions, and interest rate hedging instruments for the periods indicated (dollars in thousands):

34


 

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Gains (losses) on trading investments, net

 

$

16,890

 

 

$

(37,878

)

 

$

128,297

 

 

$

(147,113

)

TBA and specified agency MBS commitments, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TBA dollar roll income

 

 

923

 

 

 

4,604

 

 

 

4,338

 

 

 

17,989

 

Other gains (losses) from TBA and specified agency MBS

   commitments, net

 

 

2,054

 

 

 

(8,923

)

 

 

16,934

 

 

 

(61,369

)

Total gains (losses) on TBA and specified agency MBS

   commitments, net

 

 

2,977

 

 

 

(4,319

)

 

 

21,272

 

 

 

(43,380

)

Interest rate derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net interest income on interest rate swaps

 

 

4,445

 

 

 

2,295

 

 

 

12,961

 

 

 

3,962

 

Other (losses) gains from interest rate derivative

  instruments, net

 

 

(32,775

)

 

 

37,644

 

 

 

(183,863

)

 

 

131,244

 

Total (losses) gains on interest rate derivatives, net

 

 

(28,330

)

 

 

39,939

 

 

 

(170,902

)

 

 

135,206

 

Other, net

 

 

232

 

 

 

1

 

 

 

222

 

 

 

375

 

Investment loss, net

 

$

(8,231

)

 

$

(2,257

)

 

$

(21,111

)

 

$

(54,912

)

 

During the three and nine months ended September 30, 2019 and 2018, MBS spreads widened which resulted in the underperformance of our investments in agency MBS and TBA commitments relative to our interest rate hedging instruments.

General and Administrative Expenses

General and administrative expenses increased by $0.2 million, or 5.0%, from $4.0 million for the three months ended September 30, 2018 to $4.2 million for the three months ended September 30, 2019. General and administrative expenses increased by $0.3 million, or 2.6%, from $11.7 for the nine months ended September 30, 2018 to $12.0 million for the nine months ended September 30, 2019.

Compensation and benefits expense remained at $2.8 million for both the three months ended September 30, 2018 and 2019. Compensation and benefits expense increased by $0.3 million, or 3.8%, from $7.9 million for the nine months ended September 30, 2018 to $8.2 million for the nine months ended September 30, 2019.

Other general and administrative expenses increased by $0.3 million, or 27.3%, from $1.1 million for the three months ended September 30, 2018 to $1.4 million for the three months ended September 30, 2019. Other general and administrative expenses remained at $3.8 million for the nine months ended September 30, 2018 and 2019.  In the third quarter of 2019, we recognized an expense of $0.8 million related to an assessment from Arlington County, Virginia of business, professional and occupation license taxes for tax years 2018 and 2019.

Income Tax Provision

On December 27, 2018, our Board of Directors approved a plan for us to elect to be taxed and to operate in a manner that will allow us to qualify as a REIT for U.S. federal income tax purposes commencing with our taxable year ending December 31, 2019.  So long as we continue to qualify as a REIT, we will generally not be subject to U.S. federal or state corporate income taxes on our taxable income to the extent that we distribute 100% of our taxable income to our shareholders on a timely basis.  For taxable years ended December 31, 2018 and prior, we were subject to taxation as a corporation under Subchapter C of the Internal Revenue Code.

 

 

 

Non-GAAP Core Operating Income

 

In addition to the results of operations determined in accordance with generally accepted accounting principles as consistently applied in the United States (“GAAP”), we reported “non-GAAP core operating income.” We define core operating income as “economic net interest income” and investment advisory fee income less “core general and administrative expenses.”

Economic Net Interest Income

 

Economic net interest income, a non-GAAP financial measure, represents the interest income earned net of the interest expense incurred from all of our interest bearing financial instruments as well as the agency MBS which underlie, and are implicitly financed

35


 

through, our TBA dollar roll transactions. Economic net interest income is comprised of the following: (i) net interest income determined in accordance with GAAP, (ii) TBA agency MBS “dollar roll” income, and (iii) net interest income earned or expense incurred from interest rate swap agreements.

 

We believe that economic net interest income assists investors in understanding and evaluating the financial performance of the Company’s long-term-focused, net interest spread-based investment strategy, prior to the deduction of core general and administrative expenses.

 

 

Net interest income determined in accordance with GAAP.  Net interest income determined in accordance with GAAP primarily represents the interest income recognized from our investments in specified agency MBS and private-label MBS (including the amortization of purchase premiums and accretion of purchase discounts), net of the interest expense incurred from repurchase agreement financing arrangements or other short- and long-term borrowing transactions.

 

 

TBA agency MBS dollar roll income.  Dollar roll income represents the economic equivalent of net interest income (implied interest income net of financing costs) generated from our investments in non-specified fixed-rate agency MBS, executed through sequential series of forward-settling purchase and sale transactions that are settled on a net basis (known as “dollar roll” transactions). Dollar roll income is generated as a result of delaying, or “rolling,” the settlement of a forward-settling purchase of a TBA agency MBS by entering into an offsetting “spot” sale with the same counterparty prior to the settlement date, net settling the “paired-off” positions in cash, and contemporaneously entering another forward-settling purchase with the same counterparty of a TBA agency MBS of the same essential characteristics for a later settlement date at a price discount relative to the spot sale. The price discount of the forward-settling purchase relative to the contemporaneously executed spot sale reflects compensation for the interest income (inclusive of expected prepayments) that, at the time of sale, is expected to be foregone as a result of relinquishing beneficial ownership of the MBS from the settlement date of the spot sale until the settlement date of the forward purchase, net of implied repurchase financing costs. We calculate dollar roll income as the excess of the spot sale price over the forward-settling purchase price, and recognize this amount ratably over the period beginning on the settlement date of the sale and ending on the settlement date of the forward purchase. In our consolidated statements of comprehensive income prepared in accordance with GAAP, TBA agency MBS dollar roll income is reported as a component of the overall periodic change in the fair value of TBA forward commitments within the line item “gain (loss) from derivative instruments, net” of the “investment gain (loss), net” section.

 

From time to time, we may enter into forward-settling TBA agency MBS sale commitments (known as a “net short” TBA position) as a means of economically hedging a portion of the interest rate sensitivity of our agency MBS investment portfolio.  When we delay (or “roll”) the settlement of a net short TBA position, the price discount of the forward-settling sale relative to the contemporaneously executed spot purchase results in an implied net interest expense (i.e., “dollar roll expense”).  In our presentation of non-GAAP core operating income, we present TBA dollar roll income net of any implied net interest expense that resulted from rolling the settlement of net short TBA positions.

 

 

Net interest income earned or expense incurred from interest rate swap agreements. We utilize interest rate swap agreements to economically hedge a portion of our exposure to variability in future interest cash flows, attributable to changes in benchmark interest rates, associated with future roll-overs of our short-term financing arrangements. Accordingly, the net interest income earned or expense incurred (commonly referred to as “net interest carry”) from our interest rate swap agreements in combination with interest expense recognized in accordance with GAAP represents our effective “economic interest expense.” In our consolidated statements of comprehensive income prepared in accordance with GAAP, the net interest income earned or expense incurred from interest rate swap agreements is reported as a component of the overall periodic change in the fair value of derivative instruments within the line item “gain (loss) from derivative instruments, net” of the “investment gain (loss), net” section.

 

 

Core General and Administrative Expenses

 

Core general and administrative expenses are non-interest expenses reported within the line item “total general and administrative expenses” of the consolidated statements of comprehensive income less stock-based compensation expense.  For the three and nine months ended September 30, 2019, core general and administrative expenses exclude a non-recurring expense related to a one-time out-of-period payment made in the third quarter of 2019 for a business, professional and occupation license tax from Arlington County, Virginia for the 2018 tax year.  Refer to “Note 8. Income Taxes” for further information about the business, professional and occupation license tax and the associated payment made in the third quarter of 2019.

 

 

36


 

Non-GAAP Core Operating Income

 

The following table presents our computation of non-GAAP core operating income for the three and nine months ended September 30, 2019 and 2018 (amounts in thousands, except per share amounts):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

GAAP net interest income

$

4,692

 

 

$

10,338

 

 

$

19,191

 

 

$

35,504

 

TBA dollar roll income

 

923

 

 

 

4,604

 

 

 

4,338

 

 

 

17,989

 

Interest rate swap net interest income

 

4,445

 

 

 

2,295

 

 

 

12,961

 

 

 

3,962

 

Economic net interest income

 

10,060

 

 

 

17,237

 

 

 

36,490

 

 

 

57,455

 

Investment advisory fee income

 

 

 

 

 

 

 

250

 

 

 

 

Core general and administrative expenses

 

(2,797

)

 

 

(3,202

)

 

 

(9,607

)

 

 

(10,210

)

Preferred stock dividend

 

(774

)

 

 

(151

)

 

 

(1,826

)

 

 

(437

)

Non-GAAP core operating income

$

6,489

 

 

$

13,884

 

 

$

25,307

 

 

$

46,808

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP core operating income per diluted

   common share

$

0.18

 

 

$

0.47

 

 

$

0.71

 

 

$

1.62

 

Weighted average diluted common shares

   outstanding

 

36,751

 

 

 

29,718

 

 

 

35,524

 

 

 

28,875

 

 

The following table provides a reconciliation of GAAP pre-tax net income (loss) to non-GAAP core operating income for the three and nine months ended September 30, 2019 and 2018 (amounts in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

GAAP (loss) income before income taxes

$

(7,737

)

 

$

4,127

 

 

$

(13,668

)

 

$

(31,120

)

Add (less):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total investment loss, net

 

8,231

 

 

 

2,257

 

 

 

21,111

 

 

 

54,912

 

Stock-based compensation expense

 

913

 

 

 

752

 

 

 

1,903

 

 

 

1,502

 

Preferred stock dividend

 

(774

)

 

 

(151

)

 

 

(1,826

)

 

 

(437

)

Non-recurring expense

 

488

 

 

 

 

 

 

488

 

 

 

 

Add back:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TBA dollar roll income

 

923

 

 

 

4,604

 

 

 

4,338

 

 

 

17,989

 

Interest rate swap net interest income

 

4,445

 

 

 

2,295

 

 

 

12,961

 

 

 

3,962

 

Non-GAAP core operating income

$

6,489

 

 

$

13,884

 

 

$

25,307

 

 

$

46,808

 

 

 

Non-GAAP core operating income is used by management to evaluate the financial performance of the Company’s long-term-focused, net interest spread-based investment strategy and core business activities over periods of time as well as assist with the determination of the appropriate level of periodic dividends to common stockholders. In addition, we believe that non-GAAP core operating income assists investors in understanding and evaluating the financial performance of the Company’s long-term-focused, net interest spread-based investment strategy and core business activities over periods of time as well as its earnings capacity.

 

Periodic fair value gains and losses recognized with respect to our investments in MBS and our economic hedging instruments, which are reported in line item “total investment gain (loss), net” of our consolidated statements of comprehensive income, are excluded from the computation of non-GAAP core operating income as such gains on losses are not reflective of the economic interest income earned or interest expense incurred from our interest-bearing financial assets and liabilities during the indicated reporting period.  Because our long-term-focused investment strategy for our agency MBS investment portfolio is to generate a net interest spread on the leveraged assets while prudently hedging periodic changes in the fair value of those assets attributable to changes in benchmark interest rates, we generally expect the fluctuations in the fair value of our agency MBS investments and our economic hedging instruments to largely offset one another over time.

 

37


 

A limitation of utilizing this non-GAAP financial measure is that the effect of accounting for “non-core” events or transactions in accordance with GAAP does, in fact, reflect the financial results of our business and these effects should not be ignored when evaluating and analyzing our financial results. For example, the economic cost or benefit of hedging instruments other than interest rate swap agreements, such as U.S. Treasury note futures or options, do not affect the computation of non-GAAP core operating income. In addition, our calculation of non-GAAP core operating income may not be comparable to other similarly titled measures of other companies.  Therefore, we believe that non-GAAP core operating income should be considered as a supplement to, and in conjunction with, net income and comprehensive income determined in accordance with GAAP. Furthermore, there may be differences between non-GAAP core operating income and taxable income determined in accordance with the Internal Revenue Code.  As a REIT, we will be required to distribute at least 90% of our REIT taxable income (subject to certain adjustments) to qualify as a REIT and all of our taxable income in order to not be subject to any U.S. Federal or state corporate income taxes. Accordingly, non-GAAP core operating income may not equal our distribution requirements as a REIT.

 

 

Liquidity and Capital Resources

Liquidity is a measurement of our ability to meet potential cash requirements including ongoing commitments to repay borrowings, fund investments, meet margin calls on our short-term borrowings and hedging instruments, and for other general business purposes. Our primary sources of funds for liquidity consist of existing cash balances, short-term borrowings (for example, repurchase agreements), principal and interest payments from our investments in MBS, and proceeds from sales of MBS. Other sources of liquidity include proceeds from the offering of common stock, preferred stock, debt securities, or other securities registered pursuant to our effective shelf registration statement filed with the Securities and Exchange Commission (“SEC”).

Liquidity, or ready access to funds, is essential to our business. Perceived liquidity issues may affect our counterparties’ willingness to engage in transactions with us. Our liquidity could be impaired due to circumstances that we may be unable to control, such as a general market disruption or an operational problem that affects us or third parties. Further, our ability to sell assets may be impaired if other market participants are seeking to sell similar assets at the same time. If we cannot obtain funding from third parties our results of operations could be negatively impacted.

As of September 30, 2019, our debt-to-equity leverage ratio was 12.2 to 1 measured as the ratio of the sum of our total debt to our shareholders’ equity as reported on our consolidated balance sheet.  In evaluating our liquidity and leverage ratios, we also monitor our “at risk” short-term financing to investable capital ratio. Our “at risk” short-term financing to investable capital ratio is measured as the ratio of the sum of our short-term recourse financing (i.e., repurchase agreement financing), net payable or receivable for unsettled securities, net contractual forward price of our TBA commitments less our cash and cash equivalents compared to our investable capital.  Our investable capital is calculated as the sum of our stockholders’ equity and long-term unsecured debt. As of September 30, 2019, our “at risk” short-term recourse financing to investable capital ratio was 9.9 to 1.  

Cash Flows

As of September 30, 2019, our cash and cash equivalents totaled $12.1 million, representing a net decrease of $14.6 million from $26.7 million as of December 31, 2018. Cash provided by operating activities of $28.8 million during the nine months ended September 30, 2019 was attributable primarily to net interest income less our general and administrative expenses. Cash used in investing activities of $62.0 million during the nine months ended September 30, 2019 was primarily generated by purchases of new agency MBS and net payments for settlements and deposits for margin on our interest rate derivative instruments partially offset by sales of agency MBS and receipt of principal payments from agency MBS. Cash provided by financing activities of $18.6 million during the nine months ended September 30, 2019 was primarily generated by proceeds received from issuance of common and preferred stock partially offset by repayments of repurchase agreements used to finance a portion of our MBS investment portfolio and dividend payments to stockholders.

Sources of Funding

We believe that our existing cash balances, net investments in MBS, cash flows from operations, borrowing capacity, and other sources of liquidity will be sufficient to meet our cash requirements for at least the next twelve months. We may, however, seek debt or equity financings, in public or private transactions, to provide capital for corporate purposes and/or strategic business opportunities, including possible acquisitions, joint ventures, alliances or other business arrangements which could require substantial capital outlays. Our policy is to evaluate strategic business opportunities, including acquisitions and divestitures, as they arise. There can be no assurance that we will be able to generate sufficient funds from future operations, or raise sufficient debt or equity on acceptable terms, to take advantage of investment opportunities that become available. Should our needs ever exceed these sources of liquidity, we believe that substantially most of our investments could be sold, in most circumstances, to provide cash. However, we may be required to sell our assets in such instances at depressed prices.

38


 

As of September 30, 2019, liquid assets consisted primarily of cash and cash equivalents of $12.1 million and unencumbered agency MBS of $121.9 million at fair value. Cash equivalents consist primarily of money market funds invested in debt obligations of the U.S. government.

Debt Capital

Long-Term Unsecured Debt

As of September 30, 2019, we had $74.3 million of total long-term unsecured debt, net of unamortized debt issuance costs of $1.0 million. Our trust preferred debt obligations with an aggregate principal amount of $15.0 million outstanding as of September 30, 2019 accrue and require the payment of interest quarterly at three-month LIBOR plus 2.25% to 3.00% and mature between 2033 and 2035. Our 6.625% Senior Notes due 2023 with a principal amount of $25.0 million outstanding as of September 30, 2019 accrue and require payment of interest quarterly at an annual rate of 6.625% and mature on May 1, 2023. Our 6.75% Senior Notes due 2025 with a principal amount of $35.3 million outstanding as of September 30, 2019 accrue and require payment of interest quarterly at an annual rate of 6.75% and mature on March 15, 2025.

Repurchase Agreements

We have short-term financing facilities that are structured as repurchase agreements with various financial institutions to fund our investments in MBS. We have obtained, and believe we will be able to continue to obtain, short-term financing in amounts and at interest rates consistent with our financing objectives. Funding for MBS through repurchase agreements continues to be available to us at rates we consider to be attractive from multiple counterparties.

Our repurchase agreements include provisions contained in the standard master repurchase agreement as published by the Securities Industry and Financial Markets Association (“SIFMA”) and may be amended and supplemented in accordance with industry standards for repurchase facilities. Our repurchase agreements include financial covenants, with which the failure to comply would constitute an event of default under the applicable repurchase agreement. Similarly, each repurchase agreement includes events of insolvency and events of default on other indebtedness as similar financial covenants. As provided in the standard master repurchase agreement as typically amended, upon the occurrence of an event of default or termination, the applicable counterparty has the option to terminate all repurchase transactions under such counterparty’s repurchase agreement and to demand immediate payment of any amount due from us to the counterparty.

Under our repurchase agreements, we may be required to pledge additional assets to our repurchase agreement counterparties in the event the estimated fair value of the existing pledged collateral under such agreements declines and such lenders demand additional collateral (commonly referred to as a “margin call”), which may take the form of additional securities or cash. Margin calls on repurchase agreements collateralized by our MBS investments primarily result from events such as declines in the value of the underlying mortgage collateral caused by factors such as rising interest rates or prepayments. Our repurchase agreements generally provide that valuations for MBS securing our repurchase agreements are to be obtained from a generally recognized source agreed to by both parties.  However, in certain circumstances and under certain of our repurchase agreements, our lenders have the sole discretion to determine the value of the MBS securing our repurchase agreements. In such instances, our lenders are required to act in good faith in making determinations of value. Our repurchase agreements generally provide that in the event of a margin call, we must provide additional securities or cash on the same business day that the margin call is made if the lender provides us notice prior to the margin notice deadline on such day.

To date, we have not had any margin calls on our repurchase agreements that we were not able to satisfy with either cash or additional pledged collateral. However, should we encounter increases in interest rates or prepayments, margin calls on our repurchase agreements could result in a material adverse change in our liquidity position.

Our repurchase agreement counterparties apply a “haircut” to the value of the pledged collateral, which means the collateral is valued, for the purposes of the repurchase agreement transaction, at less than fair value.  Upon the renewal of a repurchase agreement financing at maturity, a lender could increase the “haircut” percentage applied to the value of the pledged collateral, thus reducing our liquidity.

Our repurchase agreements generally mature within 30 to 60 days, but may have maturities as short as one day and as long as one year. In the event that market conditions are such that we are unable to continue to obtain repurchase agreement financing for our investments in MBS in amounts and at interest rates consistent with our financing objectives, we may liquidate such investments and may incur significant losses on any such sales of MBS.

39


 

The following table provides information regarding our outstanding repurchase agreement borrowings as of the date and period indicated (dollars in thousands):

 

 

 

September 30, 2019

 

Repurchase agreements outstanding

 

$

3,697,906

 

Agency MBS collateral, at fair value

 

 

3,891,308

 

Net amount (1)

 

 

193,402

 

Weighted-average rate

 

 

2.35

%

Weighted-average term to maturity

 

22.2 days

 

Maximum amount outstanding at any month-end during the period

 

$

3,964,127

 

 

(1)

Net amount represents the value of collateral in excess of corresponding repurchase obligation. The amount of collateral at-risk is limited to the outstanding repurchase obligation and not the entire collateral balance.

To limit our exposure to counterparty risk, we diversify our repurchase agreement funding across multiple counterparties and by counterparty region. As of September 30, 2019, we had outstanding repurchase agreement balances with 15 counterparties and have master repurchase agreements in place with a total of 18 counterparties located throughout North America, Europe and Asia. As of September 30, 2019, no more than 7.3% of our stockholders’ equity was at risk with any one counterparty, with the top five counterparties representing approximately 28.9% of our stockholders’ equity. The table below includes a summary of our repurchase agreement funding by number of counterparties and counterparty region as of September 30, 2019:

 

 

 

Number of

 

 

Percentage of Repurchase

 

 

 

Counterparties

 

 

Agreement Funding

 

North America

 

 

9

 

 

 

67.0

%

Europe

 

 

2

 

 

 

15.2

%

Asia

 

 

4

 

 

 

17.8

%

 

 

 

15

 

 

 

100.0

%

Derivative Instruments

In the normal course of our operations, we are a party to financial instruments that are accounted for as derivative financial instruments including (i) interest rate hedging instruments such as interest rate swaps, U.S. Treasury note futures, Eurodollar futures, interest rate swap futures, put and call options on U.S. Treasury note futures, and options on agency MBS, and (ii) derivative instruments that economically serve as investments such as TBA purchase and sale commitments.

Interest Rate Hedging Instruments

We exchange cash variation margin with the counterparties to our interest rate hedging instruments at least on a daily basis based upon daily changes in fair value as measured by the central clearinghouse through which those derivatives are cleared. In addition, the central clearinghouse requires market participants to deposit and maintain an “initial margin” amount which is determined by the clearinghouse and is generally intended to be set at a level sufficient to protect the clearinghouse from the maximum estimated single-day price movement in that market participant’s contracts. However, the futures commission merchants (“FCMs”) through which we conduct trading of our cleared and exchanged-traded hedging instruments may require incremental initial margin in excess of the clearinghouse’s requirement. The clearing exchanges have the sole discretion to determine the value of our hedging instruments for the purpose of setting initial and variation margin requirements or otherwise.  In the event of a margin call, we must generally provide additional collateral on the same business day. To date, we have not had any margin calls on our hedging agreements that we were not able to satisfy. However, if we encounter significant decreases in long-term interest rates, margin calls on our hedging agreements could result in a material adverse change in our liquidity position.

As of September 30, 2019, we had outstanding interest rate swaps with the following aggregate notional amount and corresponding margin held in collateral deposit with the custodian (dollars in thousands):

 

 

 

September 30, 2019

 

 

 

Notional

 

 

Collateral

 

 

 

Amount

 

 

Deposit

 

Interest rate swaps

 

$

3,000,000

 

 

$

42,506

 

40


 

 

The FCMs through which we conduct trading of our hedging instruments may limit their exposure to us (due to an inherent one business day lag in the variation margin exchange process) by applying a maximum “ceiling” on their level of risk, either overall and/or by instrument type.  The FCMs generally use the amount of initial margin that we have posted with them as a measure of their level of risk exposure to us.  We currently have FCM relationships with four large financial institutions.  To date, among our four FCM arrangements, we have had sufficient excess capacity above and beyond what we believe to be a sufficient and appropriate hedge position.  However, if our FCMs substantially lowered their risk exposure thresholds, we could experience a material adverse change in our liquidity position and our ability to hedge appropriately.

TBA Dollar Roll Transactions

TBA dollar roll transactions represent a form of off-balance sheet financing accounted for as derivative instruments.  In a TBA dollar roll transaction, we do not intend to take physical delivery of the underlying agency MBS and will generally enter into an offsetting position and net settle the paired-off positions in cash.  However, under certain market conditions, it may be uneconomical for us to roll our TBA contracts into future months and we may need to take or make physical delivery of the underlying securities. If we were required to take physical delivery to settle a long TBA contract, we would have to fund our total purchase commitment with cash or other financing sources and our liquidity position could be negatively impacted.

Our TBA commitments and our commitments to purchase and sell specified agency MBS are subject to master securities forward transaction agreements published by SIFMA as well as supplemental terms and conditions with each counterparty.  Under the terms of these agreements, we may be required to pledge collateral to our counterparty in the event the fair value of our agency MBS commitments decline and such counterparty demands collateral through a margin call.  Margin calls on agency MBS commitments are generally caused by factors such as rising interest rates or prepayments.  Our agency MBS commitments provide that valuations for our commitments and any pledged collateral are to be obtained from a generally recognized source agreed to by both parties.  However, in certain circumstances, our counterparties have the sole discretion to determine the value of the agency MBS commitment and any pledged collateral. In such instances, our counterparties are required to act in good faith in making determinations of value.  In the event of a margin call, we must generally provide additional collateral on the same business day.

Equity Capital

Common Equity Offerings

On February 22, 2019, we completed a public offering in which 6,000,000 shares of our Class A common stock was sold at a price of $8.16 per share for proceeds net of offering expenses of $48.8 million.

Common Equity Distribution Agreements

On February 22, 2017, we entered into separate common equity distribution agreements (the “Equity Distribution Agreements”) with equity sales agents JMP Securities LLC, FBR Capital Markets & Co., JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. pursuant to which we may offer and sell, from time to time, up to 6,000,000 shares of our Class A common stock. On August 10, 2018, we entered into separate amendments to the Equity Distribution Agreements (the “Amended Equity Distribution Agreements”) with equity sales agents JMP Securities LLC, B. Riley FBR, Inc. (formerly, FBR Capital Markets & Co.), JonesTrading Institutional Services LLC and Ladenburg Thalman & Co. Inc. pursuant to which we may offer and sell, from time to time, up to 12,597,423 shares of our Class A common stock.

Pursuant to the common equity distribution agreements, shares of our common stock may be offered and sold through the equity sales agents in transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange or, subject to the terms of a written notice from us, in privately negotiated transactions. During the nine months ended September 30, 2019, there were no issuances of common stock under the common equity distribution agreements.

As of September 30, 2019, we had 11,302,160 shares of Class A common stock available for sale under the Amended Equity Distribution Agreements.

Preferred Stock

As of September 30, 2019, we had Series B Preferred Stock outstanding with a liquidation preference of $8.9 million.  The Series B Preferred Stock is publicly traded on the New York Stock Exchange under the ticker symbol “AI PrB.” The Series B Preferred Stock has no stated maturity, is not subject to any sinking fund and will remain outstanding indefinitely unless repurchased or redeemed by us. Holders of Series B Preferred Stock have no voting rights, except under limited conditions and are entitled to receive a cumulative cash dividend at a rate of 7.00% per annum of their $25.00 per share liquidation preference (equivalent to $1.75

41


 

per annum per share). Shares of Series B Preferred Stock are redeemable at $25.00 per share, plus accumulated and unpaid dividends (whether or not authorized or declared) exclusively at our option commencing on May 12, 2022 or earlier upon the occurrence of a change in control. Dividends are payable quarterly in arrears on the 30th day of each December, March, June and September, when and as declared. We have declared and paid all required quarterly dividends on our Series B Preferred Stock to date.

As of September 30, 2019, we had Series C Preferred Stock outstanding with a liquidation preference of $30.0 million.  The Series C Preferred Stock is publicly traded on the New York Stock Exchange under the ticker symbol “AI PrC.”  The Series C Preferred Stock has no stated maturity, is not subject to any sinking fund and will remain outstanding indefinitely unless repurchased or redeemed by us. Holders of Series C Preferred Stock have no voting rights except under limited conditions and will be entitled to receive cumulative cash dividends (i) from and including the original issue date to, but excluding, March 30, 2024 at a fixed rate equal to 8.250% per annum of the $25.00 per share liquidation preference (equivalent to $2.0625 per annum per share) and (ii) from and including March 30, 2024, at a floating rate equal to three-month LIBOR plus a spread of 5.664% per annum. Shares of Series C Preferred Stock are redeemable at $25.00 per share, plus accumulated and unpaid dividends (whether or not authorized or declared) exclusively at our option commencing on March 30, 2024 or earlier upon the occurrence of a change in control or under circumstances where it is necessary to preserve our qualification as a REIT.  Under certain circumstances upon a change of control, the Series C Preferred Stock is convertible into shares of the Company’s common stock.  Dividends will be payable quarterly in arrears on the 30th day of March, June, September and December of each year, when and as declared. We have declared and paid all required quarterly dividends on our Series C Preferred Stock to date.

Preferred Equity Distribution Agreement

On May 16, 2017, we entered into a preferred equity distribution agreement (the “Series B Preferred Equity Distribution Agreement”) with JonesTrading Institutional Services LLC, pursuant to which we may offer and sell, from time to time, up to 1,865,000 shares of our Series B Preferred Stock. On March 21, 2019, we entered into an amended and restated equity distribution agreement (“Amended Series B Preferred Equity Distribution Agreement”) with JonesTrading Institutional Services LLC, B. Riley FBR, Inc., Compass Point Research and Trading, LLC and Ladenburg Thalmann & Co. Inc. (collectively, the “Series B Preferred Equity Agents”), pursuant to which we may offer and sell, from time to time, up to 1,647,370 shares of our Series B Preferred Stock. Pursuant to the Amended Series B Preferred Equity Distribution Agreement, shares of our Series B Preferred stock may be offered and sold through the Series B Preferred Equity Sales Agents in transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange or, subject to the terms of a written notice from us, in privately negotiated transactions.  

The following table provides information about the issuances of preferred stock under the Series B Preferred Equity Distribution Agreement for the period indicated (dollars in thousands):

 

Series B Preferred Stock Issuances

 

Nine Months Ended September 30, 2019

 

Shares issued

 

 

3,444

 

Weighted average public offering price

 

$

22.39

 

Net proceeds (1)

 

$

76

 

 

(1)

Net of selling commissions and expenses.

As of September 30, 2019, we had 1,645,961 shares of Series B Preferred stock available for sale under the Amended Series B Preferred Equity Distribution Agreement.

REIT Distribution Requirements

Commencing with our taxable year ending December 31, 2019, we intend to elect to be taxed as a REIT under the Internal Revenue Code.  As a REIT, we will be required to distribute annually 90% of our REIT taxable income (subject to certain adjustments) to our shareholders.  So long as we continue to qualify as a REIT, we will generally not be subject to U.S. Federal or state corporate income taxes on our taxable income that we distribute to our shareholders on a timely basis.  At present, it is our intention to distribute 100% of our taxable income, although we will not be required to do so. We intend to make distributions of our taxable income within the time limits prescribed by the Internal Revenue Code, which may extend into the subsequent taxable year.

 

Off-Balance Sheet Arrangements

As of September 30, 2019 and December 31, 2018, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance, or special purpose or variable interest entities (“VIEs”), established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. Our

42


 

economic interests held in unconsolidated VIEs are limited in nature to those of a passive holder of MBS issued by a securitization trust. As of September 30, 2019 and December 31, 2018, we had not consolidated for financial reporting purposes any securitization trusts as we do not have the power to direct the activities that most significantly impact the economic performance of such entities. Further, as of September 30, 2019 and December 31, 2018, we had not guaranteed any obligations of unconsolidated entities or entered into any commitment or intent to provide funding to any such entities.

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market risk is the exposure to loss resulting from changes in market factors such as interest rates, foreign currency exchange rates, commodity prices, equity prices and other market changes that affect market risk sensitive instruments. The primary market risks that we are exposed to are interest rate risk, prepayment risk, extension risk, spread risk, liquidity risk and regulatory risk. See “Item 1 — Business” in our Annual Report on Form 10-K for the year ended December 31, 2018 for a description of our risk management strategies. The following is additional information regarding certain of these market risks.

Interest Rate Risk

We are exposed to interest rate risk in our MBS portfolio. Our investments in MBS are financed with short-term borrowing facilities such as repurchase agreements, which are interest rate sensitive financial instruments. Our exposure to interest rate risk fluctuates based upon changes in the level and volatility of interest rates, mortgage prepayments, and in the shape and slope of the yield curve, among other factors. Through the use of interest rate hedging instruments, we attempt to economically hedge a portion of our exposure to changes, attributable to changes in benchmark interest rates, in agency MBS fair values and future interest cash flows on our short-term financing arrangements. Our primary interest rate hedging instruments include interest rate swaps as well as U.S. Treasury note futures, options on U.S. Treasury note futures, and options on agency MBS. Historically, we have also utilized Eurodollar futures and interest rate swap futures.

Changes in both short- and long-term interest rates affect us in several ways, including our financial position. As interest rates increase, the fair value of fixed-rate agency MBS may be expected to decline, prepayment rates may be expected to decrease and duration may be expected to extend. However, an increase in interest rates results in an increase in the fair value of our interest rate hedging instruments. Conversely, if interest rates decline, the fair value of fixed-rate agency MBS is generally expected to increase while the fair value of our interest rate hedging instruments is expected to decline.

The tables that follow illustrate the estimated change in fair value for our current investments in agency MBS and derivative instruments under several hypothetical scenarios of interest rate movements. For the purposes of this illustration, interest rates are defined by the U.S. Treasury yield curve. Changes in fair value are measured as percentage changes from their respective fair values presented in the column labeled “Value.” Our estimate of the change in the fair value of agency MBS is based upon the same assumptions we use to manage the impact of interest rates on the portfolio. The interest rate sensitivity of our agency MBS and TBA commitments is derived from The Yield Book, a third-party model. Actual results could differ significantly from these estimates. The effective durations are based on observed fair value changes, as well as our own estimate of the effect of interest rate changes on the fair value of the investments, including assumptions regarding prepayments based, in part, on age and interest rate of the mortgages underlying the MBS, prior exposure to refinancing opportunities, and an overall analysis of historical prepayment patterns under a variety of historical interest rate conditions.

The interest rate sensitivity analyses illustrated by the tables that follow have certain limitations, most notably the following:

 

The 50 and 100 basis point upward and downward shocks to interest rates that are applied in the analyses represent parallel shocks to the forward yield curve. The analyses do not consider the sensitivity of stockholders’ equity to changes in the shape or slope of the forward yield curve.

 

The analyses assume that spreads remain constant and, therefore, do not reflect an estimate of the impact that changes in spreads would have on the value of our MBS investments or our LIBOR-based derivative instruments, such as our interest rate swap agreements.

 

The analyses assume a static portfolio and do not reflect activities and strategic actions that management may take in the future to manage interest rate risk in response to significant changes in interest rates or other market conditions.

43


 

These analyses are not intended to provide a precise forecast. Actual results could differ materially from these estimates (dollars in thousands, except per share amounts):

 

 

 

September 30, 2019

 

 

 

 

 

 

 

Value

 

 

Value

 

 

 

 

 

 

 

with 50

 

 

with 50

 

 

 

 

 

 

 

Basis Point

 

 

Basis Point

 

 

 

 

 

 

 

Increase in

 

 

Decrease in

 

 

 

Value

 

 

Interest Rates

 

 

Interest Rates

 

Agency MBS

 

$

4,013,161

 

 

$

3,954,569

 

 

$

4,052,900

 

TBA commitments

 

 

(274

)

 

 

(2,840

)

 

 

1,814

 

Interest rate swaps

 

 

225

 

 

 

49,313

 

 

 

(48,863

)

Equity available to common stock

 

 

269,326

 

 

 

257,257

 

 

 

262,064

 

Book value per common share

 

$

7.35

 

 

$

7.02

 

 

$

7.15

 

Book value per common share percent change

 

 

 

 

 

 

(4.48

)%

 

 

(2.70

)%

 

 

 

September 30, 2019

 

 

 

 

 

 

 

Value

 

 

Value

 

 

 

 

 

 

 

with 100

 

 

with 100

 

 

 

 

 

 

 

Basis Point

 

 

Basis Point

 

 

 

 

 

 

 

Increase in

 

 

Decrease in

 

 

 

Value

 

 

Interest Rates

 

 

Interest Rates

 

Agency MBS

 

$

4,013,161

 

 

$

3,874,473

 

 

$

4,083,075

 

TBA commitments

 

 

(274

)

 

 

(5,781

)

 

 

3,386

 

Interest rate swaps

 

 

225

 

 

 

98,402

 

 

 

(97,952

)

Equity available to common stock

 

 

269,326

 

 

 

223,307

 

 

 

244,724

 

Book value per common share

 

$

7.35

 

 

$

6.10

 

 

$

6.68

 

Book value per common share percent change

 

 

 

 

 

 

(17.09

)%

 

 

(9.13

)%

 

Spread Risk

Our investments in MBS expose us to “spread risk.”  Spread risk, also known as “basis risk,” is the risk of an increase in the spread between market participants’ required rate of return (or “market yield”) on our MBS and prevailing benchmark interest rates, such as the U.S. Treasury or interest rate swap rates.

The spread risk inherent to our investments in agency MBS and the resulting fluctuations in fair value of these securities can occur independent of changes in prevailing benchmark interest rates and may relate to other factors impacting the mortgage and fixed income markets, such as actual or anticipated monetary policy actions by the U. S. Federal Reserve, liquidity, or changes in market participants’ required rates of return on different assets. While we use interest rate hedging instruments to attempt to mitigate the sensitivity of our net book value to changes in prevailing benchmark interest rates, such instruments are generally not designed to mitigate spread risk inherent to our investment in agency MBS. Consequently, the value of our agency MBS and, in turn, our net book value, could decline independent of changes in interest rates.

The tables that follow illustrate the estimated change in fair value for our investments in agency MBS and TBA commitments under several hypothetical scenarios of agency MBS spread movements. Changes in fair value are measured as percentage changes from their respective fair values presented in the column labeled “Value.” The sensitivity of our agency MBS and TBA commitments to changes in MBS spreads is derived from The Yield Book, a third-party model. The analysis to follow reflects an assumed spread duration for our investment in agency MBS of 4.5 years, which is a model-based assumption that is dependent upon the size and composition of our investment portfolio as well as economic conditions present as of September 30, 2019.

These analyses are not intended to provide a precise forecast. Actual results could differ materially from these estimates (dollars in thousands, except per share amounts):

44


 

 

 

 

September 30, 2019

 

 

 

 

 

 

 

Value with

 

 

Value with

 

 

 

 

 

 

 

10 Basis Point

 

 

10 Basis Point

 

 

 

 

 

 

 

Increase in

 

 

Decrease In

 

 

 

 

 

 

 

Agency MBS

 

 

Agency MBS

 

 

 

Value

 

 

Spreads

 

 

Spreads

 

Agency MBS

 

$

4,013,161

 

 

$

3,995,191

 

 

$

4,031,131

 

TBA commitments

 

 

(274

)

 

 

(830

)

 

 

283

 

Equity available to common stock

 

 

269,326

 

 

 

250,800

 

 

 

287,853

 

Book value per common share

 

$

7.35

 

 

$

6.85

 

 

$

7.86

 

Book value per common share percent change

 

 

 

 

 

 

(6.88

)%

 

 

6.88

%

 

 

 

September 30, 2019

 

 

 

 

 

 

 

Value with

 

 

Value with

 

 

 

 

 

 

 

25 Basis Point

 

 

25 Basis Point

 

 

 

 

 

 

 

Increase in

 

 

Decrease In

 

 

 

 

 

 

 

Agency MBS

 

 

Agency MBS

 

 

 

Value

 

 

Spreads

 

 

Spreads

 

Agency MBS

 

$

4,013,161

 

 

$

3,968,236

 

 

$

4,058,086

 

TBA commitments

 

 

(274

)

 

 

(1,666

)

 

 

1,119

 

Equity available to common stock

 

 

269,326

 

 

 

223,009

 

 

 

315,644

 

Book value per common share

 

$

7.35

 

 

$

6.09

 

 

$

8.62

 

Book value per common share percent change

 

 

 

 

 

 

(17.20

)%

 

 

17.20

%

 

Inflation

Virtually all of our assets and liabilities are interest rate sensitive in nature. As a result, interest rates and other factors influence our performance far more than inflation. Changes in interest rates do not necessarily correlate with inflation rates or changes in inflation rates. Our financial statements are prepared in accordance with GAAP and our distributions are determined by our Board of Directors in its sole discretion; in each case, our activities and balance sheet are measured with reference to fair value without considering inflation.

Cautionary Statement About Forward-Looking Information

When used in this Quarterly Report on Form 10-Q, in future filings with the Securities and Exchange Commission (“SEC”) or in press releases or other written or oral communications, statements which are not historical in nature, including those containing words such as “believe,” “expect,” “anticipate,” “estimate,” “plan,” “continue,” “intend,” “should,” “may” or similar expressions, are intended to identify “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and, as such, may involve known and unknown risks, uncertainties and assumptions. The forward-looking statements we make in this Quarterly Report on Form 10-Q include, but are not limited to, statements about the following:

 

the availability and terms of, and our ability to deploy, capital and our ability to grow our business through our current strategy focused on acquiring primarily residential mortgage-backed securities (“MBS”) that are either issued by U.S. government agencies or guaranteed as to principal and interest by U.S. government agencies or U.S. government sponsored agencies (“agency MBS”), and MBS issued by private organizations (“private-label MBS”);

 

our ability to qualify and maintain our qualification as a real estate investment trust (“REIT”);

 

our ability to forecast our tax attributes, which are based upon various facts and assumptions, and our ability to protect and use our net operating losses (“NOLs”) and net capital losses (“NCLs”) to offset future taxable income, including whether our shareholder rights plan (“Rights Plan”) will be effective in preventing an ownership change that would significantly limit our ability to utilize such losses;

 

our business, acquisition, leverage, asset allocation, operational, investment, hedging and financing strategies and the success of, or changes in, these strategies;

 

the effect of changes in prepayment rates, interest rates and default rates on our portfolio;

 

the effect of governmental regulation and actions on our business, including, without limitation, changes to monetary and fiscal policy and tax laws;

45


 

 

our ability to quantify and manage risk;

 

our ability to roll our repurchase agreements on favorable terms, if at all;

 

our liquidity;

 

our asset valuation policies;

 

our decisions with respect to, and ability to make, future dividends;

 

investing in assets other than MBS or pursuing business activities other than investing in MBS;

 

our ability to successfully operate our business as a REIT;

 

our ability to maintain our exclusion from the definition of “investment company” under the Investment Company Act of 1940, as amended; and

 

the effect of general economic conditions on our business.

Forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account information currently in our possession. These beliefs, assumptions and expectations may change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, the performance of our portfolio and our business, financial condition, liquidity and results of operations may vary materially from those expressed, anticipated or contemplated in our forward-looking statements. You should carefully consider these risks, along with the following factors that could cause actual results to vary from our forward-looking statements, before making an investment in our securities:

 

the overall environment for interest rates, changes in interest rates, interest rate spreads, the yield curve and prepayment rates, including the timing of increases in the Federal Funds rate by the U.S. Federal Reserve;

 

the effect of any changes to LIBOR and establishment of alternative reference rates;

 

current conditions and further adverse developments in the residential mortgage market and the overall economy;

 

potential risk attributable to our mortgage-related portfolios, including changes in fair value;

 

our use of leverage and our dependence on repurchase agreements and other short-term borrowings to finance our mortgage-related holdings;

 

the availability of certain short-term liquidity sources;

 

competition for investment opportunities;

 

the U.S. Federal Reserve’s balance sheet normalization program of gradually reducing its reinvestment of principal payments of U.S. Treasury securities and agency MBS;

 

the federal conservatorship of the Federal National Mortgage Association (“Fannie Mae”) and the Federal Home Loan Mortgage Corporation (“Freddie Mac”) and related efforts, along with any changes in laws and regulations affecting the relationship between Fannie Mae and Freddie Mac and the federal government;

 

mortgage loan prepayment activity, modification programs and future legislative action;

 

changes in, and success of, our acquisition, hedging and leverage strategies, changes in our asset allocation and changes in our operational policies, all of which may be changed by us without shareholder approval;

 

failure of sovereign or municipal entities to meet their debt obligations or a downgrade in the credit rating of such debt obligations;

 

fluctuations of the value of our hedge instruments;

 

fluctuating quarterly operating results;

 

changes in laws and regulations and industry practices that may adversely affect our business;

 

volatility of the securities markets and activity in the secondary securities markets in the United States and elsewhere;

 

our ability to qualify and maintain our qualification as a REIT for federal income tax purposes;

 

our ability to successfully expand our business into areas other than investing in MBS and our expectations of the returns of expanding into any such areas; and

46


 

 

the other important factors identified in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the year ended December 31, 2018 under the caption “Item 1A — Risk Factors”.

These and other risks, uncertainties and factors, including those described elsewhere in this Quarterly Report on Form 10-Q, could cause our actual results to differ materially from those projected in any forward-looking statements we make. All forward-looking statements speak only as of the date on which they are made. New risks and uncertainties arise over time and it is not possible to predict those events or how they may affect us. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Item 4. Controls and Procedures

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, our management, with the participation of our Chief Executive Officer, J. Rock Tonkel, Jr., and our Chief Financial Officer, Richard E. Konzmann, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) pursuant to Rule 13a-15(b) of the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding disclosure.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

47


 

PART II

OTHER INFORMATION

Item 1. Legal Proceedings

We are from time to time involved in civil lawsuits, legal proceedings and arbitration matters that we consider to be in the ordinary course of our business. There can be no assurance that these matters individually or in the aggregate will not have a material adverse effect on our financial condition or results of operations in a future period. We are also subject to the risk of litigation, including litigation that may be without merit. As we intend to actively defend such litigation, significant legal expenses could be incurred. An adverse resolution of any future litigation against us could materially affect our financial condition, results of operations and liquidity. Furthermore, we operate in highly-regulated markets that currently are under intense regulatory scrutiny, and we have received, and we expect in the future that we may receive, inquiries and requests for documents and information from various federal, state and foreign regulators. In addition, one or more of our subsidiaries have received requests to repurchase loans from various parties in connection with the former securitization business conducted by a subsidiary. We believe that the continued scrutiny of MBS, structured finance, and derivative market participants increases the risk of additional inquiries and requests from regulatory or enforcement agencies and other parties. We cannot provide any assurance that these inquiries and requests will not result in further investigation of or the initiation of a proceeding against us or that, if any such investigation or proceeding were to arise, it would not materially adversely affect our Company.

Item 1A. Risk Factors

None.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities by the Issuer

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

 

Exhibit
Number

 

Exhibit Title

 

 

 

3.01

 

Amended and Restated Articles of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q filed on November 9, 2009).

 

 

 

3.02

 

Articles of Amendment to the Amended and Restated Articles of Incorporation designating the shares of 7.00% Series B Cumulative Perpetual Redeemable Preferred Stock, $0.01 par value per share (incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form 8-A filed on May 9, 2017).

 

 

 

3.03

 

Articles of Amendment to the Amended and Restated Articles of Incorporation of Arlington Asset Investment Corp. designating the Company’s 8.250% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, par value $0.01 per share (incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form 8-A filed on March 11, 2019).

 

 

 

3.04

 

Articles of Amendment to the Amended and Restated Articles of Incorporation of Arlington Asset Investment Corp. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 25, 2019).

 

 

 

48


 

Exhibit
Number

 

Exhibit Title

3.05

 

Amended and Restated Bylaws, as amended (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on July 28, 2011).

 

 

 

3.06

 

Amendment No. 1 to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on February 4, 2015).

 

 

 

3.07

 

Amendment No. 2 to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 26, 2016).

 

 

 

3.08

 

Amendment No. 3 to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on January 17, 2019).

 

 

 

4.01

 

Form of Indenture governing the Senior Debt Securities by and between the Company and The Bank of New York Mellon, as Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-3 (File No. 333-215384) filed on December 30, 2016).

 

 

 

4.02

 

Form of Indenture governing the Subordinated Debt Securities by and between the Company and The Bank of New York Mellon, as Trustee (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-3 (File No. 333-215384) filed on December 30, 2016).

 

 

 

4.03

 

Indenture dated as of May 1, 2013 between the Company and Wells Fargo Bank, National Association, as trustee (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed on May 1, 2013).

 

 

 

4.04

 

First Supplemental Indenture dated as of May 1, 2013 between the Company and Wells Fargo Bank, National Association, as trustee (incorporated by reference to Exhibit 4.2 of the Company’s Current Report on Form 8-K filed on May 1, 2013).

 

 

 

4.05

 

Second Supplemental Indenture, dated as of March 18, 2015, between the Company, Wells Fargo Bank, National Association, as Trustee and The Bank of New York Mellon, as Series Trustee (incorporated by reference to Exhibit 4.3 to the Company’s Form 8-A filed on March 18, 2015).

 

 

 

4.06

 

Form of Senior Note (incorporated by reference to Exhibit 4.5 to the Company’s Registration Statement on Form S-3 (File No. 333-215384) filed on December 30, 2016).

 

 

 

4.07

 

Form of Subordinated Note (incorporated by reference to Exhibit 4.6 to the Company’s Registration Statement on Form S-3 (File No. 333-215384) filed on December 30, 2016).

 

 

 

4.08

 

Form of 6.625% Senior Notes due 2023 (incorporated by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K filed by the Company on May 1, 2013).

 

 

 

4.09

 

Form of 6.750% Notes due 2025 (incorporated by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K filed by the Company on March 17, 2015).

 

 

 

4.10

 

Form of Certificate for Class A common stock (incorporated by reference to Exhibit 4.01 of the Company’s Annual Report on Form 10-K filed with the SEC on February 24, 2010).

 

 

 

4.11

 

Form of specimen certificate representing the shares of 7.00% Series B Perpetual Redeemable Preferred Stock (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form 8-A filed on May 9, 2017).

 

 

 

4.12

 

Form of specimen certificate representing the shares of 8.250% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form 8-A filed on March 11, 2019).

 

 

 

4.13

 

Shareholder Rights Agreement, dated June 5, 2009 (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed with the SEC on June 5, 2009).

 

 

 

4.14

 

First Amendment to Shareholder Rights Agreement, dated as of April 13, 2018 (incorporated by reference to Exhibit 4.2 of the Company’s Current Report on Form 8-K filed with the SEC on April 13,2018).

 

 

 

31.01 

 

Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

 

 

 

31.02 

 

Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

 

 

 

49


 

Exhibit
Number

 

Exhibit Title

32.01 

 

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

 

 

 

32.02 

 

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

 

 

 

101.INS 

 

INSTANCE DOCUMENT***

 

 

 

101.SCH

 

SCHEMA DOCUMENT***

 

 

 

101.CAL

 

CALCULATION LINKBASE DOCUMENT***

 

 

 

101.LAB

 

LABELS LINKBASE DOCUMENT***

 

 

 

101.PRE

 

PRESENTATION LINKBASE DOCUMENT***

 

 

 

101.DEF

 

DEFINITION LINKBASE DOCUMENT***

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*

Filed herewith.

**

Furnished herewith.

***

Submitted electronically herewith. Attached as Exhibit 101 are the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets at September 30, 2019 and December 31, 2018; (ii) Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2019 and 2018; (iii) Consolidated Statements of Changes in Equity for the Three Months Ended March 31, 2019 and 2018, the Three Months Ended June 30, 2019 and 2018, and the Three Months Ended September 30, 2019 and 2018; and (iv) Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2019 and 2018.

50


 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

ARLINGTON ASSET INVESTMENT CORP.

 

By:

 

/s/ RICHARD E. KONZMANN

 

 

 

Richard E. Konzmann

 

 

 

Executive Vice President, Chief Financial Officer and Treasurer

 

 

 

(Principal Financial Officer)

Date: November 8, 2019

 

 

 

 

51

ai-ex3101_7.htm

Exhibit 31.01

CERTIFICATION

I, J. Rock Tonkel, Jr., certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 of Arlington Asset Investment Corp.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 8, 2019

 

/s/ J. ROCK TONKEL, JR.

 

 

J. Rock Tonkel, Jr.

President and Chief Executive Officer

(Principal Executive Officer)

 

ai-ex3102_8.htm

 

Exhibit 31.02

CERTIFICATION

I, Richard E. Konzmann, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 of Arlington Asset Investment Corp.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 8, 2019

 

/s/ RICHARD E. KONZMANN

 

 

Richard E. Konzmann

Executive Vice President,

Chief Financial Officer and Treasurer

(Principal Financial Officer)

 

 

ai-ex3201_6.htm

 

Exhibit 32.01

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Arlington Asset Investment Corp. (the “Company”) for the period ended September 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, J. Rock Tonkel, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 8, 2019

 

/s/ J. ROCK TONKEL, JR.

 

 

J. Rock Tonkel, Jr.

 

 

President and Chief Executive Officer

(Principal Executive Officer)

 

 

ai-ex3202_9.htm

Exhibit 32.02

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Arlington Asset Investment Corp. (the “Company”) for the period ended September 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard E. Konzmann, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 8, 2019

 

/s/ RICHARD E. KONZMANN

 

 

Richard E. Konzmann

 

 

Executive Vice President,

 

 

Chief Financial Officer and Treasurer

 

 

(Principal Financial Officer)

 

 

v3.19.3
Investments in Agency MBS - Additional Information About Gains and Losses Recognized with Respect to Investments in MBS classified as trading securities (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Net gains (losses) recognized in earnings for:        
Total $ 16,890 $ (37,878) $ 128,297 $ (147,113)
Agency MBS        
Net gains (losses) recognized in earnings for:        
MBS still held at period end 12,576 (29,744) 62,220 (103,536)
MBS sold during the period 4,315 (8,113) 66,076 (43,547)
Total $ 16,891 $ (37,857) $ 128,296 $ (147,083)
v3.19.3
Derivative Instruments (Tables)
9 Months Ended
Sep. 30, 2019
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]  
Schedule of Derivative Instruments

The following table presents the fair value of the Company’s derivative instruments as of the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

 

 

Assets

 

 

Liabilities

 

 

Assets

 

 

Liabilities

 

Interest rate swaps

 

$

269

 

 

$

(44

)

 

$

 

 

$

(5,709

)

10-year U.S. Treasury note futures

 

 

 

 

 

 

 

 

 

 

 

(1,250

)

TBA commitments

 

 

406

 

 

 

(680

)

 

 

438

 

 

 

 

Total

 

$

675

 

 

$

(724

)

 

$

438

 

 

$

(6,959

)

Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location

The following tables provide information about the derivative gains and losses recognized within the periods indicated:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Interest rate derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net interest income (1)

$

4,445

 

 

$

2,295

 

 

$

12,961

 

 

$

3,962

 

Unrealized (losses) gains, net

 

(18,087

)

 

 

11,386

 

 

 

(100,337

)

 

 

66,023

 

(Losses) gains realized upon early termination, net

 

(11,992

)

 

 

17,567

 

 

 

(67,181

)

 

 

38,050

 

Total interest rate swap (losses) gains, net

 

(25,634

)

 

 

31,248

 

 

 

(154,557

)

 

 

108,035

 

U.S. Treasury note futures, net

 

(2,696

)

 

 

8,691

 

 

 

(16,421

)

 

 

27,171

 

Options on U.S. Treasury note futures, net

 

 

 

 

 

 

 

76

 

 

 

 

Total interest rate derivative (losses) gains, net

 

(28,330

)

 

 

39,939

 

 

 

(170,902

)

 

 

135,206

 

TBA and specified agency MBS commitments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TBA dollar roll income (2)

 

923

 

 

 

4,604

 

 

 

4,338

 

 

 

17,989

 

Other gains (losses) on agency MBS commitments, net

 

2,054

 

 

 

(8,923

)

 

 

16,934

 

 

 

(61,369

)

Total gains (losses) on agency MBS commitments, net

 

2,977

 

 

 

(4,319

)

 

 

21,272

 

 

 

(43,380

)

Total derivative (losses) gains, net

$

(25,353

)

 

$

35,620

 

 

$

(149,630

)

 

$

91,826

 

 

 

(1)

Represents the periodic net interest settlement incurred during the period (often referred to as “net interest carry”). Also includes “price alignment interest” income earned or expense incurred on cumulative variation margin paid or received, respectively, associated with centrally cleared interest rate swap agreements.

 

 

(2)

Represents the price discount of forward-settling TBA purchases relative to a contemporaneously executed “spot” TBA sale, which economically equates to net interest income that is earned ratably over the period beginning on the settlement date of the sale and ending on the settlement date of the forward-settling purchase.

Derivative Instrument Volume of Activity

The following tables summarize the volume of activity, in terms of notional amount, related to derivative instruments for the periods indicated:

  

 

 

For the Three Months Ended September 30, 2019

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled

Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

2,600,000

 

 

$

750,000

 

 

$

(250,000

)

 

$

(100,000

)

 

$

3,000,000

 

2-year U.S. Treasury note futures

 

 

 

 

 

139,000

 

 

 

(139,000

)

 

 

 

 

 

 

10-year U.S. Treasury note futures

 

 

155,000

 

 

 

 

 

 

(155,000

)

 

 

 

 

 

 

Commitments to purchase (sell) MBS, net

 

 

550,000

 

 

 

900,000

 

 

 

(1,350,000

)

 

 

 

 

 

100,000

 

 

 

 

For the Three Months Ended September 30, 2018

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

3,325,000

 

 

$

750,000

 

 

$

 

 

$

(600,000

)

 

$

3,475,000

 

10-year U.S. Treasury note futures

 

 

700,000

 

 

 

700,000

 

 

 

(700,000

)

 

 

 

 

 

700,000

 

Commitments to purchase (sell) MBS, net

 

 

1,100,000

 

 

 

3,050,000

 

 

 

(3,400,000

)

 

 

 

 

 

750,000

 

 

 

 

For the Nine Months Ended September 30, 2019

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled

Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

3,100,000

 

 

$

1,800,000

 

 

$

(250,000

)

 

$

(1,650,000

)

 

$

3,000,000

 

2-year U.S. Treasury note futures

 

 

 

 

 

139,000

 

 

 

(139,000

)

 

 

 

 

 

 

10-year U.S. Treasury note futures

 

 

320,000

 

 

 

826,600

 

 

 

(885,000

)

 

 

(261,600

)

 

 

 

Sold call options on 10-year U.S. Treasury note futures

 

 

 

 

 

250,000

 

 

 

(250,000

)

 

 

 

 

 

 

Purchased call options on 10-year U.S. Treasury note

  futures

 

 

 

 

 

500,000

 

 

 

(500,000

)

 

 

 

 

 

 

Commitments to purchase (sell) MBS, net

 

 

 

 

 

5,620,000

 

 

 

(5,520,000

)

 

 

 

 

 

100,000

 

 

 

 

For the Nine Months Ended September 30, 2018

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

3,600,000

 

 

$

1,300,000

 

 

$

 

 

$

(1,425,000

)

 

$

3,475,000

 

5-year U.S. Treasury note futures

 

 

21,600

 

 

 

 

 

 

(21,600

)

 

 

 

 

 

 

10-year U.S. Treasury note futures

 

 

650,000

 

 

 

2,550,000

 

 

 

(2,500,000

)

 

 

 

 

 

700,000

 

Commitments to purchase (sell) MBS, net

 

 

1,265,000

 

 

 

11,170,000

 

 

 

(11,685,000

)

 

 

 

 

 

750,000

 

 

Derivative Instruments and Other Financial Instrument Cash Collateral

The following table presents information about the cash collateral posted and received by the Company in respect of its derivative and other financial instruments, which is included in the line item “deposits, net” in the accompanying consolidated balance sheets, for the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

Cash collateral posted for:

 

 

 

 

 

 

 

 

Interest rate swaps (cash initial margin)

 

$

42,506

 

 

$

54,883

 

U.S. Treasury note futures (cash initial margin)

 

 

 

 

 

6,169

 

Unsettled MBS trades and TBA commitments, net

 

 

792

 

 

 

 

Total cash collateral posted, net

 

$

43,298

 

 

$

61,052

 

TBA Commitments  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]  
Schedule of Derivative Instruments

The following tables present information about the Company’s TBA commitments as of the dates indicated:

 

 

 

September 30, 2019

 

 

 

Notional Amount:

Purchase (Sale)

Commitment

 

 

Contractual Forward Price

 

 

Market Price

 

 

Fair Value

 

2.5% 30-year MBS purchase commitments

 

$

100,000

 

 

$

100,273

 

 

$

99,593

 

 

$

(680

)

3.0% 30-year MBS purchase commitments

 

 

100,000

 

 

 

101,547

 

 

 

101,563

 

 

 

16

 

3.0% 30-year MBS sale commitments

 

 

(100,000

)

 

 

(101,953

)

 

 

(101,563

)

 

 

390

 

Total TBA commitments, net

 

$

100,000

 

 

$

99,867

 

 

$

99,593

 

 

$

(274

)

 

 

 

December 31, 2018

 

 

 

Notional Amount:

Purchase (Sale)

Commitment

 

 

Contractual Forward Price

 

 

Market Price

 

 

Fair Value

 

5.0% 30-year MBS purchase commitments

 

$

100,000

 

 

$

103,750

 

 

$

104,047

 

 

$

297

 

5.0% 30-year MBS sale commitments

 

 

(100,000

)

 

 

(104,188

)

 

 

(104,047

)

 

 

141

 

Total TBA commitments, net

 

$

 

 

$

(438

)

 

$

 

 

$

438

 

Interest Rate Swap  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]  
Schedule of Derivative Instruments

The following table presents information about the Company’s interest rate swap agreements that were in effect as of September 30, 2019:

 

 

 

 

 

 

 

Weighted-average:

 

 

 

 

 

 

 

Notional Amount

 

 

Fixed Pay Rate

 

 

Variable Receive Rate

 

 

Net Receive (Pay) Rate

 

 

Remaining Life (Years)

 

 

Fair Value

 

Years to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less than 3 years

 

$

2,175,000

 

 

 

1.73

%

 

 

2.19

%

 

 

0.46

%

 

 

1.7

 

 

$

157

 

3 to less than 7 years

 

 

500,000

 

 

 

1.62

%

 

 

2.12

%

 

 

0.50

%

 

 

6.3

 

 

 

68

 

7 to less than 10 years

 

 

300,000

 

 

 

2.85

%

 

 

2.16

%

 

 

(0.69

)%

 

 

9.3

 

 

 

33

 

10 or more years

 

 

25,000

 

 

 

2.96

%

 

 

2.16

%

 

 

(0.80

)%

 

 

28.5

 

 

 

(33

)

Total / weighted-average

 

$

3,000,000

 

 

 

1.83

%

 

 

2.17

%

 

 

0.34

%

 

 

3.4

 

 

$

225

 

The following table presents information about the Company’s interest rate swap agreements that were in effect as of December 31, 2018:

 

 

 

 

 

 

 

Weighted-average:

 

 

 

 

 

 

 

Notional Amount

 

 

Fixed Pay Rate

 

 

Variable Receive Rate

 

 

Net Receive

(Pay) Rate

 

 

Remaining Life (Years)

 

 

Fair Value

 

Years to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less than 3 years

 

$

1,050,000

 

 

 

1.53

%

 

 

2.60

%

 

 

1.07

%

 

 

1.5

 

 

$

(152

)

3 to less than 7 years

 

 

325,000

 

 

 

2.00

%

 

 

2.73

%

 

 

0.73

%

 

 

4.4

 

 

 

(432

)

7 to less than 10 years

 

 

1,600,000

 

 

 

2.35

%

 

 

2.70

%

 

 

0.35

%

 

 

8.5

 

 

 

(4,572

)

10 or more years

 

 

125,000

 

 

 

3.02

%

 

 

2.66

%

 

 

(0.36

)%

 

 

29.6

 

 

 

(553

)

Total / weighted-average

 

$

3,100,000

 

 

 

2.07

%

 

 

2.67

%

 

 

0.60

%

 

 

6.6

 

 

$

(5,709

)

v3.19.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2019
Schedule of Dividends Payable The Board of Directors has approved and the Company declared and paid the following dividends on its common stock to date in 2019:

 

Quarter Ended

 

Dividend

Amount

 

 

Declaration Date

 

Record Date

 

Pay Date

September 30

 

$

0.225

 

 

September 17

 

September 30

 

October 31

June 30

 

 

0.225

 

 

June 24

 

July 5

 

July 31

March 31

 

 

0.375

 

 

March 18

 

March 29

 

April 30

 

The Board of Directors approved and the Company declared and paid the following dividends for 2018:

 

Quarter Ended

 

Dividend

Amount

 

 

Declaration Date

 

Record Date

 

Pay Date

December 31

 

$

0.375

 

 

December 13

 

December 31

 

January 31, 2019

September 30

 

 

0.375

 

 

September 13

 

September 28

 

October 31

June 30

 

 

0.375

 

 

June 14

 

June 29

 

July 31

March 31

 

 

0.550

 

 

March 15

 

March 29

 

April 30

Common Equity Distribution Agreements  
Issuances of Stock under Equity Distribution Agreements The following table provides information about the issuances of common stock under the common equity distribution agreements for the periods indicated:

 

Class A Common Stock Issuances

 

Year Ended

December 31, 2018

 

Shares issued

 

 

2,226,557

 

Weighted average public offering price

 

$

10.19

 

Net proceeds (1)

 

$

22,326

 

 

 

(1)

Net of selling commissions and expenses.

Series B Preferred Equity Distribution Agreement  
Issuances of Stock under Equity Distribution Agreements

The following table provides information about the issuances of preferred stock under the preferred equity distribution agreements for the periods indicated:

 

Series B Preferred Stock Issuances

 

Nine Months Ended September 30, 2019

 

 

Year Ended

December 31, 2018

 

Shares issued

 

 

3,444

 

 

 

47,304

 

Weighted average public offering price

 

$

22.39

 

 

$

24.75

 

Net proceeds (1)

 

$

76

 

 

$

1,137

 

 

 

(1)

Net of selling commissions and expenses.

v3.19.3
Earnings (Loss) Per Share - Computations of Basic and Diluted Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Earnings Per Share [Abstract]        
Basic weighted-average common shares outstanding 36,572 29,382 35,399 28,601
Diluted weighted-average common shares outstanding 36,572 29,382 35,399 28,601
Net loss attributable to common stock $ (8,511) $ (5,652) $ (15,494) $ (65,929)
Basic loss per common share $ (0.23) $ (0.19) $ (0.44) $ (2.31)
Diluted loss per common share $ (0.23) $ (0.19) $ (0.44) $ (2.31)
v3.19.3
Fair Value Measurements - Additional Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2018
USD ($)
Sep. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]      
Long-term unsecured debt, carrying value   $ 74,272 $ 74,104
Long-term unsecured debt, Fair Value   69,168 66,562
Cumulative effect increase (net of taxes) in stockholders' equity $ 4,059    
Private Equity Funds      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]      
Investment in equity securities and investment funds measured at fair value   $ 6,239 $ 6,115
Private Equity Funds | Stock Price to Net Asset Multiple | Fair Value, Inputs, Level 3      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]      
Fair value discount rate   95 91
Private Equity Funds | Discount Factor for Lack of Marketability and Control | Fair Value, Inputs, Level 3      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]      
Fair value discount rate   9 8
Private Equity Funds | Cost of Equity Discount Rate | Fair Value, Inputs, Level 3      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]      
Fair value discount rate   12 12
Private Equity Funds | ASU No. 2016-01      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]      
Cumulative effect increase (net of taxes) in stockholders' equity $ 4,059    
v3.19.3
Stockholders' Equity - Issuances of Stock under Equity Distribution Agreements (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Feb. 22, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Dec. 31, 2018
Common Class A | Common Stock                
Class Of Stock [Line Items]                
Shares issued 6,000,000   6,000,000 2,007,216 66,989      
Common Class A | Common Stock | Common Equity Distribution Agreements                
Class Of Stock [Line Items]                
Shares issued               2,226,557
Weighted average public offering price               $ 10.19
Net proceeds [1]               $ 22,326
Series B Preferred Stock | Preferred Stock                
Class Of Stock [Line Items]                
Shares issued   1,409 2,035 5,404 18,030 19,431    
Series B Preferred Stock | Preferred Stock | Series B Preferred Equity Distribution Agreement                
Class Of Stock [Line Items]                
Shares issued             3,444 47,304
Weighted average public offering price             $ 22.39 $ 24.75
Net proceeds [1]             $ 76 $ 1,137
[1] Net of selling commissions and expenses.
v3.19.3
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Interest income        
Other $ 215 $ 183 $ 904 $ 419
Total interest income 28,674 32,864 95,223 93,779
Interest expense        
Total interest expense 23,982 22,526 76,032 58,275
Net interest income 4,692 10,338 19,191 35,504
Investment advisory fee income     250  
Investment loss, net        
Gain (loss) on trading investments, net 16,890 (37,878) 128,297 (147,113)
(Loss) gain from derivative instruments, net (25,353) 35,620 (149,630) 91,826
Other, net 232 1 222 375
Total investment loss, net (8,231) (2,257) (21,111) (54,912)
General and administrative expenses        
Compensation and benefits 2,833 2,833 8,182 7,934
Other general and administrative expenses 1,365 1,121 3,816 3,778
Total general and administrative expenses 4,198 3,954 11,998 11,712
(Loss) income before income taxes (7,737) 4,127 (13,668) (31,120)
Income tax provision   9,628   34,372
Net loss (7,737) (5,501) (13,668) (65,492)
Dividend on preferred stock (774) (151) (1,826) (437)
Net loss attributable to common stock $ (8,511) $ (5,652) $ (15,494) $ (65,929)
Basic loss per common share $ (0.23) $ (0.19) $ (0.44) $ (2.31)
Diluted loss per common share $ (0.23) $ (0.19) $ (0.44) $ (2.31)
Weighted-average common shares outstanding (in thousands)        
Basic 36,572 29,382 35,399 28,601
Diluted 36,572 29,382 35,399 28,601
Secured Debt        
Interest expense        
Short-term debt $ 22,721 $ 21,265 $ 72,230 $ 54,526
Unsecured Debt        
Interest expense        
Long-term debt 1,261 1,261 3,802 3,749
Agency MBS        
Interest income        
Mortgage-backed securities 28,455 32,679 94,300 93,344
Private-Label MBS        
Interest income        
Mortgage-backed securities $ 4 $ 2 $ 19 $ 16
v3.19.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

Cash Equivalents

Cash equivalents include demand deposits with banks, money market accounts and highly liquid investments with original maturities of three months or less. As of September 30, 2019 and December 31, 2018, approximately 96% and 99%, respectively, of the Company’s cash equivalents were invested in money market funds that invest primarily in U.S. Treasuries and other securities backed by the U.S. government.

Investment Security Purchases and Sales

Purchases and sales of investment securities are recorded on the settlement date of the transfer unless the trade qualifies as a “regular-way” trade and the associated commitment qualifies for an exemption from the accounting guidance applicable to derivative instruments. A regular-way trade is an investment security purchase or sale transaction that is expected to settle within the period of time following the trade date that is prevalent or traditional for that specific type of security. Any amounts payable or receivable for unsettled security trades are recorded as “sold securities receivable” or “purchased securities payable” in the consolidated balance sheets.

Interest Income Recognition for Investments in Agency MBS

The Company recognizes interest income for its investments in agency MBS by applying the “interest method” permitted by GAAP, whereby purchase premiums and discounts are amortized and accreted, respectively, as an adjustment to contractual interest income accrued at each security’s stated coupon rate. The interest method is applied at the individual security level based upon each security’s effective interest rate. The Company calculates each security’s effective interest rate at the time of purchase by solving for the discount rate that equates the present value of that security's remaining contractual cash flows (assuming no principal prepayments) to its purchase price. Because each security’s effective interest rate does not reflect an estimate of future prepayments, the Company refers to this manner of applying the interest method as the “contractual effective interest method.” When applying the contractual effective interest method to its investments in agency MBS, as principal prepayments occur, a proportional amount of the unamortized premium or discount is recognized in interest income such that the contractual effective interest rate on the remaining security balance is unaffected.

Other Significant Accounting Policies

Certain of the Company’s other significant accounting policies are summarized in the following notes:

 

Investments in agency MBS, subsequent measurement

Note 3

Borrowings

Note 4

To-be-announced agency MBS transactions, including “dollar rolls”

Note 5

Derivative instruments

Note 5

Balance sheet offsetting

Note 6

Fair value measurements

Note 7

 

Refer to the Company’s 2018 Annual Report on Form 10-K for a complete inventory and summary of the Company’s significant accounting policies.

 

Recent Accounting Pronouncements

The following table provides a brief description of recently issued accounting pronouncements and their actual or expected effect on the Company’s consolidated financial statements:

 

Standard

Description

Date of

Adoption

Effect on the Consolidated

Financial Statements

Recently Adopted Accounting Guidance

Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842)

This amendment replaces the existing lease accounting model with a revised model.  The primary change effectuated by the revised lease accounting model is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases.

January 1, 2019

The primary impact of the adoption of ASU No. 2016-02 was the recognition of lease liabilities and associated right-of-use assets, as a component of “Other liabilities” and “Other assets,” respectively, on the Company’s consolidated balance sheets as of September 30, 2019.  The adoption of ASU No. 2016-02 did not have an effect on the timing or amount of periodic lease expense recognized in net income.  The adoption of ASU No. 2016-02 did not have a material effect on the Company’s consolidated financial statements.

 

 

 

 

ASU No. 2017-08, Premium Amortization of Purchased Callable Debt Securities (Subtopic 310-20)

This amendment requires purchase premiums for investments in debt securities that are noncontingently callable by the issuer (at a fixed price and preset date) to be amortized to the earliest call date. Previously, purchase premiums for such investments were permitted to be amortized to the instrument’s maturity date.

 

January 1, 2019

 

 

Investments in prepayable financial assets, such as residential MBS, for which the embedded call options are not held by the issuer are not within the scope of ASU No. 2017-08. Accordingly, the adoption of ASU No. 2017-08 did not have an effect on the Company’s consolidated financial statements.

 

 

 

 

ASU No. 2017-12, Targeted Improvements to Accounting for Hedging Activities (Topic 815)

This update made several targeted amendments to existing GAAP with the objectives of facilitating (i) financial reporting that more closely reflects entities’ risk management strategies and (ii) greater ease of understanding and interpreting the effects of hedge accounting on an entities’ reported results.

January 1, 2019

Hedge accounting pursuant to GAAP is an elective, rather than a required, accounting model.  The Company does not elect to apply hedge accounting.  The adoption of ASU No. 2017-12 did not have an effect on the Company’s consolidated financial statements.

 

 

 

 

Recently Issued Accounting Guidance Not Yet Adopted

 

 

 

 

ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 606)

The amendments in this update require financial assets measured at amortized cost as well as available-for-sale debt securities to be measured for impairment on the basis of the net amount expected to be collected.  Credit losses are to be recognized through an allowance for credit losses, which differs from the direct write-down of the amortized cost basis currently required for other-than-temporary impairments of investments in debt securities.  This update also makes substantial changes to the manner in which interest income is to be recognized for financial assets acquired with a more-than-insignificant amount of credit deterioration since origination.

 

This update will not affect the accounting for investments in debt securities that are classified as trading securities.

January 1, 2020

As of September 30, 2019, all of the Company’s investments in debt securities are classified as trading securities. Accordingly, the Company does not expect ASU No. 2016-13 to have a material impact on its consolidated financial statements.

 

v3.19.3
Offsetting of Financial Assets and Liabilities
9 Months Ended
Sep. 30, 2019
Offsetting [Abstract]  
Offsetting of Financial Assets and Liabilities

Note 6. Offsetting of Financial Assets and Liabilities

The agreements that govern certain of the Company’s derivative instruments and collateralized short-term financing arrangements provide for a right of setoff in the event of default or bankruptcy with respect to either party to such transactions. The Company presents derivative assets and liabilities as well as collateralized short-term financing arrangements on a gross basis.

Receivables recognized for the right to reclaim cash initial margin posted in respect of interest rate derivative instruments are included in the line item “deposits” in the accompanying consolidated balance sheets.

The daily exchange of variation margin associated with a centrally cleared or exchange-traded derivative instrument is legally characterized as the daily settlement of the derivative instrument itself, as opposed to a pledge of collateral. Accordingly, the Company accounts for the daily receipt or payment of variation margin associated with its interest rate swaps and futures as a direct reduction to the carrying value of the interest rate swap derivative asset or liability, respectively. The carrying amount of interest rate swaps and futures reflected in the Company’s consolidated balance sheets is equal to the unsettled fair value of such instruments; because variation margin is exchanged on a one-day lag, the unsettled fair value of such instruments generally represents the change in fair value that occurred on the last day of the reporting period.

The following tables present information, as of the dates indicated, about the Company’s derivative instruments, short-term borrowing arrangements, and associated collateral, including those subject to master netting (or similar) arrangements:

 

 

 

As of September 30, 2019

 

 

 

Gross Amount

Recognized

 

 

Amount Offset

in the

Consolidated

Balance Sheets

 

 

Net Amount

Presented in the

Consolidated

Balance Sheets

 

 

Gross Amount Not Offset in the

Consolidated Balance Sheets

 

 

Net

Amount

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial

Instruments (1)

 

 

Cash

Collateral (2)

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

269

 

 

$

 

 

$

269

 

 

$

(44

)

 

$

 

 

$

225

 

TBA commitments

 

 

406

 

 

 

 

 

 

406

 

 

 

 

 

 

 

 

 

406

 

Total derivative instruments

 

 

675

 

 

 

 

 

 

675

 

 

 

(44

)

 

 

 

 

 

631

 

Total assets

 

$

675

 

 

$

 

 

$

675

 

 

$

(44

)

 

$

 

 

$

631

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

44

 

 

$

 

 

$

44

 

 

$

(44

)

 

$

 

 

$

 

TBA commitments

 

 

680

 

 

 

 

 

 

680

 

 

 

 

 

 

(680

)

 

 

 

Total derivative instruments

 

 

724

 

 

 

 

 

 

724

 

 

 

(44

)

 

 

(680

)

 

 

 

Repurchase agreements

 

 

3,697,906

 

 

 

 

 

 

3,697,906

 

 

 

(3,697,906

)

 

 

 

 

 

 

Total liabilities

 

$

3,698,630

 

 

$

 

 

$

3,698,630

 

 

$

(3,697,950

)

 

$

(680

)

 

$

 

 

 

 

As of December 31, 2018

 

 

 

Gross Amount

Recognized

 

 

Amount Offset

in the

Consolidated

Balance Sheets

 

 

Net Amount

Presented in the

Consolidated

Balance Sheets

 

 

Gross Amount Not Offset in the

Consolidated Balance Sheets

 

 

Net

Amount

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial

Instruments (1)

 

 

Cash

Collateral (2)

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TBA commitments

 

$

438

 

 

$

 

 

$

438

 

 

$

 

 

$

(438

)

 

$

 

Total derivative instruments

 

 

438

 

 

 

 

 

 

438

 

 

 

 

 

 

(438

)

 

 

 

Total assets

 

$

438

 

 

$

 

 

$

438

 

 

$

 

 

$

(438

)

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

5,709

 

 

$

 

 

$

5,709

 

 

$

 

 

$

(5,709

)

 

$

 

10-year U.S. Treasury note futures

 

 

1,250

 

 

 

 

 

 

1,250

 

 

 

 

 

 

(1,250

)

 

 

 

Total derivative instruments

 

 

6,959

 

 

 

 

 

 

6,959

 

 

 

 

 

 

(6,959

)

 

 

 

Repurchase agreements

 

 

3,721,629

 

 

 

 

 

 

3,721,629

 

 

 

(3,721,629

)

 

 

 

 

 

 

Total liabilities

 

$

3,728,588

 

 

$

 

 

$

3,728,588

 

 

$

(3,721,629

)

 

$

(6,959

)

 

$

 

 

(1)

Does not include the fair value amount of financial instrument collateral pledged in respect of repurchase agreements that exceeds the associated liability presented in the consolidated balance sheets.

(2)

Does not include the amount of cash collateral pledged in respect of derivative instruments that exceeds the associated derivative liability presented in the consolidated balance sheets.

 

v3.19.3
Stockholders' Equity
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Stockholders' Equity

Note 10. Stockholders’ Equity

Common Stock

The Company has authorized common share capital of 450,000,000 shares of Class A common stock, par value $0.01 per share, and 100,000,000 shares of Class B common stock, par value $0.01 per share. Holders of the Class A and Class B common stock are entitled to one vote and three votes per share, respectively, on all matters voted upon by the shareholders. Shares of Class B common stock are convertible into shares of Class A common stock on a one-for-one basis at the option of the Company in certain circumstances including either (i) upon sale or other transfer, or (ii) at the time the holder of such shares of Class B common stock ceases to be employed by the Company. As of September 30, 2019 and December 31, 2018, there were no outstanding shares of Class B common stock. The Class A common stock is publicly traded on the New York Stock Exchange under the ticker symbol “AI.”

Common Stock Dividends

The Board of Directors evaluates common stock dividends on a quarterly basis and, in its sole discretion, approves the payment of dividends. The Company’s common stock dividend payments, if any, may vary significantly from quarter to quarter. The Board of Directors has approved and the Company declared and paid the following dividends on its common stock to date in 2019:

 

Quarter Ended

 

Dividend

Amount

 

 

Declaration Date

 

Record Date

 

Pay Date

September 30

 

$

0.225

 

 

September 17

 

September 30

 

October 31

June 30

 

 

0.225

 

 

June 24

 

July 5

 

July 31

March 31

 

 

0.375

 

 

March 18

 

March 29

 

April 30

 

The Board of Directors approved and the Company declared and paid the following dividends for 2018:

 

Quarter Ended

 

Dividend

Amount

 

 

Declaration Date

 

Record Date

 

Pay Date

December 31

 

$

0.375

 

 

December 13

 

December 31

 

January 31, 2019

September 30

 

 

0.375

 

 

September 13

 

September 28

 

October 31

June 30

 

 

0.375

 

 

June 14

 

June 29

 

July 31

March 31

 

 

0.550

 

 

March 15

 

March 29

 

April 30

Common Equity Offerings

 

On February 22, 2019, the Company completed a public offering in which 6,000,000 shares of its Class A common stock were sold at a price of $8.16 per share for proceeds net of offering expenses of $48,827.

Common Equity Distribution Agreements

 

   On February 22, 2017, the Company entered into separate common equity distribution agreements (the “Equity Distribution Agreements”) with equity sales agents JMP Securities LLC, FBR Capital Markets & Co., JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. pursuant to which the Company may offer and sell, from time to time, up to 6,000,000 shares of the Company’s Class A common stock. On August 10, 2018, the Company entered into separate amendments to the Equity Distribution Agreements (the “Amended Equity Distribution Agreements”) with equity sales agents JMP Securities LLC, B. Riley FBR, Inc. (formerly, FBR Capital Markets & Co.), JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. pursuant to which the Company may offer and sell, from time to time, up to 12,597,423 shares of the Company’s Class A common stock.

Pursuant to the common equity distribution agreements, shares of the Company’s common stock may be offered and sold through the equity sales agents in transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange or, subject to the terms of a written notice from the Company, in privately negotiated transactions.

The following table provides information about the issuances of common stock under the common equity distribution agreements for the periods indicated:

 

Class A Common Stock Issuances

 

Year Ended

December 31, 2018

 

Shares issued

 

 

2,226,557

 

Weighted average public offering price

 

$

10.19

 

Net proceeds (1)

 

$

22,326

 

 

 

(1)

Net of selling commissions and expenses.

As of September 30, 2019, the Company had 11,302,160 shares of Class A common stock available for sale under the Amended Equity Distribution Agreements.

Common Share Repurchase Program

 

The Company’s Board of Directors authorized a share repurchase program pursuant to which the Company may repurchase up to 2,000,000 shares of Class A common stock (the “Repurchase Program”). Repurchases under the Repurchase Program may be made from time to time on the open market and in private transactions at management’s discretion in accordance with applicable federal securities laws. The timing of repurchases and the exact number of shares of Class A common stock to be repurchased will depend upon market conditions and other factors. The Repurchase Program is funded using the Company’s cash on hand and cash generated from operations. The Repurchase Program has no expiration date and may be suspended or terminated at any time without prior notice. There were no shares repurchased by the Company under the Repurchase Program during the three and nine months ended September 30, 2019 and the year ended December 31, 2018. As of September 30, 2019, there remain available for repurchase 1,951,305 shares of Class A common stock under the Repurchase Program.

Preferred Stock

The Company has authorized preferred share capital of (i) 100,000 shares designated as Series A Preferred Stock that is unissued; (ii) 2,000,000 shares designated as 7.00% Series B Cumulative Perpetual Redeemable Preferred Stock (the “Series B Preferred Stock”), par value of $0.01 per share; (iii) 2,500,000 shares designated as 8.250% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (the “Series C Preferred Stock”), par value of $0.01 per share; and (iv) 20,400,000 shares of undesignated preferred stock. The Company’s Board of Directors has the authority, without further action by the shareholders, to issue additional preferred stock in one or more series and to fix the terms and rights of the preferred stock. The Company’s preferred stock ranks senior to its common stock with respect to the payment of dividends and the distribution of assets upon a voluntary or involuntary liquidation, dissolution, or winding up of the Company. The Company’s preferred stock ranks on parity with each other.  The Series B Preferred Stock and Series C Preferred Stock are publicly traded on the New York Stock Exchange under the ticker symbols “AI PrB” and “AI PrC,” respectively.

The Series B Preferred Stock has no stated maturity, is not subject to any sinking fund and will remain outstanding indefinitely unless repurchased or redeemed by the Company. Holders of Series B Preferred Stock have no voting rights, except under limited conditions, and are entitled to receive a cumulative cash dividend at a rate of 7.00% per annum of their $25.00 per share liquidation preference (equivalent to $1.75 per annum per share). Shares of Series B Preferred Stock are redeemable at $25.00 per share, plus accumulated and unpaid dividends (whether or not authorized or declared), exclusively at the Company’s option commencing on May 12, 2022 or earlier upon the occurrence of a change in control. Dividends are payable quarterly in arrears on the 30th day of March, June, September and December of each year, when and as declared. We have declared and paid all required quarterly dividends on the Company’s Series B Preferred Stock to date in 2019.

On March 12, 2019, the Company completed an initial public offering in which 1,200,000 shares of its Series C Preferred Stock were issued to the public at a public offering price of $25.00 per share for proceeds net of underwriting discounts and commissions and expenses of $28,944.

The Series C Preferred Stock has no stated maturity, is not subject to any sinking fund and will remain outstanding indefinitely unless repurchased or redeemed by the Company. Holders of Series C Preferred Stock have no voting rights, except under limited conditions, and are entitled to receive a cumulative cash dividend (i) from and including the original issue date to, but excluding, March 30, 2024 at a fixed rate equal to 8.250% per annum of the $25.00 per share liquidation preference (equivalent to $2.0625 per annum per share) and (ii) from and including March 30, 2024, at a floating rate equal to three-month LIBOR plus a spread of 5.664% per annum of the $25.00 per share liquidation preference. Shares of Series C Preferred Stock are redeemable at $25.00 per share, plus accumulated and unpaid dividends (whether or not authorized or declared), exclusively at the Company’s option commencing on March 30, 2024 or earlier upon the occurrence of a change in control or under circumstances where it is necessary to preserve the Company’s qualification as a REIT. Under certain circumstances upon a change of control, the Series C Preferred Stock is convertible into shares of the Company’s common stock. Dividends will be payable quarterly in arrears on the 30th day of March, June, September and December of each year, when and as declared, beginning on June 30, 2019. The first dividend of $0.61875 per share, paid on July 1, 2019, was considered a long first dividend period from the original date of issuance. We have declared and paid all required quarterly dividends on the Company’s Series C Preferred Stock to date in 2019.  

 

Preferred Equity Distribution Agreements

On May 16, 2017, the Company entered into an equity distribution agreement (the “Series B Preferred Equity Distribution Agreement”) with JonesTrading Institutional Services LLC, pursuant to which the Company may offer and sell, from time to time, up to 1,865,000 shares of the Company’s Series B Preferred Stock. On March 21, 2019, the Company entered into an amended and restated equity distribution agreement (“Amended Series B Preferred Equity Distribution Agreement”) with JonesTrading Institutional Services LLC, B. Riley FBR, Inc., Compass Point Research and Trading, LLC and Ladenburg Thalmann & Co. Inc. (collectively, the “Series B Preferred Equity Agents”), pursuant to which the Company may offer and sell, from time to time, up to 1,647,370 shares of the Company’s Series B Preferred Stock.  Pursuant to the Amended Series B Preferred Equity Distribution Agreement, shares of the Company’s Series B Preferred stock may be offered and sold through the Series B Preferred Equity Sales Agents in transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange or, subject to the terms of a written notice from the Company, in privately negotiated transactions.

The following table provides information about the issuances of preferred stock under the preferred equity distribution agreements for the periods indicated:

 

Series B Preferred Stock Issuances

 

Nine Months Ended September 30, 2019

 

 

Year Ended

December 31, 2018

 

Shares issued

 

 

3,444

 

 

 

47,304

 

Weighted average public offering price

 

$

22.39

 

 

$

24.75

 

Net proceeds (1)

 

$

76

 

 

$

1,137

 

 

 

(1)

Net of selling commissions and expenses.

As of September 30, 2019, the Company had 1,645,961 shares of Series B Preferred stock available for sale under the Amended Series B Preferred Equity Distribution Agreement.

 

 

Shareholder Rights Agreement

On June 1, 2009, the Board of Directors approved a shareholder rights agreement (“Rights Plan”) and the Company’s shareholders approved the Rights Plan at its annual meeting of shareholders on June 2, 2010.  On April 9, 2018, the Board of Directors approved a first amendment to the Rights Plan (“First Amendment”) to extend the term for an additional three years and the Company’s shareholders approved the First Amendment at its annual meeting of shareholders on June 14, 2018.  

Under the terms of the Rights Plan, in general, if a person or group acquires or commences a tender or exchange offer for beneficial ownership of 4.9% or more of the outstanding shares of our Class A common stock upon a determination by our Board of Directors (an “Acquiring Person”), all of our other Class A and Class B common shareholders will have the right to purchase securities from us at a discount to such securities’ fair market value, thus causing substantial dilution to the Acquiring Person.

The Board of Directors adopted the Rights Plan in an effort to protect against a possible limitation on the Company’s ability to use its NOL carryforwards, NCL carryforwards, and built-in losses under Sections 382 and 383 of the Code. The Company’s ability to use its NOLs, NCLs and built-in losses would be limited if it experienced an “ownership change” under Section 382 of the Code. In general, an “ownership change” would occur if there is a cumulative change in the ownership of the Company’s common stock of more than 50% by one or more “5% shareholders” during a three-year period. The Rights Plan was adopted to dissuade any person or group from acquiring 4.9% or more of the Company’s outstanding Class A common stock, each, an Acquiring Person, without the approval of the Board of Directors and triggering an “ownership change” as defined by Section 382.

The Rights Plan, as amended, and any outstanding rights will expire at the earliest of (i) June 4, 2022, (ii) the time at which the rights are redeemed or exchanged pursuant to the Rights Plan, (iii) the repeal of Section 382 and 383 of the Code or any successor statute if the Board of Directors determines that the Rights Plan is no longer necessary for the preservation of the applicable tax benefits, or (iv) the beginning of a taxable year to which the Board of Directors determines that no applicable tax benefits may be carried forward.

v3.19.3
Derivative Instruments - Additional Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2018
Sep. 30, 2019
Jun. 30, 2019
Sep. 30, 2018
Jun. 30, 2018
Dec. 31, 2017
Derivative [Line Items]            
Derivative asset, cash collateral [1] $ 438,000 $ 0        
10-year U.S. Treasury Note Futures            
Derivative [Line Items]            
Notional Amount $ 320,000,000 0 $ 155,000,000 $ 700,000,000 $ 700,000,000 $ 650,000,000
Maturity date 2019-03          
Derivative outstanding options $ 0 0        
U.S. Treasury Note Futures            
Derivative [Line Items]            
Notional Amount   $ 0        
Forward-Settling TBA Commitments            
Derivative [Line Items]            
Derivative asset, cash collateral $ 438,000          
[1] Does not include the amount of cash collateral pledged in respect of derivative instruments that exceeds the associated derivative liability presented in the consolidated balance sheets.
v3.19.3
Borrowings - Additional Information (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Debt Disclosure [Abstract]    
Long-term unsecured debt $ 74,272 $ 74,104
Unamortized debt issuance costs $ 1,028 $ 1,196
v3.19.3
Derivative Instruments - Cash Collateral Posted and Received in Respect of Derivative and Other Financial Instruments (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Cash collateral posted, net $ 43,298 $ 61,052
U.S. Treasury Note Futures    
Cash collateral posted, net 0 6,169
Interest Rate Swap    
Cash collateral posted, net 42,506 54,883
Unsettled MBS Trades and TBA Commitments, Net    
Cash collateral posted, net $ 792 $ 0
v3.19.3
Fair Value Measurements
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 7. Fair Value Measurements

Fair Value of Financial Instruments

The accounting principles related to fair value measurements define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial Accounting Standards Board Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosures, establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels, giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3) as described below:

 

 

Level 1 Inputs - 

Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible by the Company at the measurement date;

 

 

Level 2 Inputs - 

Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly; and

 

 

Level 3 Inputs - 

Unobservable inputs for the asset or liability, including significant judgments made by the Company about the assumptions that a market participant would use.

The Company measures the fair value of the following assets and liabilities:

Mortgage-backed securities

Agency MBS - The Company’s investments in agency MBS are classified within Level 2 of the fair value hierarchy. Inputs to fair value measurements of the Company’s investments in agency MBS include price estimates obtained from third-party pricing services. In determining fair value, third-party pricing services use a market approach. The inputs used in the fair value measurements performed by the third-party pricing services are based upon readily observable transactions for securities with similar characteristics (such as issuer/guarantor, coupon rate, stated maturity, and collateral pool characteristics) occurring on the measurement date. The Company makes inquiries of the third-party pricing sources to understand the significant inputs and assumptions used to determine prices. The Company reviews the various third-party fair value estimates and performs procedures to validate their reasonableness, including comparison to recent trading activity for similar securities and an overall review for consistency with market conditions observed as of the measurement date.

Derivative instruments

Exchange-traded derivative instruments - Exchange-traded derivative instruments, which include U.S. Treasury note futures, Eurodollar futures, interest rate swap futures, and options on futures, are classified within Level 1 of the fair value hierarchy as they are measured using quoted prices for identical instruments in liquid markets.

Interest rate swaps - Interest rate swaps are classified within Level 2 of the fair value hierarchy. The fair values of the Company’s centrally cleared interest rate swaps are measured using the daily valuations reported by the clearinghouse through which the instrument was cleared. In performing its end-of-day valuations, the clearinghouse constructs forward interest rate curves (for example, three-month LIBOR forward rates) from its specific observations of that day’s trading activity. The clearinghouse uses the applicable forward interest rate curve to develop a market-based forecast of future remaining contractually required cash flows for each interest rate swap. Each market-based cash flow forecast is then discounted using the overnight index swap rate curve (sourced from the Federal Reserve Bank of New York) to determine a net present value amount which represents the instrument’s fair value.

Forward-settling purchases and sales of TBA securities – Forward-settling purchases and sales of TBA securities are classified within Level 2 of the fair value hierarchy. The fair value of each forward-settling TBA contract is measured using price estimates obtained from a third-party pricing service, which are based upon readily observable transaction prices occurring on the measurement date for forward-settling contracts to buy or sell TBA securities with the same guarantor, contractual maturity, and coupon rate for delivery on the same forward settlement date as the commitment under measurement.

Other

Long-term unsecured debt - As of September 30, 2019 and December 31, 2018, the carrying value of the Company’s long-term unsecured debt was $74,272 and $74,104, respectively, net of unamortized debt issuance costs, and consists of Senior Notes and trust preferred debt issued by the Company. The Company’s estimate of the fair value of long-term unsecured debt is $69,168 and $66,562 as of September 30, 2019 and December 31, 2018, respectively. The Company’s Senior Notes, which are publicly traded on the New York Stock Exchange, are classified within Level 1 of the fair value hierarchy. Trust preferred debt is classified within Level 2 of the fair value hierarchy as the fair value is estimated based on the quoted prices of the Company’s publicly traded Senior Notes.

Investments in equity securities of non-public companies and investment funds – As of September 30, 2019 and December 31, 2018, the Company had investment in equity securities and investment funds measured at fair value of $6,239 and $6,115, respectively, which is included in the line item “other assets” in the accompanying consolidated balance sheets. ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (Subtopic 825-10), effective January 1, 2018, requires entities to measure investments in equity securities at fair value, unless fair value measurement is impractical, with changes in fair value recognized in current period earnings. Upon the adoption of ASU No. 2016-01, the Company recognized a cumulative-effect increase of $4,059 (net of taxes) in stockholders’ equity representing, as of January 1, 2018, the excess of fair value over historical cost of its investments in equity securities that were previously carried at their historical cost (net of impairments).

Investments in equity securities and investment funds are classified within Level 3 of the fair value hierarchy. The fair values of the Company’s investments in equity securities and investment funds are not readily determinable. Accordingly, for its investments in equity securities, the Company estimates fair value by estimating the enterprise value of the investee which it then allocates to the investee’s securities in the order of their preference relative to one another. To estimate the enterprise value of the investee, the Company uses traditional valuation methodologies based on income and market approaches, including the consideration of recent investments in, or tender offers for, the equity securities of the investee, a discounted cash flow analysis and a comparable guideline public company valuation. The primary unobservable inputs used in estimating the fair value of an equity security of a non-public company include (i) a stock price to net asset multiple for similar public companies that is applied to the entity’s net assets, (ii) a discount factor for lack of marketability and control, and (iii) a cost of equity discount rate, used to discount to present value the equity cash flows available for distribution and the terminal value of the entity. As of September 30, 2019, the stock price to net asset multiple for similar public companies, the discount factor for lack of marketability and control, and the cost of equity discount rate used as inputs were 95 percent, 9 percent, and 12 percent, respectively. As of December 31, 2018, the stock price to net asset multiple for similar public companies, the discount factor for lack of marketability and control, and the cost of equity discount rate used as inputs were 91 percent, 8 percent, and 12 percent, respectively. For its investments in investment funds, the Company estimates fair value based upon the investee’s net asset value per share.

Financial assets and liabilities for which carrying value approximates fair value - Cash and cash equivalents, deposits, receivables, repurchase agreements, payables, and other assets and liabilities are generally reflected in the consolidated balance sheets at their cost, which, due to the short-term nature of these instruments and their limited inherent credit risk, approximates fair value.

Fair Value Hierarchy

Financial Instruments Measured at Fair Value on a Recurring Basis

The following tables set forth financial instruments measured at fair value by level within the fair value hierarchy as of September 30, 2019 and December 31, 2018. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

 

 

September 30, 2019

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

MBS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency MBS

 

$

4,013,161

 

 

$

 

 

$

4,013,161

 

 

$

 

Private-label MBS

 

 

25

 

 

 

 

 

 

 

 

 

25

 

Total MBS

 

 

4,013,186

 

 

 

 

 

 

4,013,161

 

 

 

25

 

Derivative assets

 

 

675

 

 

 

 

 

 

675

 

 

 

 

Derivative liabilities

 

 

(724

)

 

 

 

 

 

(724

)

 

 

 

Other assets

 

 

6,239

 

 

 

 

 

 

 

 

 

6,239

 

Total

 

$

4,019,376

 

 

$

 

 

$

4,013,112

 

 

$

6,264

 

 

 

 

December 31, 2018

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

MBS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency MBS

 

$

3,982,106

 

 

$

 

 

$

3,982,106

 

 

$

 

Private-label MBS

 

 

24

 

 

 

 

 

 

 

 

 

24

 

Total MBS

 

 

3,982,130

 

 

 

 

 

 

3,982,106

 

 

 

24

 

Derivative assets

 

 

438

 

 

 

 

 

 

438

 

 

 

 

Derivative liabilities

 

 

(6,959

)

 

 

(1,250

)

 

 

(5,709

)

 

 

 

Other assets

 

 

6,115

 

 

 

 

 

 

 

 

 

6,115

 

Total

 

$

3,981,724

 

 

$

(1,250

)

 

$

3,976,835

 

 

$

6,139

 

 

Level 3 Financial Assets and Liabilities

The table below sets forth an attribution of the change in the fair value of the Company’s Level 3 investments that are measured at fair value on a recurring basis for the periods indicated:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Beginning balance

$

6,052

 

 

$

6,235

 

 

$

6,139

 

 

$

515

 

Investments in equity securities measured at fair value beginning January 1, 2018

 

 

 

 

 

 

 

 

 

 

5,362

 

Included in investment gain (loss), net

 

231

 

 

 

(21

)

 

 

224

 

 

 

343

 

Purchases

 

 

 

 

 

 

 

 

 

 

 

Sales

 

 

 

 

 

 

 

 

 

 

 

Payments, net

 

(23

)

 

 

(46

)

 

 

(118

)

 

 

(66

)

Accretion of discount

 

4

 

 

 

2

 

 

 

19

 

 

 

16

 

Ending balance

$

6,264

 

 

$

6,170

 

 

$

6,264

 

 

$

6,170

 

Net unrealized gains (losses) included in earnings for the

   period for Level 3 assets still held at the reporting date

$

231

 

 

$

(21

)

 

$

239

 

 

$

343

 

v3.19.3
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2019
Cash Equivalents

Cash Equivalents

Cash equivalents include demand deposits with banks, money market accounts and highly liquid investments with original maturities of three months or less. As of September 30, 2019 and December 31, 2018, approximately 96% and 99%, respectively, of the Company’s cash equivalents were invested in money market funds that invest primarily in U.S. Treasuries and other securities backed by the U.S. government.

Investment Security Purchases and Sales

Investment Security Purchases and Sales

Purchases and sales of investment securities are recorded on the settlement date of the transfer unless the trade qualifies as a “regular-way” trade and the associated commitment qualifies for an exemption from the accounting guidance applicable to derivative instruments. A regular-way trade is an investment security purchase or sale transaction that is expected to settle within the period of time following the trade date that is prevalent or traditional for that specific type of security. Any amounts payable or receivable for unsettled security trades are recorded as “sold securities receivable” or “purchased securities payable” in the consolidated balance sheets.

Interest Income Recognition for Investments in Agency MBS

Interest Income Recognition for Investments in Agency MBS

The Company recognizes interest income for its investments in agency MBS by applying the “interest method” permitted by GAAP, whereby purchase premiums and discounts are amortized and accreted, respectively, as an adjustment to contractual interest income accrued at each security’s stated coupon rate. The interest method is applied at the individual security level based upon each security’s effective interest rate. The Company calculates each security’s effective interest rate at the time of purchase by solving for the discount rate that equates the present value of that security's remaining contractual cash flows (assuming no principal prepayments) to its purchase price. Because each security’s effective interest rate does not reflect an estimate of future prepayments, the Company refers to this manner of applying the interest method as the “contractual effective interest method.” When applying the contractual effective interest method to its investments in agency MBS, as principal prepayments occur, a proportional amount of the unamortized premium or discount is recognized in interest income such that the contractual effective interest rate on the remaining security balance is unaffected.

Other Significant Accounting Policies

Other Significant Accounting Policies

Certain of the Company’s other significant accounting policies are summarized in the following notes:

 

Investments in agency MBS, subsequent measurement

Note 3

Borrowings

Note 4

To-be-announced agency MBS transactions, including “dollar rolls”

Note 5

Derivative instruments

Note 5

Balance sheet offsetting

Note 6

Fair value measurements

Note 7

 

Refer to the Company’s 2018 Annual Report on Form 10-K for a complete inventory and summary of the Company’s significant accounting policies.

Recent Accounting Pronouncements

 

Recent Accounting Pronouncements

The following table provides a brief description of recently issued accounting pronouncements and their actual or expected effect on the Company’s consolidated financial statements:

 

Standard

Description

Date of

Adoption

Effect on the Consolidated

Financial Statements

Recently Adopted Accounting Guidance

Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842)

This amendment replaces the existing lease accounting model with a revised model.  The primary change effectuated by the revised lease accounting model is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases.

January 1, 2019

The primary impact of the adoption of ASU No. 2016-02 was the recognition of lease liabilities and associated right-of-use assets, as a component of “Other liabilities” and “Other assets,” respectively, on the Company’s consolidated balance sheets as of September 30, 2019.  The adoption of ASU No. 2016-02 did not have an effect on the timing or amount of periodic lease expense recognized in net income.  The adoption of ASU No. 2016-02 did not have a material effect on the Company’s consolidated financial statements.

 

 

 

 

ASU No. 2017-08, Premium Amortization of Purchased Callable Debt Securities (Subtopic 310-20)

This amendment requires purchase premiums for investments in debt securities that are noncontingently callable by the issuer (at a fixed price and preset date) to be amortized to the earliest call date. Previously, purchase premiums for such investments were permitted to be amortized to the instrument’s maturity date.

 

January 1, 2019

 

 

Investments in prepayable financial assets, such as residential MBS, for which the embedded call options are not held by the issuer are not within the scope of ASU No. 2017-08. Accordingly, the adoption of ASU No. 2017-08 did not have an effect on the Company’s consolidated financial statements.

 

 

 

 

ASU No. 2017-12, Targeted Improvements to Accounting for Hedging Activities (Topic 815)

This update made several targeted amendments to existing GAAP with the objectives of facilitating (i) financial reporting that more closely reflects entities’ risk management strategies and (ii) greater ease of understanding and interpreting the effects of hedge accounting on an entities’ reported results.

January 1, 2019

Hedge accounting pursuant to GAAP is an elective, rather than a required, accounting model.  The Company does not elect to apply hedge accounting.  The adoption of ASU No. 2017-12 did not have an effect on the Company’s consolidated financial statements.

 

 

 

 

Recently Issued Accounting Guidance Not Yet Adopted

 

 

 

 

ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 606)

The amendments in this update require financial assets measured at amortized cost as well as available-for-sale debt securities to be measured for impairment on the basis of the net amount expected to be collected.  Credit losses are to be recognized through an allowance for credit losses, which differs from the direct write-down of the amortized cost basis currently required for other-than-temporary impairments of investments in debt securities.  This update also makes substantial changes to the manner in which interest income is to be recognized for financial assets acquired with a more-than-insignificant amount of credit deterioration since origination.

 

This update will not affect the accounting for investments in debt securities that are classified as trading securities.

January 1, 2020

As of September 30, 2019, all of the Company’s investments in debt securities are classified as trading securities. Accordingly, the Company does not expect ASU No. 2016-13 to have a material impact on its consolidated financial statements.

Repurchase Agreements

The Company finances the purchase of MBS through repurchase agreements, which are accounted for as collateralized borrowing arrangements. In a repurchase transaction, the Company sells MBS to a counterparty under a master repurchase agreement in exchange for cash and concurrently agrees to repurchase the same security at a future date in an amount equal to the cash initially exchanged plus an agreed-upon amount of interest. MBS sold under agreements to repurchase remain on the Company’s consolidated balance sheets because the Company maintains effective control over such securities throughout the duration of the arrangement. Throughout the contractual term of a repurchase agreement, the Company recognizes a “repurchase agreement” liability on its consolidated balance sheets to reflect the obligation to repay to the counterparty the proceeds received upon the initial transfer of the MBS. The difference between the proceeds received by the Company upon the initial transfer of the MBS and the contractually agreed-upon repurchase price is recognized as interest expense ratably over the term of the repurchase arrangement.

Derivative Instruments

In the normal course of its operations, the Company is a party to financial instruments that are accounted for as derivative instruments. Derivative instruments are recorded at fair value as either “derivative assets” or “derivative liabilities” in the consolidated balance sheets, with all periodic changes in fair value reflected as a component of “investment gain (loss), net” in the consolidated statements of comprehensive income. Cash receipts or payments related to derivative instruments are classified as investing activities within the consolidated statements of cash flows.

In addition to interest rate hedging instruments that are used for interest rate risk management, the Company is a party to derivative instruments that economically serve as investments, such as forward commitments to purchase fixed-rate “pass-through” agency MBS on a non-specified pool basis, which are known as to-be-announced (“TBA”) securities. A TBA security is a forward commitment for the purchase or sale of a fixed-rate agency MBS at a predetermined price, face amount, issuer, coupon, and stated maturity for settlement on an agreed upon future date. The specific agency MBS that will be delivered to satisfy the TBA trade is not known at the inception of the trade. The specific agency MBS to be delivered is determined 48 hours prior to the settlement date. The Company accounts for TBA securities as derivative instruments because the Company cannot assert that it is probable at inception and throughout the term of an individual TBA commitment that its settlement will result in physical delivery of the underlying agency MBS, or the individual TBA commitment will not settle in the shortest time period possible.

Derivatives, Offsetting of Financial Assets and Liabilities

The agreements that govern certain of the Company’s derivative instruments and collateralized short-term financing arrangements provide for a right of setoff in the event of default or bankruptcy with respect to either party to such transactions. The Company presents derivative assets and liabilities as well as collateralized short-term financing arrangements on a gross basis.

Receivables recognized for the right to reclaim cash initial margin posted in respect of interest rate derivative instruments are included in the line item “deposits” in the accompanying consolidated balance sheets.

The daily exchange of variation margin associated with a centrally cleared or exchange-traded derivative instrument is legally characterized as the daily settlement of the derivative instrument itself, as opposed to a pledge of collateral. Accordingly, the Company accounts for the daily receipt or payment of variation margin associated with its interest rate swaps and futures as a direct reduction to the carrying value of the interest rate swap derivative asset or liability, respectively. The carrying amount of interest rate swaps and futures reflected in the Company’s consolidated balance sheets is equal to the unsettled fair value of such instruments; because variation margin is exchanged on a one-day lag, the unsettled fair value of such instruments generally represents the change in fair value that occurred on the last day of the reporting period.

Fair Value of Financial Instruments

The accounting principles related to fair value measurements define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial Accounting Standards Board Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosures, establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels, giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3) as described below:

 

 

Level 1 Inputs - 

Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible by the Company at the measurement date;

 

 

Level 2 Inputs - 

Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly; and

 

 

Level 3 Inputs - 

Unobservable inputs for the asset or liability, including significant judgments made by the Company about the assumptions that a market participant would use.

The Company measures the fair value of the following assets and liabilities:

Agency MBS  
Investment Security Purchases and Sales

The Company’s investments in agency MBS are reported in the accompanying consolidated balance sheets at fair value. As of September 30, 2019 and December 31, 2018, the Company had $4,013,161 and $3,982,106, respectively, of fair value in agency MBS classified as trading securities.

v3.19.3
Derivative Instruments - Volume of Activity, in terms of Notional Amount, Related to Derivative Instruments (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Interest Rate Swap        
Derivative [Line Items]        
Beginning of Period $ 2,600,000,000 $ 3,325,000,000 $ 3,100,000,000 $ 3,600,000,000
Additions 750,000,000 750,000,000 1,800,000,000 1,300,000,000
Scheduled Settlements (250,000,000) 0 (250,000,000) 0
Early Terminations (100,000,000) (600,000,000) (1,650,000,000) (1,425,000,000)
End of Period 3,000,000,000 3,475,000,000 3,000,000,000 3,475,000,000
5-year U.S. Treasury Note Futures        
Derivative [Line Items]        
Beginning of Period       21,600,000
Additions       0
Scheduled Settlements       (21,600,000)
Early Terminations       0
End of Period   0   0
2-year U.S. Treasury Note Futures        
Derivative [Line Items]        
Beginning of Period 0   0  
Additions 139,000,000   139,000,000  
Scheduled Settlements (139,000,000)   (139,000,000)  
Early Terminations 0   0  
End of Period 0   0  
10-year U.S. Treasury Note Futures        
Derivative [Line Items]        
Beginning of Period 155,000,000 700,000,000 320,000,000 650,000,000
Additions 0 700,000,000 826,600,000 2,550,000,000
Scheduled Settlements (155,000,000) (700,000,000) (885,000,000) (2,500,000,000)
Early Terminations 0 0 (261,600,000) 0
End of Period 0 700,000,000 0 700,000,000
Sold Call Options on Ten Year U.S. Treasury Note Futures        
Derivative [Line Items]        
Beginning of Period     0  
Additions     250,000,000  
Scheduled Settlements     (250,000,000)  
Early Terminations     0  
End of Period 0   0  
Purchased Call Options on Ten Year U.S. Treasury Note Futures        
Derivative [Line Items]        
Beginning of Period     0  
Additions     500,000,000  
Scheduled Settlements     (500,000,000)  
Early Terminations     0  
End of Period 0   0  
Commitments To Purchase (sell) MBS        
Derivative [Line Items]        
Beginning of Period 550,000,000 1,100,000,000 0 1,265,000,000
Additions 900,000,000 3,050,000,000 5,620,000,000 11,170,000,000
Scheduled Settlements (1,350,000,000) (3,400,000,000) (5,520,000,000) (11,685,000,000)
Early Terminations 0 0 0 0
End of Period $ 100,000,000 $ 750,000,000 $ 100,000,000 $ 750,000,000
v3.19.3
Derivative Instruments - Interest Rate Swap Agreements (Details) - Interest Rate Swap - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Jun. 30, 2019
Sep. 30, 2018
Jun. 30, 2018
Dec. 31, 2017
Notional Amount $ 3,000,000,000 $ 3,100,000,000 $ 2,600,000,000 $ 3,475,000,000 $ 3,325,000,000 $ 3,600,000,000
Weighted-average: Fixed Pay Rate 1.83% 2.07%        
Weighted-average: Variable Receive Rate 2.17% 2.67%        
Weighted-average: Net Receive (Pay) Rate 0.34% 0.60%        
Weighted-average: Remaining Life (in years) 3 years 4 months 24 days 6 years 7 months 6 days        
Fair Value, Asset and (Liability) $ 225,000 $ (5,709,000)        
Less Than Three Years Maturity            
Notional Amount $ 2,175,000,000 $ 1,050,000,000        
Weighted-average: Fixed Pay Rate 1.73% 1.53%        
Weighted-average: Variable Receive Rate 2.19% 2.60%        
Weighted-average: Net Receive (Pay) Rate 0.46% 1.07%        
Weighted-average: Remaining Life (in years) 1 year 8 months 12 days 1 year 6 months        
Fair Value, Asset and (Liability) $ 157,000 $ (152,000)        
Three To Less Than Seven Years Maturity            
Notional Amount $ 500,000,000 $ 325,000,000        
Weighted-average: Fixed Pay Rate 1.62% 2.00%        
Weighted-average: Variable Receive Rate 2.12% 2.73%        
Weighted-average: Net Receive (Pay) Rate 0.50% 0.73%        
Weighted-average: Remaining Life (in years) 6 years 3 months 18 days 4 years 4 months 24 days        
Fair Value, Asset and (Liability) $ 68,000 $ (432,000)        
Seven to Less Than Ten Years Maturity            
Notional Amount $ 300,000,000 $ 1,600,000,000        
Weighted-average: Fixed Pay Rate 2.85% 2.35%        
Weighted-average: Variable Receive Rate 2.16% 2.70%        
Weighted-average: Net Receive (Pay) Rate (0.69%) 0.35%        
Weighted-average: Remaining Life (in years) 9 years 3 months 18 days 8 years 6 months        
Fair Value, Asset and (Liability) $ 33,000 $ (4,572,000)        
Ten or More Years Maturity            
Notional Amount $ 25,000,000 $ 125,000,000        
Weighted-average: Fixed Pay Rate 2.96% 3.02%        
Weighted-average: Variable Receive Rate 2.16% 2.66%        
Weighted-average: Net Receive (Pay) Rate (0.80%) (0.36%)        
Weighted-average: Remaining Life (in years) 28 years 6 months 29 years 7 months 6 days        
Fair Value, Asset and (Liability) $ (33,000) $ (553,000)        
v3.19.3
Borrowings - Information Regarding Outstanding Repurchase Agreement Borrowings During the Period (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Debt Disclosure [Abstract]        
Weighted-average outstanding balance $ 3,609,519 $ 3,841,280 $ 3,672,844 $ 3,730,460
Weighted-average rate 2.46% 2.17% 2.59% 1.93%
v3.19.3
Offsetting of Financial Assets and Liabilities (Tables)
9 Months Ended
Sep. 30, 2019
Offsetting [Abstract]  
Offsetting of Financial Assets and Liabilities

The following tables present information, as of the dates indicated, about the Company’s derivative instruments, short-term borrowing arrangements, and associated collateral, including those subject to master netting (or similar) arrangements:

 

 

 

As of September 30, 2019

 

 

 

Gross Amount

Recognized

 

 

Amount Offset

in the

Consolidated

Balance Sheets

 

 

Net Amount

Presented in the

Consolidated

Balance Sheets

 

 

Gross Amount Not Offset in the

Consolidated Balance Sheets

 

 

Net

Amount

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial

Instruments (1)

 

 

Cash

Collateral (2)

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

269

 

 

$

 

 

$

269

 

 

$

(44

)

 

$

 

 

$

225

 

TBA commitments

 

 

406

 

 

 

 

 

 

406

 

 

 

 

 

 

 

 

 

406

 

Total derivative instruments

 

 

675

 

 

 

 

 

 

675

 

 

 

(44

)

 

 

 

 

 

631

 

Total assets

 

$

675

 

 

$

 

 

$

675

 

 

$

(44

)

 

$

 

 

$

631

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

44

 

 

$

 

 

$

44

 

 

$

(44

)

 

$

 

 

$

 

TBA commitments

 

 

680

 

 

 

 

 

 

680

 

 

 

 

 

 

(680

)

 

 

 

Total derivative instruments

 

 

724

 

 

 

 

 

 

724

 

 

 

(44

)

 

 

(680

)

 

 

 

Repurchase agreements

 

 

3,697,906

 

 

 

 

 

 

3,697,906

 

 

 

(3,697,906

)

 

 

 

 

 

 

Total liabilities

 

$

3,698,630

 

 

$

 

 

$

3,698,630

 

 

$

(3,697,950

)

 

$

(680

)

 

$

 

 

 

 

As of December 31, 2018

 

 

 

Gross Amount

Recognized

 

 

Amount Offset

in the

Consolidated

Balance Sheets

 

 

Net Amount

Presented in the

Consolidated

Balance Sheets

 

 

Gross Amount Not Offset in the

Consolidated Balance Sheets

 

 

Net

Amount

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial

Instruments (1)

 

 

Cash

Collateral (2)

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TBA commitments

 

$

438

 

 

$

 

 

$

438

 

 

$

 

 

$

(438

)

 

$

 

Total derivative instruments

 

 

438

 

 

 

 

 

 

438

 

 

 

 

 

 

(438

)

 

 

 

Total assets

 

$

438

 

 

$

 

 

$

438

 

 

$

 

 

$

(438

)

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

5,709

 

 

$

 

 

$

5,709

 

 

$

 

 

$

(5,709

)

 

$

 

10-year U.S. Treasury note futures

 

 

1,250

 

 

 

 

 

 

1,250

 

 

 

 

 

 

(1,250

)

 

 

 

Total derivative instruments

 

 

6,959

 

 

 

 

 

 

6,959

 

 

 

 

 

 

(6,959

)

 

 

 

Repurchase agreements

 

 

3,721,629

 

 

 

 

 

 

3,721,629

 

 

 

(3,721,629

)

 

 

 

 

 

 

Total liabilities

 

$

3,728,588

 

 

$

 

 

$

3,728,588

 

 

$

(3,721,629

)

 

$

(6,959

)

 

$

 

 

(1)

Does not include the fair value amount of financial instrument collateral pledged in respect of repurchase agreements that exceeds the associated liability presented in the consolidated balance sheets.

(2)

Does not include the amount of cash collateral pledged in respect of derivative instruments that exceeds the associated derivative liability presented in the consolidated balance sheets.

v3.19.3
Organization and Basis of Presentation - Additional Information (Details)
9 Months Ended
Sep. 30, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Required annual distribution of taxable income 90.00%
Intended annual distribution of taxable income 100.00%
v3.19.3
Borrowings - Outstanding Repurchase Agreement Borrowings (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Repurchase Agreement Counterparty [Line Items]    
Repurchase agreements outstanding $ 3,697,906 $ 3,721,629
Pledged with agency-backed MBS    
Repurchase Agreement Counterparty [Line Items]    
Repurchase agreements outstanding 3,697,906 3,721,629
MBS collateral, at fair value 3,891,308 3,931,232
Net amount [1] $ 193,402 $ 209,603
Weighted-average rate 2.35% 2.72%
Weighted-average term to maturity (in days) 22 days 17 days
[1] Net amount represents the value of collateral in excess of corresponding repurchase obligation. The amount of collateral at-risk is limited to the outstanding repurchase obligation and not the entire collateral balance.
v3.19.3
Stockholders' Equity - Dividends Declared and Paid (Details) - $ / shares
3 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Equity [Abstract]              
Dividend Amount (in dollars per share) $ 0.225 $ 0.225 $ 0.375 $ 0.375 $ 0.375 $ 0.375 $ 0.550
Declaration Date Sep. 17, 2019 Jun. 24, 2019 Mar. 18, 2019 Dec. 13, 2018 Sep. 13, 2018 Jun. 14, 2018 Mar. 15, 2018
Record Date Sep. 30, 2019 Jul. 05, 2019 Mar. 29, 2019 Dec. 31, 2018 Sep. 28, 2018 Jun. 29, 2018 Mar. 29, 2018
Pay Date Oct. 31, 2019 Jul. 31, 2019 Apr. 30, 2019 Jan. 31, 2019 Oct. 31, 2018 Jul. 31, 2018 Apr. 30, 2018
v3.19.3
Income Taxes - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 21, 2019
May 29, 2018
Sep. 30, 2019
Sep. 30, 2019
Dec. 31, 2018
Income Tax Disclosure [Line Items]          
Intended annual distribution of taxable income       100.00%  
Required annual distribution of taxable income       90.00%  
Estimated net operating loss carryforwards     $ 14,588 $ 14,588  
Net operating loss carryforwards, expiration year       2028  
Capital loss carryforwards expiration remainder of fiscal year     111,177 $ 111,177  
Capital loss carryforwards expiration in year 2020     102,322 102,322  
Capital loss carryforwards expiration in year 2021     66,862 66,862  
Capital loss carryforwards expiration in year 2022     3,763 3,763  
Capital loss carryforwards expiration in year 2023     110,323 $ 110,323  
Excess AMT credit carryforwards refundable rate       50.00%  
AMT credit carryforward cash tax refund       $ 4,566  
AMT credit carryforward     4,566 $ 4,566 $ 9,132
Income tax examination, description       BPOL tax years 2016 and 2017 remain subject to examination by Arlington County, although the county has previously informally indicated that it did not intend to pursue assessments for those years at such time.  
Tax Year 2018 | Arlington County, Virginia          
Income Tax Disclosure [Line Items]          
Tax assessment received for business, professional and occupation license tax $ 488 $ 9,380      
Tax Year 2019 | Arlington County, Virginia          
Income Tax Disclosure [Line Items]          
Revised tax assessment received for business, professional and occupation license tax $ 471        
Tax Year 2018 and 2019 | Arlington County, Virginia | Other General and Administrative Expense          
Income Tax Disclosure [Line Items]          
BPOL tax expense     842    
Tax Year 2016 | Arlington County, Virginia          
Income Tax Disclosure [Line Items]          
Income tax remain subject to examination year       2016  
Tax Year 2017 | Arlington County, Virginia          
Income Tax Disclosure [Line Items]          
Income tax remain subject to examination year       2017  
Capital Loss Carryforward          
Income Tax Disclosure [Line Items]          
Tax Credit Carryforward, Amount     $ 394,447 $ 394,447  
v3.19.3
Offsetting of Financial Assets and Liabilities - Derivative Instruments and Short-term Borrowing Arrangements, including those Subject to Master Netting or Similar Arrangements (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Derivative instruments:    
Derivative Asset, Gross Amount Recognized $ 675 $ 438
Derivative Asset, Amount Offset 0 0
Derivative Asset, Net Amount 675 438
Derivative Asset, Financial Instruments [1] (44) 0
Derivative Asset, Cash Collateral [2] 0 (438)
Derivative Asset, Net amount Total 631 0
Derivative instruments:    
Derivative Liabilities, Gross Amount Recognized 724 6,959
Derivative Liabilities, Amount Offset 0 0
Derivative Liabilities, Net Amount 724 6,959
Derivative Liabilities, Financial Instruments [1] (44) 0
Derivative Liabilities, Cash Collateral [2] (680) (6,959)
Derivative Liabilities, Net amount Total 0 0
Derivative Financial Instruments, Liabilities    
Derivative instruments:    
Derivative Liabilities, Gross Amount Recognized 3,698,630 3,728,588
Derivative Liabilities, Amount Offset 0 0
Derivative Liabilities, Net Amount 3,698,630 3,728,588
Derivative Liabilities, Financial Instruments [1] (3,697,950) (3,721,629)
Derivative Liabilities, Cash Collateral [2] (680) (6,959)
Derivative Liabilities, Net amount Total 0 0
Derivative Financial Instruments, Assets    
Derivative instruments:    
Derivative Asset, Gross Amount Recognized 675 438
Derivative Asset, Amount Offset 0 0
Derivative Asset, Net Amount 675 438
Derivative Asset, Financial Instruments [1] (44) 0
Derivative Asset, Cash Collateral [2] 0 (438)
Derivative Asset, Net amount Total 631 0
Repurchase Agreements    
Derivative instruments:    
Derivative Liabilities, Gross Amount Recognized 3,697,906 3,721,629
Derivative Liabilities, Amount Offset 0 0
Derivative Liabilities, Net Amount 3,697,906 3,721,629
Derivative Liabilities, Financial Instruments [1] (3,697,906) (3,721,629)
Derivative Liabilities, Cash Collateral [2] 0 0
Derivative Liabilities, Net amount Total 0 0
Interest Rate Swap    
Derivative instruments:    
Derivative Asset, Gross Amount Recognized 269  
Derivative Asset, Amount Offset 0  
Derivative Asset, Net Amount 269 0
Derivative Asset, Financial Instruments [1] (44)  
Derivative Asset, Cash Collateral [2] 0  
Derivative Asset, Net amount Total 225  
Derivative instruments:    
Derivative Liabilities, Gross Amount Recognized 44 5,709
Derivative Liabilities, Amount Offset 0 0
Derivative Liabilities, Net Amount 44 5,709
Derivative Liabilities, Financial Instruments [1] (44) 0
Derivative Liabilities, Cash Collateral [2] 0 (5,709)
Derivative Liabilities, Net amount Total 0 0
TBA Commitments    
Derivative instruments:    
Derivative Asset, Gross Amount Recognized 406 438
Derivative Asset, Amount Offset 0 0
Derivative Asset, Net Amount 406 438
Derivative Asset, Financial Instruments [1] 0 0
Derivative Asset, Cash Collateral [2] 0 (438)
Derivative Asset, Net amount Total 406 0
Derivative instruments:    
Derivative Liabilities, Gross Amount Recognized 680  
Derivative Liabilities, Amount Offset 0  
Derivative Liabilities, Net Amount 680 0
Derivative Liabilities, Financial Instruments [1] 0  
Derivative Liabilities, Cash Collateral [2] (680)  
Derivative Liabilities, Net amount Total 0  
10-year U.S. Treasury Note Futures    
Derivative instruments:    
Derivative Asset, Net Amount 0 0
Derivative instruments:    
Derivative Liabilities, Gross Amount Recognized   1,250
Derivative Liabilities, Amount Offset   0
Derivative Liabilities, Net Amount $ 0 1,250
Derivative Liabilities, Financial Instruments [1]   0
Derivative Liabilities, Cash Collateral [2]   (1,250)
Derivative Liabilities, Net amount Total   $ 0
[1] Does not include the fair value amount of financial instrument collateral pledged in respect of repurchase agreements that exceeds the associated liability presented in the consolidated balance sheets.
[2] Does not include the amount of cash collateral pledged in respect of derivative instruments that exceeds the associated derivative liability presented in the consolidated balance sheets.
v3.19.3
Investments in Agency MBS
9 Months Ended
Sep. 30, 2019
Agency MBS  
Investments in MBS

Note 3. Investments in Agency MBS

The Company’s investments in agency MBS are reported in the accompanying consolidated balance sheets at fair value. As of September 30, 2019 and December 31, 2018, the Company had $4,013,161 and $3,982,106, respectively, of fair value in agency MBS classified as trading securities. As of September 30, 2019, all the Company’s investments in agency MBS represent undivided (or “pass-through”) beneficial interests in specified pools of fixed-rate mortgage loans.

 

All periodic changes in the fair value of trading agency MBS that are not attributed to interest income are recognized as a component of “investment gain (loss), net” in the accompanying consolidated statements of comprehensive income. The following table provides additional information about the gains and losses recognized as a component of “investment gain (loss), net” in the Company’s consolidated statements of comprehensive income for the periods indicated with respect to investments in agency MBS classified as trading securities:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Net gains (losses) recognized in earnings for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency MBS still held at period end

 

$

12,576

 

 

$

(29,744

)

 

$

62,220

 

 

$

(103,536

)

Agency MBS sold during the period

 

 

4,315

 

 

 

(8,113

)

 

 

66,076

 

 

 

(43,547

)

Total

 

$

16,891

 

 

$

(37,857

)

 

$

128,296

 

 

$

(147,083

)

 

The Company also invests in and finances fixed-rate agency MBS on a generic pool basis through sequential series of to-be-announced security transactions commonly referred to as “dollar rolls.” Dollar rolls are accounted for as a sequential series of derivative instruments. Refer to “Note 5. Derivative Instruments” for further information about dollar rolls.

 

v3.19.3
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2019
Oct. 31, 2019
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q3  
Entity Registrant Name Arlington Asset Investment Corp.  
Entity Central Index Key 0001209028  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business false  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Shell Company false  
Entity File Number 001-34374  
Entity Incorporation, State or Country Code VA  
Entity Tax Identification Number 54-1873198  
Entity Common Stock, Shares Outstanding   36,755,387
Entity Address, Address Line One 6862 Elm Street  
Entity Address, Address Line Two Suite 320  
Entity Address, City or Town McLean  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 22101  
City Area Code 703  
Local Phone Number 373-0200  
Document Quarterly Report true  
Document Transition Report false  
Class A Common    
Document Information [Line Items]    
Title of 12(b) Security Class A Common Stock  
Security Exchange Name NYSE  
Trading Symbol AI  
7.00% Series B Cumulative Perpetual Redeemable Preferred Stock    
Document Information [Line Items]    
Title of 12(b) Security 7.00% Series B Cumulative Perpetual Redeemable Preferred Stock  
Security Exchange Name NYSE  
Trading Symbol AI PrB  
8.250% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock    
Document Information [Line Items]    
Title of 12(b) Security 8.250% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock  
Security Exchange Name NYSE  
Trading Symbol AI PrC  
v3.19.3
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Class A
Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Common Stock
Common Class A
Additional Paid-in Capital
Accumulated Deficit
Balances at Dec. 31, 2017 $ 386,317     $ 7,108   $ 281 $ 1,974,941 $ (1,596,013)
Balances (in shares) at Dec. 31, 2017       303,291   28,140,721    
Net Income (loss) (56,383)             (56,383)
Issuance of stock   $ (23) $ 459 $ 459     (23)  
Issuance of stock (in shares)       19,431        
Cumulative-effect of accounting change (see Note 7) 4,059             4,059
Stock-based compensation 451           451  
Dividends declared (15,875)             (15,875)
Balances at Mar. 31, 2018 319,005     $ 7,567   $ 281 1,975,369 (1,664,212)
Balances (in shares) at Mar. 31, 2018       322,722   28,140,721    
Balances at Dec. 31, 2017 386,317     $ 7,108   $ 281 1,974,941 (1,596,013)
Balances (in shares) at Dec. 31, 2017       303,291   28,140,721    
Net Income (loss) (65,492)              
Balances at Sep. 30, 2018 310,690     $ 8,138   $ 303 1,997,281 (1,695,032)
Balances (in shares) at Sep. 30, 2018       346,156   30,345,646    
Balances at Dec. 31, 2017 386,317     $ 7,108   $ 281 1,974,941 (1,596,013)
Balances (in shares) at Dec. 31, 2017       303,291   28,140,721    
Balances at Dec. 31, 2018 274,444     $ 8,245   $ 305 1,997,876 (1,731,982)
Balances (in shares) at Dec. 31, 2018       350,595   30,497,998    
Balances at Mar. 31, 2018 319,005     $ 7,567   $ 281 1,975,369 (1,664,212)
Balances (in shares) at Mar. 31, 2018       322,722   28,140,721    
Net Income (loss) (3,608)             (3,608)
Issuance of stock   711 440 $ 440   $ 1 710  
Issuance of stock (in shares)       18,030   66,989    
Repurchase of Class A commonstock under stock-basedcompensation plans (67)           (67)  
Repurchase of Class A common stock under stock-based compensation plans           (6,011)    
Stock-based compensation 297           297  
Dividends declared (10,311)             (10,311)
Balances at Jun. 30, 2018 306,467     $ 8,007   $ 282 1,976,309 (1,678,131)
Balances (in shares) at Jun. 30, 2018       340,752   28,201,699    
Net Income (loss) (5,501)             (5,501)
Issuance of stock   20,377 131 $ 131   $ 20 20,357  
Issuance of stock (in shares)       5,404   2,007,216    
Issuance of Class A common stock under stock-based compensation plans 124         $ 1 123  
Issuance of Class A common stock under stock-based compensation plans (in shares)           164,585    
Repurchase of Class A commonstock under stock-basedcompensation plans (260)           (260)  
Repurchase of Class A common stock under stock-based compensation plans           (27,854)    
Stock-based compensation 752           752  
Dividends declared (11,400)             (11,400)
Balances at Sep. 30, 2018 310,690     $ 8,138   $ 303 1,997,281 (1,695,032)
Balances (in shares) at Sep. 30, 2018       346,156   30,345,646    
Balances at Dec. 31, 2018 274,444     $ 8,245   $ 305 1,997,876 (1,731,982)
Balances (in shares) at Dec. 31, 2018       350,595   30,497,998    
Net Income (loss) 17,594             17,594
Issuance of stock   48,810 28,925 $ 45 $ 28,880 $ 60 48,750  
Issuance of stock (in shares)       2,035 1,200,000 6,000,000    
Issuance of Class A common stock under stock-based compensation plans           $ 1 (1)  
Issuance of Class A common stock under stock-based compensation plans (in shares)           74,619    
Stock-based compensation 773           773  
Dividends declared (14,135)             (14,135)
Balances at Mar. 31, 2019 356,411     $ 8,290 $ 28,880 $ 366 2,047,398 (1,728,523)
Balances (in shares) at Mar. 31, 2019       352,630 1,200,000 36,572,617    
Balances at Dec. 31, 2018 274,444     $ 8,245   $ 305 1,997,876 (1,731,982)
Balances (in shares) at Dec. 31, 2018       350,595   30,497,998    
Net Income (loss) (13,668)              
Balances at Sep. 30, 2019 308,177     $ 8,283 $ 28,944 $ 368 2,048,423 (1,777,841)
Balances (in shares) at Sep. 30, 2019       354,039 1,200,000 36,755,387    
Balances at Mar. 31, 2019 356,411     $ 8,290 $ 28,880 $ 366 2,047,398 (1,728,523)
Balances (in shares) at Mar. 31, 2019       352,630 1,200,000 36,572,617    
Net Income (loss) (23,525)             (23,525)
Issuance of stock   1 70 $ 6 $ 64   1  
Issuance of stock (in shares)       1,409        
Stock-based compensation 217           217  
Dividends declared (8,885)             (8,885)
Balances at Jun. 30, 2019 324,289     $ 8,296 $ 28,944 $ 366 2,047,616 (1,760,933)
Balances (in shares) at Jun. 30, 2019       354,039 1,200,000 36,572,617    
Net Income (loss) (7,737)             (7,737)
Issuance of stock   $ (9) $ (13) $ (13)     (9)  
Issuance of Class A common stock under stock-based compensation plans 109         $ 2 107  
Issuance of Class A common stock under stock-based compensation plans (in shares)           219,395    
Repurchase of Class A commonstock under stock-basedcompensation plans (204)           (204)  
Repurchase of Class A common stock under stock-based compensation plans           (36,625)    
Stock-based compensation 913           913  
Dividends declared (9,171)             (9,171)
Balances at Sep. 30, 2019 $ 308,177     $ 8,283 $ 28,944 $ 368 $ 2,048,423 $ (1,777,841)
Balances (in shares) at Sep. 30, 2019       354,039 1,200,000 36,755,387    
v3.19.3
Derivative Instruments - TBA Commitments (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Fair Value, Asset $ 675,000 $ 438,000
Fair Value, Liability (724,000) (6,959,000)
TBA Commitments    
Notional Amount: Purchase Commitment 100,000,000 0
Contractual Forward Price 99,867,000 (438,000)
Market Price 99,593,000 0
Fair Value, Asset 406,000 438,000
Fair Value, Liability (680,000) 0
Fair Value (274,000)  
TBA Commitments | Two Point Five Percent Thirty Year Mortgage Backed Securities Purchase (Sale) Commitments, Purchase    
Notional Amount: Purchase Commitment 100,000,000  
Contractual Forward Price 100,273,000  
Market Price 99,593,000  
Fair Value, Liability (680,000)  
TBA Commitments | Three Point Zero Percent Thirty Year Mortgage Backed Securities Purchase (Sale) Commitments, Purchase    
Notional Amount: Purchase Commitment 100,000,000  
Contractual Forward Price 101,547,000  
Market Price 101,563,000  
Fair Value, Asset 16,000  
TBA Commitments | Three Point Zero Percent Thirty Year Mortgage Backed Securities Purchase (Sale) Commitments, Sale    
Notional Amount: Purchase Commitment 100,000,000  
Contractual Forward Price (101,953,000)  
Market Price (101,563,000)  
Fair Value, Asset $ 390,000  
TBA Commitments | Five Point Zero Percent Thirty Year Mortgage Backed Securities Purchase (Sale) Commitments, Purchase    
Notional Amount: Purchase Commitment   100,000,000
Contractual Forward Price   103,750,000
Market Price   104,047,000
Fair Value, Asset   297,000
TBA Commitments | Five Point Zero Percent Thirty Year Mortgage Backed Securities Purchase (Sale) Commitments, Sales    
Notional Amount: Purchase Commitment   100,000,000
Contractual Forward Price   (104,188,000)
Market Price   (104,047,000)
Fair Value, Asset   $ 141,000
v3.19.3
Borrowings - Long-term Unsecured Debt Instruments (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Senior Notes Due 2025    
Debt Instrument [Line Items]    
Outstanding Principal $ 35,300 $ 35,300
Annual Interest Rate 6.75% 6.75%
Interest Payment Frequency Quarterly Quarterly
Weighted-Average Interest Rate 6.75% 6.75%
Maturity Mar. 15, 2025 Mar. 15, 2025
Early Redemption Date Mar. 15, 2018 Mar. 15, 2018
Senior Notes Due 2023    
Debt Instrument [Line Items]    
Outstanding Principal $ 25,000 $ 25,000
Annual Interest Rate 6.625% 6.625%
Interest Payment Frequency Quarterly Quarterly
Weighted-Average Interest Rate 6.625% 6.625%
Maturity May 01, 2023 May 01, 2023
Early Redemption Date May 01, 2016 May 01, 2016
Trust Preferred Debt    
Debt Instrument [Line Items]    
Outstanding Principal $ 15,000 $ 15,000
Interest Payment Frequency Quarterly Quarterly
Weighted-Average Interest Rate 5.05% 5.19%
Annual Interest Rate LIBOR+ 2.25 - 3.00 % LIBOR+ 2.25 - 3.00 %
Trust Preferred Debt | Minimum    
Debt Instrument [Line Items]    
Maturity 2033 2033
Early Redemption Date 2008 2008
Trust Preferred Debt | Maximum    
Debt Instrument [Line Items]    
Maturity 2035 2035
Early Redemption Date 2010 2010
v3.19.3
Borrowings (Tables)
9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Schedule of Repurchase Agreements

As of September 30, 2019 and December 31, 2018, the Company had no amount at risk with a single repurchase agreement counterparty or lender greater than 10% of equity. The following table provides information regarding the Company’s outstanding repurchase agreement borrowings as of the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

Pledged with agency MBS:

 

 

 

 

 

 

 

 

Repurchase agreements outstanding

 

$

3,697,906

 

 

$

3,721,629

 

Agency MBS collateral, at fair value

 

 

3,891,308

 

 

 

3,931,232

 

Net amount (1)

 

 

193,402

 

 

 

209,603

 

Weighted-average rate

 

 

2.35

%

 

 

2.72

%

Weighted-average term to maturity

 

22.2 days

 

 

17.3 days

 

 

(1)

Net amount represents the value of collateral in excess of corresponding repurchase obligation. The amount of collateral at-risk is limited to the outstanding repurchase obligation and not the entire collateral balance.

 

The following table provides information regarding the Company’s outstanding repurchase agreement borrowings during the three and nine months ended September 30, 2019 and 2018:

 

 

 

September 30, 2019

 

 

September 30, 2018

 

Weighted-average outstanding balance during the three months ended

 

$

3,609,519

 

 

$

3,841,280

 

Weighted-average rate during the three months ended

 

 

2.46

%

 

 

2.17

%

Weighted-average outstanding balance during the nine months ended

 

$

3,672,844

 

 

$

3,730,460

 

Weighted-average rate during the nine months ended

 

 

2.59

%

 

 

1.93

%

Schedule of Long-term Unsecured Debt Instruments As of September 30, 2019 and December 31, 2018, the Company had $74,272 and $74,104, respectively, of outstanding long-term unsecured debentures, net of unamortized debt issuance costs of $1,028 and $1,196, respectively. The Company’s long-term debentures consisted of the following as of the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

 

 

Senior

Notes Due 2025

 

 

Senior

Notes Due 2023

 

 

Trust

Preferred Debt

 

 

Senior

Notes Due 2025

 

 

Senior

Notes Due 2023

 

 

Trust

Preferred Debt

 

Outstanding Principal

 

$

35,300

 

 

$

25,000

 

 

$

15,000

 

 

$

35,300

 

 

$

25,000

 

 

$

15,000

 

Annual Interest Rate

 

 

6.75

%

 

 

6.625

%

 

LIBOR+

2.25 - 3.00 %

 

 

 

6.75

%

 

 

6.625

%

 

LIBOR+

2.25 - 3.00 %

 

Interest Payment Frequency

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

Weighted-Average Interest Rate

 

 

6.75

%

 

 

6.625

%

 

 

5.05

%

 

 

6.75

%

 

 

6.625

%

 

 

5.19

%

Maturity

 

March 15, 2025

 

 

May 1, 2023

 

 

2033 - 2035

 

 

March 15, 2025

 

 

May 1, 2023

 

 

2033 - 2035

 

Early Redemption Date

 

March 15, 2018

 

 

May 1, 2016

 

 

2008 - 2010

 

 

March 15, 2018

 

 

May 1, 2016

 

 

2008 - 2010

 

v3.19.3
Derivative Instruments
9 Months Ended
Sep. 30, 2019
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Derivative Instruments

Note 5. Derivative Instruments

In the normal course of its operations, the Company is a party to financial instruments that are accounted for as derivative instruments. Derivative instruments are recorded at fair value as either “derivative assets” or “derivative liabilities” in the consolidated balance sheets, with all periodic changes in fair value reflected as a component of “investment gain (loss), net” in the consolidated statements of comprehensive income. Cash receipts or payments related to derivative instruments are classified as investing activities within the consolidated statements of cash flows.

Types and Uses of Derivative Instruments

Interest Rate Hedging Instruments

The Company is party to interest rate hedging instruments that are intended to economically hedge changes, attributable to changes in benchmark interest rates, in certain MBS fair values and future interest cash flows on the Company’s short-term financing arrangements. Interest rate hedging instruments include centrally cleared interest rate swaps, exchange-traded instruments, such as U.S. Treasury note futures, Eurodollar futures, interest rate swap futures and options on futures, and non-exchange-traded instruments such as options on agency MBS. While the Company uses its interest rate hedging instruments to economically hedge a portion of its interest rate risk, it has not designated such contracts as hedging instruments for financial reporting purposes.

The Company exchanges cash “variation margin” with the counterparties to its interest rate hedging instruments at least on a daily basis based upon daily changes in fair value as measured by the Chicago Mercantile Exchange (“CME”), the central clearinghouse through which those instruments are cleared. In addition, the CME requires market participants to deposit and maintain an “initial margin” amount which is determined by the CME and is generally intended to be set at a level sufficient to protect the CME from the maximum estimated single-day price movement in that market participant’s contracts. However, futures commission merchants may require “initial margin” in excess of the CME’s requirement.

Receivables recognized for the right to reclaim cash initial margin posted in respect of interest rate hedging instruments are included in the line item “deposits” in the accompanying consolidated balance sheets.

The daily exchange of variation margin associated with a centrally cleared or exchange-traded hedging instrument is legally characterized as the daily settlement of the instrument itself, as opposed to a pledge of collateral. Accordingly, the Company accounts for the daily receipt or payment of variation margin associated with its interest rate swaps and futures as a direct reduction to the carrying value of the derivative asset or liability, respectively. The carrying amount of interest rate swaps and futures reflected in the Company’s consolidated balance sheets is equal to the unsettled fair value of such instruments; because variation margin is exchanged on a one-day lag, the unsettled fair value of such instruments generally represents the change in fair value that occurred on the last day of the reporting period.

To-Be-Announced Agency MBS Transactions, Including “Dollar Rolls”

In addition to interest rate hedging instruments that are used for interest rate risk management, the Company is a party to derivative instruments that economically serve as investments, such as forward commitments to purchase fixed-rate “pass-through” agency MBS on a non-specified pool basis, which are known as to-be-announced (“TBA”) securities. A TBA security is a forward commitment for the purchase or sale of a fixed-rate agency MBS at a predetermined price, face amount, issuer, coupon, and stated maturity for settlement on an agreed upon future date. The specific agency MBS that will be delivered to satisfy the TBA trade is not known at the inception of the trade. The specific agency MBS to be delivered is determined 48 hours prior to the settlement date. The Company accounts for TBA securities as derivative instruments because the Company cannot assert that it is probable at inception and throughout the term of an individual TBA commitment that its settlement will result in physical delivery of the underlying agency MBS, or the individual TBA commitment will not settle in the shortest time period possible.

The Company’s agency MBS investment portfolio includes net purchase (or “net long”) positions in TBA securities, which are primarily the result of executing sequential series of “dollar roll” transactions. The Company executes dollar roll transactions as a means of investing in and financing non-specified fixed-rate agency MBS. Such transactions involve effectively delaying (or “rolling”) the settlement of a forward purchase of a TBA agency MBS by entering into an offsetting sale with the same counterparty prior to the settlement date, net settling the “paired-off” positions in cash, and contemporaneously entering, with the same counterparty, another forward purchase of a TBA agency MBS of the same characteristics for a later settlement date. TBA securities purchased for a forward settlement month are generally priced at a discount relative to TBA securities sold for settlement in the current month. This discount, often referred to as the dollar roll “price drop,” reflects compensation for the net interest income (interest income less financing costs) that is foregone as a result of relinquishing beneficial ownership of the MBS for the duration of the dollar roll (also known as “dollar roll income”). By executing a sequential series of dollar roll transactions, the Company is able to create the economic experience of investing in an agency MBS, financed with a repurchase agreement, over a period of time. Forward purchases and sales of TBA securities are accounted for as derivative instruments in the Company’s financial statements. Accordingly, dollar roll income is recognized as a component of “investment gain (loss), net” along with all other periodic changes in the fair value of TBA commitments.

In addition to transacting in net long positions in TBA securities for investment purposes, the Company may also, from time to time, transact in net sale (or “net short”) positions in TBA securities for the purpose of economically hedging a portion of the sensitivity of the fair value of the Company’s investments in agency MBS to changes in interest rates.

Under the terms of these forward commitments, the daily exchange of variation margin may occur based on changes in the fair value of the agency MBS commitments if a party to the transaction demands it. Receivables recognized for the right to reclaim cash collateral posted by the Company in respect of TBA transactions is included in the line item “deposits” in the accompanying consolidated balance sheets. Liabilities recognized for the obligation to return cash collateral received by the Company in respect of TBA transactions is included in the line item “other liabilities” in the accompanying consolidated balance sheets.

In addition to TBA transactions, the Company may, from time to time, enter into commitments to purchase or sell specified agency MBS that do not qualify as regular-way security trades. Such commitments are also accounted for as derivative instruments.

Derivative Instrument Population and Fair Value

The following table presents the fair value of the Company’s derivative instruments as of the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

 

 

Assets

 

 

Liabilities

 

 

Assets

 

 

Liabilities

 

Interest rate swaps

 

$

269

 

 

$

(44

)

 

$

 

 

$

(5,709

)

10-year U.S. Treasury note futures

 

 

 

 

 

 

 

 

 

 

 

(1,250

)

TBA commitments

 

 

406

 

 

 

(680

)

 

 

438

 

 

 

 

Total

 

$

675

 

 

$

(724

)

 

$

438

 

 

$

(6,959

)

 

Interest Rate Swaps

The Company’s interest rate swap agreements represent agreements to make semiannual interest payments based upon a fixed interest rate and receive quarterly variable interest payments based upon the prevailing three-month LIBOR on the date of reset.

 

The following table presents information about the Company’s interest rate swap agreements that were in effect as of September 30, 2019:

 

 

 

 

 

 

 

Weighted-average:

 

 

 

 

 

 

 

Notional Amount

 

 

Fixed Pay Rate

 

 

Variable Receive Rate

 

 

Net Receive (Pay) Rate

 

 

Remaining Life (Years)

 

 

Fair Value

 

Years to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less than 3 years

 

$

2,175,000

 

 

 

1.73

%

 

 

2.19

%

 

 

0.46

%

 

 

1.7

 

 

$

157

 

3 to less than 7 years

 

 

500,000

 

 

 

1.62

%

 

 

2.12

%

 

 

0.50

%

 

 

6.3

 

 

 

68

 

7 to less than 10 years

 

 

300,000

 

 

 

2.85

%

 

 

2.16

%

 

 

(0.69

)%

 

 

9.3

 

 

 

33

 

10 or more years

 

 

25,000

 

 

 

2.96

%

 

 

2.16

%

 

 

(0.80

)%

 

 

28.5

 

 

 

(33

)

Total / weighted-average

 

$

3,000,000

 

 

 

1.83

%

 

 

2.17

%

 

 

0.34

%

 

 

3.4

 

 

$

225

 

 

The following table presents information about the Company’s interest rate swap agreements that were in effect as of December 31, 2018:

 

 

 

 

 

 

 

Weighted-average:

 

 

 

 

 

 

 

Notional Amount

 

 

Fixed Pay Rate

 

 

Variable Receive Rate

 

 

Net Receive

(Pay) Rate

 

 

Remaining Life (Years)

 

 

Fair Value

 

Years to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less than 3 years

 

$

1,050,000

 

 

 

1.53

%

 

 

2.60

%

 

 

1.07

%

 

 

1.5

 

 

$

(152

)

3 to less than 7 years

 

 

325,000

 

 

 

2.00

%

 

 

2.73

%

 

 

0.73

%

 

 

4.4

 

 

 

(432

)

7 to less than 10 years

 

 

1,600,000

 

 

 

2.35

%

 

 

2.70

%

 

 

0.35

%

 

 

8.5

 

 

 

(4,572

)

10 or more years

 

 

125,000

 

 

 

3.02

%

 

 

2.66

%

 

 

(0.36

)%

 

 

29.6

 

 

 

(553

)

Total / weighted-average

 

$

3,100,000

 

 

 

2.07

%

 

 

2.67

%

 

 

0.60

%

 

 

6.6

 

 

$

(5,709

)

 

U.S. Treasury Note Futures

The Company may purchase or sell exchange-traded U.S. Treasury note futures with the objective of economically hedging a portion of its interest rate risk. Upon the maturity date of these futures contracts, the Company has the option to either net settle each contract in cash in an amount equal to the difference between the then-current fair value of the underlying U.S. Treasury note and the contractual sale price inherent to the futures contract, or to physically settle the contract by delivering the underlying U.S. Treasury note.

As of September 30, 2019, the Company held no U.S. Treasury note futures. As of December 31, 2018, the Company held short positions of 10-year U.S. Treasury note futures with an aggregate notional amount of $320,000 with a maturity date in March 2019.

Options on 10-year U.S. Treasury Note Futures

The Company may purchase or sell exchange-traded options on 10-year U.S. Treasury note futures contracts with the objective of economically hedging a portion of the sensitivity of its investments in agency MBS to significant changes in interest rates. The Company may purchase put options which provide the Company with the right to sell 10-year U.S. Treasury note futures to a counterparty, and the Company may also write call options that provide a counterparty with the option to buy 10-year U.S. Treasury note futures from the Company. In order to limit its exposure on its interest rate derivative instruments from a significant decline in long-term interest rates, the Company may also purchase contracts that provide the Company with the option to buy, or call, 10-year U.S. Treasury note futures from a counterparty. The options may be exercised at any time prior to their expiry, and if exercised, may be net settled in cash or through physical receipt or delivery of the underlying futures contracts.

As of September 30, 2019 and December 31, 2018, the Company had no outstanding options on 10-year U.S. Treasury note futures contracts.

TBA Commitments

The following tables present information about the Company’s TBA commitments as of the dates indicated:

 

 

 

September 30, 2019

 

 

 

Notional Amount:

Purchase (Sale)

Commitment

 

 

Contractual Forward Price

 

 

Market Price

 

 

Fair Value

 

2.5% 30-year MBS purchase commitments

 

$

100,000

 

 

$

100,273

 

 

$

99,593

 

 

$

(680

)

3.0% 30-year MBS purchase commitments

 

 

100,000

 

 

 

101,547

 

 

 

101,563

 

 

 

16

 

3.0% 30-year MBS sale commitments

 

 

(100,000

)

 

 

(101,953

)

 

 

(101,563

)

 

 

390

 

Total TBA commitments, net

 

$

100,000

 

 

$

99,867

 

 

$

99,593

 

 

$

(274

)

 

 

 

December 31, 2018

 

 

 

Notional Amount:

Purchase (Sale)

Commitment

 

 

Contractual Forward Price

 

 

Market Price

 

 

Fair Value

 

5.0% 30-year MBS purchase commitments

 

$

100,000

 

 

$

103,750

 

 

$

104,047

 

 

$

297

 

5.0% 30-year MBS sale commitments

 

 

(100,000

)

 

 

(104,188

)

 

 

(104,047

)

 

 

141

 

Total TBA commitments, net

 

$

 

 

$

(438

)

 

$

 

 

$

438

 

 

Derivative Instrument Gains and Losses

The following tables provide information about the derivative gains and losses recognized within the periods indicated:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Interest rate derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net interest income (1)

$

4,445

 

 

$

2,295

 

 

$

12,961

 

 

$

3,962

 

Unrealized (losses) gains, net

 

(18,087

)

 

 

11,386

 

 

 

(100,337

)

 

 

66,023

 

(Losses) gains realized upon early termination, net

 

(11,992

)

 

 

17,567

 

 

 

(67,181

)

 

 

38,050

 

Total interest rate swap (losses) gains, net

 

(25,634

)

 

 

31,248

 

 

 

(154,557

)

 

 

108,035

 

U.S. Treasury note futures, net

 

(2,696

)

 

 

8,691

 

 

 

(16,421

)

 

 

27,171

 

Options on U.S. Treasury note futures, net

 

 

 

 

 

 

 

76

 

 

 

 

Total interest rate derivative (losses) gains, net

 

(28,330

)

 

 

39,939

 

 

 

(170,902

)

 

 

135,206

 

TBA and specified agency MBS commitments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TBA dollar roll income (2)

 

923

 

 

 

4,604

 

 

 

4,338

 

 

 

17,989

 

Other gains (losses) on agency MBS commitments, net

 

2,054

 

 

 

(8,923

)

 

 

16,934

 

 

 

(61,369

)

Total gains (losses) on agency MBS commitments, net

 

2,977

 

 

 

(4,319

)

 

 

21,272

 

 

 

(43,380

)

Total derivative (losses) gains, net

$

(25,353

)

 

$

35,620

 

 

$

(149,630

)

 

$

91,826

 

 

 

(1)

Represents the periodic net interest settlement incurred during the period (often referred to as “net interest carry”). Also includes “price alignment interest” income earned or expense incurred on cumulative variation margin paid or received, respectively, associated with centrally cleared interest rate swap agreements.

 

 

(2)

Represents the price discount of forward-settling TBA purchases relative to a contemporaneously executed “spot” TBA sale, which economically equates to net interest income that is earned ratably over the period beginning on the settlement date of the sale and ending on the settlement date of the forward-settling purchase.

Derivative Instrument Activity

The following tables summarize the volume of activity, in terms of notional amount, related to derivative instruments for the periods indicated:

  

 

 

For the Three Months Ended September 30, 2019

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled

Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

2,600,000

 

 

$

750,000

 

 

$

(250,000

)

 

$

(100,000

)

 

$

3,000,000

 

2-year U.S. Treasury note futures

 

 

 

 

 

139,000

 

 

 

(139,000

)

 

 

 

 

 

 

10-year U.S. Treasury note futures

 

 

155,000

 

 

 

 

 

 

(155,000

)

 

 

 

 

 

 

Commitments to purchase (sell) MBS, net

 

 

550,000

 

 

 

900,000

 

 

 

(1,350,000

)

 

 

 

 

 

100,000

 

 

 

 

For the Three Months Ended September 30, 2018

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

3,325,000

 

 

$

750,000

 

 

$

 

 

$

(600,000

)

 

$

3,475,000

 

10-year U.S. Treasury note futures

 

 

700,000

 

 

 

700,000

 

 

 

(700,000

)

 

 

 

 

 

700,000

 

Commitments to purchase (sell) MBS, net

 

 

1,100,000

 

 

 

3,050,000

 

 

 

(3,400,000

)

 

 

 

 

 

750,000

 

 

 

 

For the Nine Months Ended September 30, 2019

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled

Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

3,100,000

 

 

$

1,800,000

 

 

$

(250,000

)

 

$

(1,650,000

)

 

$

3,000,000

 

2-year U.S. Treasury note futures

 

 

 

 

 

139,000

 

 

 

(139,000

)

 

 

 

 

 

 

10-year U.S. Treasury note futures

 

 

320,000

 

 

 

826,600

 

 

 

(885,000

)

 

 

(261,600

)

 

 

 

Sold call options on 10-year U.S. Treasury note futures

 

 

 

 

 

250,000

 

 

 

(250,000

)

 

 

 

 

 

 

Purchased call options on 10-year U.S. Treasury note

  futures

 

 

 

 

 

500,000

 

 

 

(500,000

)

 

 

 

 

 

 

Commitments to purchase (sell) MBS, net

 

 

 

 

 

5,620,000

 

 

 

(5,520,000

)

 

 

 

 

 

100,000

 

 

 

 

For the Nine Months Ended September 30, 2018

 

 

 

Beginning of

Period

 

 

Additions

 

 

Scheduled Settlements

 

 

Early

Terminations

 

 

End of Period

 

Interest rate swaps

 

$

3,600,000

 

 

$

1,300,000

 

 

$

 

 

$

(1,425,000

)

 

$

3,475,000

 

5-year U.S. Treasury note futures

 

 

21,600

 

 

 

 

 

 

(21,600

)

 

 

 

 

 

 

10-year U.S. Treasury note futures

 

 

650,000

 

 

 

2,550,000

 

 

 

(2,500,000

)

 

 

 

 

 

700,000

 

Commitments to purchase (sell) MBS, net

 

 

1,265,000

 

 

 

11,170,000

 

 

 

(11,685,000

)

 

 

 

 

 

750,000

 

 

Cash Collateral Posted and Received for Derivative and Other Financial Instruments

The following table presents information about the cash collateral posted and received by the Company in respect of its derivative and other financial instruments, which is included in the line item “deposits, net” in the accompanying consolidated balance sheets, for the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

Cash collateral posted for:

 

 

 

 

 

 

 

 

Interest rate swaps (cash initial margin)

 

$

42,506

 

 

$

54,883

 

U.S. Treasury note futures (cash initial margin)

 

 

 

 

 

6,169

 

Unsettled MBS trades and TBA commitments, net

 

 

792

 

 

 

 

Total cash collateral posted, net

 

$

43,298

 

 

$

61,052

 

 

As of December 31, 2018, the Company had received $438 of cash collateral in respect of its forward-settling TBA commitments. The Company recognized a corresponding obligation to return this cash collateral to its counterparties, which is included in the line item “other liabilities” in the accompanying consolidated balance sheets.

 

v3.19.3
Earnings (Loss) Per Share
9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share

Note 9. Earnings (Loss) Per Share

Basic earnings (loss) per share includes no dilution and is computed by dividing net income or loss applicable to common stock by the weighted-average number of common shares outstanding for the respective period. Diluted earnings per share includes the impact of dilutive securities such as unvested shares of restricted stock and performance share units. The following tables present the computations of basic and diluted earnings (loss) per share for the periods indicated:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(Shares in thousands)

2019

 

 

2018

 

 

2019

 

 

2018

 

Basic weighted-average common shares outstanding

 

36,572

 

 

 

29,382

 

 

 

35,399

 

 

 

28,601

 

Performance share units and unvested restricted stock

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted-average common shares outstanding

 

36,572

 

 

 

29,382

 

 

 

35,399

 

 

 

28,601

 

Net loss attributable to common stock

$

(8,511

)

 

$

(5,652

)

 

$

(15,494

)

 

$

(65,929

)

Basic loss per common share

$

(0.23

)

 

$

(0.19

)

 

$

(0.44

)

 

$

(2.31

)

Diluted loss per common share

$

(0.23

)

 

$

(0.19

)

 

$

(0.44

)

 

$

(2.31

)

 

 The diluted loss per share for the three and nine months ended September 30, 2019 did not include the antidilutive effect of 179,464 and 125,403 shares of unvested shares of restricted stock and performance share units, respectively. The diluted loss per share for the three and nine months ended September 30, 2018 did not include the antidilutive effect of 335,491 and 273,979 shares of unvested shares of restricted stock and performance share units, respectively.

 

v3.19.3
Earnings (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
Computations of Basic and Diluted Earnings (Loss) Per Share The following tables present the computations of basic and diluted earnings (loss) per share for the periods indicated:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(Shares in thousands)

2019

 

 

2018

 

 

2019

 

 

2018

 

Basic weighted-average common shares outstanding

 

36,572

 

 

 

29,382

 

 

 

35,399

 

 

 

28,601

 

Performance share units and unvested restricted stock

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted-average common shares outstanding

 

36,572

 

 

 

29,382

 

 

 

35,399

 

 

 

28,601

 

Net loss attributable to common stock

$

(8,511

)

 

$

(5,652

)

 

$

(15,494

)

 

$

(65,929

)

Basic loss per common share

$

(0.23

)

 

$

(0.19

)

 

$

(0.44

)

 

$

(2.31

)

Diluted loss per common share

$

(0.23

)

 

$

(0.19

)

 

$

(0.44

)

 

$

(2.31

)

v3.19.3
Investments in Agency MBS - Additional Information (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Agency MBS    
Fair Value of MBS $ 4,013,161 $ 3,982,106
v3.19.3
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Series B Preferred Stock    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, issued (in shares) 354,039 350,595
Preferred stock, outstanding (in shares) 354,039 350,595
Preferred stock, liquidation preference $ 8,851 $ 8,765
Series C Preferred Stock    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, issued (in shares) 1,200,000 0
Preferred stock, outstanding (in shares) 1,200,000 0
Preferred stock, liquidation preference $ 30,000 $ 0
Common Class A    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 450,000,000 450,000,000
Common stock, shares issued (in shares) 36,755,387 30,497,998
Common stock, shares outstanding (in shares) 36,755,387 30,497,998
v3.19.3
Organization and Basis of Presentation
9 Months Ended
Sep. 30, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Organization and Basis of Presentation

Note 1. Organization and Basis of Presentation

Arlington Asset Investment Corp. (“Arlington Asset”) and its consolidated subsidiaries (unless the context otherwise provides, collectively, the “Company”) is an investment firm that focuses on acquiring and holding a levered portfolio of residential mortgage-backed securities (“MBS”), consisting of “agency MBS” and “private-label MBS.” Agency MBS include residential mortgage pass-through certificates for which the principal and interest payments are guaranteed by either a U.S. government sponsored enterprise (“GSE”), such as the Federal National Mortgage Association (“Fannie Mae”) and the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or by a U.S. government agency, such as the Government National Mortgage Association (“Ginnie Mae”). Private-label MBS, or “non-agency MBS,” include residential MBS that are not guaranteed by a GSE or the U.S. government. Arlington Asset is a Virginia corporation that is internally managed.

For the Company’s tax years ended December 31, 2018 and earlier, the Company was taxed as a C corporation for U.S. federal tax purposes. Commencing with its taxable year ending December 31, 2019, the Company intends to elect to be taxed as a REIT under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”). As a REIT, the Company will be required to distribute annually 90% of its REIT taxable income (subject to certain adjustments). So long as the Company continues to qualify as a REIT, it will generally not be subject to U.S. Federal or state corporate income taxes on its taxable income that it distributes to its shareholders on a timely basis. At present, it is the Company’s intention to distribute 100% of its taxable income, although the Company will not be required to do so. The Company intends to make distributions of its taxable income within the time limits prescribed by the Internal Revenue Code, which may extend into the subsequent taxable year.

The unaudited interim consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Article 10 of Regulation S-X. The Company’s unaudited interim consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited annual consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

The Company’s consolidated financial statements include the accounts of Arlington Asset and all other entities in which the Company has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect amounts reported in the consolidated financial statements. Although the Company bases these estimates and assumptions on historical experience and all other reasonably available information that the Company believes to be relevant under the circumstances, such estimates frequently require management to exercise significant subjective judgment about matters that are inherently uncertain. Actual results may differ from these estimates materially.

Certain amounts in the consolidated financial statements and notes for prior periods have been reclassified to conform to the current year’s presentation. These reclassifications had no impact on the previously reported net income, total assets or total liabilities.

v3.19.3
Earnings (Loss) Per Share - Additional Information (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Restricted Stock and Performance Shares        
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 179,464 335,491 125,403 273,979
v3.19.3
Fair Value Measurements - Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
MBS    
Derivative assets, at fair value $ 675 $ 438
Derivative Liabilities (724) (6,959)
Agency MBS    
MBS    
Fair Value of MBS 4,013,161 3,982,106
Private-Label MBS    
MBS    
Fair Value of MBS 25 24
Fair Value, Measurements, Recurring    
MBS    
Fair Value of MBS 4,013,186 3,982,130
Derivative assets, at fair value 675 438
Derivative Liabilities (724) (6,959)
Other assets 6,239 6,115
Total 4,019,376 3,981,724
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1    
MBS    
Fair Value of MBS 0 0
Derivative assets, at fair value 0 0
Derivative Liabilities 0 (1,250)
Other assets 0 0
Total 0 (1,250)
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2    
MBS    
Fair Value of MBS 4,013,161 3,982,106
Derivative assets, at fair value 675 438
Derivative Liabilities (724) (5,709)
Other assets 0 0
Total 4,013,112 3,976,835
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3    
MBS    
Fair Value of MBS 25 24
Derivative assets, at fair value 0 0
Derivative Liabilities 0 0
Other assets 6,239 6,115
Total 6,264 6,139
Fair Value, Measurements, Recurring | Agency MBS    
MBS    
Trading securities 4,013,161 3,982,106
Fair Value, Measurements, Recurring | Agency MBS | Fair Value, Inputs, Level 1    
MBS    
Trading securities 0 0
Fair Value, Measurements, Recurring | Agency MBS | Fair Value, Inputs, Level 2    
MBS    
Trading securities 4,013,161 3,982,106
Fair Value, Measurements, Recurring | Agency MBS | Fair Value, Inputs, Level 3    
MBS    
Trading securities 0 0
Fair Value, Measurements, Recurring | Private-Label MBS    
MBS    
Trading securities 25 24
Fair Value, Measurements, Recurring | Private-Label MBS | Fair Value, Inputs, Level 1    
MBS    
Trading securities 0 0
Fair Value, Measurements, Recurring | Private-Label MBS | Fair Value, Inputs, Level 2    
MBS    
Trading securities 0 0
Fair Value, Measurements, Recurring | Private-Label MBS | Fair Value, Inputs, Level 3    
MBS    
Trading securities $ 25 $ 24
v3.19.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Financial Instruments Measured at Fair Value on a Recurring Basis

The following tables set forth financial instruments measured at fair value by level within the fair value hierarchy as of September 30, 2019 and December 31, 2018. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

 

 

September 30, 2019

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

MBS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency MBS

 

$

4,013,161

 

 

$

 

 

$

4,013,161

 

 

$

 

Private-label MBS

 

 

25

 

 

 

 

 

 

 

 

 

25

 

Total MBS

 

 

4,013,186

 

 

 

 

 

 

4,013,161

 

 

 

25

 

Derivative assets

 

 

675

 

 

 

 

 

 

675

 

 

 

 

Derivative liabilities

 

 

(724

)

 

 

 

 

 

(724

)

 

 

 

Other assets

 

 

6,239

 

 

 

 

 

 

 

 

 

6,239

 

Total

 

$

4,019,376

 

 

$

 

 

$

4,013,112

 

 

$

6,264

 

 

 

 

December 31, 2018

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

MBS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency MBS

 

$

3,982,106

 

 

$

 

 

$

3,982,106

 

 

$

 

Private-label MBS

 

 

24

 

 

 

 

 

 

 

 

 

24

 

Total MBS

 

 

3,982,130

 

 

 

 

 

 

3,982,106

 

 

 

24

 

Derivative assets

 

 

438

 

 

 

 

 

 

438

 

 

 

 

Derivative liabilities

 

 

(6,959

)

 

 

(1,250

)

 

 

(5,709

)

 

 

 

Other assets

 

 

6,115

 

 

 

 

 

 

 

 

 

6,115

 

Total

 

$

3,981,724

 

 

$

(1,250

)

 

$

3,976,835

 

 

$

6,139

 

Change in Fair Value of Level 3 Investments that are Measured at Fair Value on Recurring Basis

The table below sets forth an attribution of the change in the fair value of the Company’s Level 3 investments that are measured at fair value on a recurring basis for the periods indicated:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Beginning balance

$

6,052

 

 

$

6,235

 

 

$

6,139

 

 

$

515

 

Investments in equity securities measured at fair value beginning January 1, 2018

 

 

 

 

 

 

 

 

 

 

5,362

 

Included in investment gain (loss), net

 

231

 

 

 

(21

)

 

 

224

 

 

 

343

 

Purchases

 

 

 

 

 

 

 

 

 

 

 

Sales

 

 

 

 

 

 

 

 

 

 

 

Payments, net

 

(23

)

 

 

(46

)

 

 

(118

)

 

 

(66

)

Accretion of discount

 

4

 

 

 

2

 

 

 

19

 

 

 

16

 

Ending balance

$

6,264

 

 

$

6,170

 

 

$

6,264

 

 

$

6,170

 

Net unrealized gains (losses) included in earnings for the

   period for Level 3 assets still held at the reporting date

$

231

 

 

$

(21

)

 

$

239

 

 

$

343

 

v3.19.3
Summary of Significant Accounting Policies - Additional Information (Details)
Sep. 30, 2019
Dec. 31, 2018
Accounting Policies [Abstract]    
Cash Equivalents Percentage Held in Us Government Backed Securities 96.00% 99.00%
v3.19.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
ASSETS    
Cash and cash equivalents $ 12,129 $ 26,713
Interest receivable 11,684 13,349
Derivative assets, at fair value 675 438
Deposits 43,298 61,052
Other assets 18,566 15,768
Total assets 4,099,538 4,099,450
Liabilities:    
Repurchase agreements 3,697,906 3,721,629
Interest payable 3,356 4,646
Accrued compensation and benefits 3,502 3,732
Dividend payable 8,397 11,736
Derivative liabilities, at fair value 724 6,959
Other liabilities 3,204 2,200
Long-term unsecured debt 74,272 74,104
Total liabilities 3,791,361 3,825,006
Commitments and contingencies
Stockholders’ Equity:    
Additional paid-in capital 2,048,423 1,997,876
Accumulated deficit (1,777,841) (1,731,982)
Total stockholders’ equity 308,177 274,444
Total liabilities and stockholders’ equity 4,099,538 4,099,450
Agency MBS    
ASSETS    
Mortgage-backed securities, at fair value 4,013,161 3,982,106
Liabilities:    
Repurchase agreements 3,697,906 3,721,629
Private-Label MBS    
ASSETS    
Mortgage-backed securities, at fair value 25 24
Series B Preferred Stock    
Stockholders’ Equity:    
Preferred stock 8,283 8,245
Series C Preferred Stock    
Stockholders’ Equity:    
Preferred stock 28,944  
Common Class A    
Stockholders’ Equity:    
Common stock $ 368 $ 305
v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net loss $ (13,668) $ (65,492)
Adjustments to reconcile net loss to net cash provided by operating activities    
Investment loss, net 21,111 54,912
Net premium amortization on mortgage-backed securities 20,500 24,580
Deferred tax provision   34,372
Other 1,991 1,476
Changes in operating assets    
Interest receivable 1,665 (2,272)
Other assets (351) (153)
Changes in operating liabilities    
Interest payable and other liabilities (2,223) 84
Accrued compensation and benefits (230) (1,350)
Net cash provided by operating activities 28,795 46,157
Cash flows from investing activities:    
Proceeds from sales of agency mortgage-backed securities 3,365,166 1,815,796
Receipt of principal payments on agency mortgage-backed securities 369,029 367,356
(Payments for) proceeds from derivatives and deposits, net (138,792) 76,232
Other 31 29
Net cash used in investing activities (62,020) (440,444)
Cash flows from financing activities:    
(Repayments of) proceeds from repurchase agreements, net (23,723) 425,070
Proceeds from issuance of common stock 48,804 21,065
Proceeds from issuance of preferred stock 28,982 1,030
Dividends paid (35,422) (42,293)
Net cash provided by financing activities 18,641 404,872
Net (decrease) increase in cash and cash equivalents (14,584) 10,585
Cash and cash equivalents, beginning of period 26,713 21,614
Cash and cash equivalents, end of period 12,129 32,199
Supplemental cash flow information:    
Cash payments for interest 77,154 58,284
Agency MBS    
Cash flows from investing activities:    
Purchases of mortgage-backed securities $ (3,657,454) $ (2,699,857)
v3.19.3
Stockholders' Equity - Additional Information (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 12, 2019
USD ($)
$ / shares
shares
Feb. 22, 2019
USD ($)
$ / shares
shares
Jun. 01, 2009
Sep. 30, 2019
$ / shares
shares
Jun. 30, 2019
shares
Mar. 31, 2019
shares
Dec. 31, 2018
$ / shares
shares
Sep. 30, 2018
shares
Jun. 30, 2018
shares
Mar. 31, 2018
shares
Sep. 30, 2019
$ / shares
shares
Dec. 31, 2018
$ / shares
shares
Mar. 21, 2019
shares
Aug. 10, 2018
shares
May 16, 2017
shares
Feb. 22, 2017
shares
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Dividend payable date       Oct. 31, 2019 Jul. 31, 2019 Apr. 30, 2019 Jan. 31, 2019 Oct. 31, 2018 Jul. 31, 2018 Apr. 30, 2018            
Shareholder Rights Plan                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Rights plan, amended term of agreement     3 years                          
Common Class A                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Common stock, shares authorized (in shares)       450,000,000     450,000,000       450,000,000 450,000,000        
Common stock, par value (in dollars per share) | $ / shares       $ 0.01     $ 0.01       $ 0.01 $ 0.01        
Common Stock Voting Rights Per Share Owned       1             1          
Common stock, shares outstanding (in shares)       36,755,387     30,497,998       36,755,387 30,497,998        
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased       1,951,305             1,951,305          
Common Class A | Maximum                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Stock Repurchase Program, Number of Shares Authorized to be Repurchased       2,000,000             2,000,000          
Common Class A | Minimum | Shareholder Rights Plan                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Percentage of beneficial ownership of common stock     4.90%                          
Common Class A | Common Stock                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Issuance of stock (in shares)   6,000,000       6,000,000   2,007,216 66,989              
Public Offering Price Per Share | $ / shares   $ 8.16                            
Net proceeds underwriting discounts and commissions and expenses | $   $ 48,827                            
Repurchase of Class A common stock (in shares)       0             0 0        
Common Class A | Common Stock | Amended Equity Distribution Agreements                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Number of shares offer and sell       11,302,160             11,302,160          
Common Class A | Common Stock | Maximum | Equity Distribution Agreements                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Number of shares offer and sell                               6,000,000
Common Class A | Common Stock | Maximum | Amended Equity Distribution Agreements                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Number of shares offer and sell                           12,597,423    
Common Class B                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Common stock, shares authorized (in shares)       100,000,000             100,000,000          
Common stock, par value (in dollars per share) | $ / shares       $ 0.01             $ 0.01          
Common Stock Voting Rights Per Share Owned       3             3          
Common stock, shares outstanding (in shares)       0     0       0 0        
7.00% Series B Cumulative Perpetual Redeemable Preferred Stock                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Preferred stock, shares authorized (in shares)       2,000,000             2,000,000          
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.01             $ 0.01          
Series C Preferred Stock                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Public Offering Price Per Share | $ / shares $ 25.00                              
Net proceeds underwriting discounts and commissions and expenses | $ $ 28,944                              
Preferred stock, shares authorized (in shares)       2,500,000             2,500,000          
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.01     $ 0.01       $ 0.01 $ 0.01        
Preferred stock, dividend rate percentage                     8.25%          
Preferred stock voting rights per share owned       0             0          
Preferred stock, liquidation preference per share | $ / shares       $ 25.00             $ 25.00          
Preferred stock, redeemable price per share | $ / shares       25.00             $ 25.00          
Preferred stock, dividend payment terms                     Dividends will be payable quarterly in arrears on the 30th day of March, June, September and December of each year, when and as declared, beginning on June 30, 2019.          
Preferred stock, annual dividend rate per share | $ / shares       2.0625             $ 2.0625          
Preferred stock, rate conversion date                     Mar. 30, 2024          
Preferred stock, first long dividend rate per share | $ / shares       $ 0.61875             $ 0.61875          
Dividend payable date                     Jul. 01, 2019          
Series C Preferred Stock | LIBOR                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Preferred stock, variable dividend spread rate                     5.664%          
Series C Preferred Stock | Preferred Stock                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Issuance of stock (in shares) 1,200,000         1,200,000                    
Undesignated Preferred Stock                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Preferred stock, shares authorized (in shares)       20,400,000             20,400,000          
Series A Preferred Stock                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Preferred stock, shares authorized (in shares)       100,000             100,000          
Preferred stock shares unissued       100,000             100,000          
Series B Preferred Stock                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.01     $ 0.01       $ 0.01 $ 0.01        
Preferred stock, dividend rate percentage                     7.00%          
Preferred stock voting rights per share owned       0             0          
Preferred stock, liquidation preference per share | $ / shares       $ 25.00             $ 25.00          
Preferred stock, redeemable price per share | $ / shares       25.00             $ 25.00          
Preferred stock, redemption date                     May 12, 2022          
Preferred stock, dividend payment terms                     Dividends are payable quarterly in arrears on the 30th day of March, June, September and December of each year, when and as declared.          
Preferred stock, annual dividend rate per share | $ / shares       $ 1.75             $ 1.75          
Series B Preferred Stock | Preferred Stock                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Issuance of stock (in shares)         1,409 2,035   5,404 18,030 19,431            
Series B Preferred Stock | Preferred Stock | Series B Preferred Equity Distribution Agreement                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Issuance of stock (in shares)                     3,444 47,304        
Number of Shares Offer and Sell       1,645,961             1,645,961          
Series B Preferred Stock | Preferred Stock | Maximum                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Number of Shares Offer and Sell                             1,865,000  
Series B Preferred Stock | Preferred Stock | Maximum | Series B Preferred Equity Distribution Agreement                                
Share based Compensation Arrangement by Share based Payment Award [Line Items]                                
Number of Shares Offer and Sell                         1,647,370      
v3.19.3
Fair Value Measurements - Change in Fair Value of Level 3 Investments that are Measured at Fair Value on Recurring Basis (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Fair Value Disclosures [Abstract]        
Beginning balance $ 6,052 $ 6,235 $ 6,139 $ 515
Investments in equity securities measured at fair value beginning January 1, 2018       5,362
Included in investment gain (loss), net 231 (21) 224 343
Payments, net (23) (46) (118) (66)
Accretion of discount 4 2 19 16
Ending balance 6,264 6,170 6,264 6,170
Net unrealized gains (losses) included in earnings for the period for Level 3 assets still held at the reporting date $ 231 $ (21) $ 239 $ 343
v3.19.3
Derivative Instruments - Derivative Gains and Losses Recognized Within the Periods (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Interest rate derivative (losses) gains, net $ (28,330) $ 39,939 $ (170,902) $ 135,206
Total derivative (losses) gains, net (25,353) 35,620 (149,630) 91,826
Interest Rate Swap (Losses) Gains, Net        
Interest rate derivative (losses) gains, net (25,634) 31,248 (154,557) 108,035
Interest Rate Swaps Net Interest Income        
Interest rate derivative (losses) gains, net [1] 4,445 2,295 12,961 3,962
Interest Rate Swaps Unrealized (Losses) Gains, Net        
Interest rate derivative (losses) gains, net (18,087) 11,386 (100,337) 66,023
Interest Rate Swaps (Losses) Gains Realized Upon Early Termination, Net        
Interest rate derivative (losses) gains, net (11,992) 17,567 (67,181) 38,050
Options on U.S. Treasury Note Futures, Net        
Interest rate derivative (losses) gains, net 0 0 76 0
TBA Dollar Roll Income        
Gains (losses) on agency commitments [2] 923 4,604 4,338 17,989
Other Gains (Losses) on Agency MBS Commitments, Net        
Gains (losses) on agency commitments 2,054 (8,923) 16,934 (61,369)
Gains (Losses) on Agency MBS Commitments, Net        
Gains (losses) on agency commitments 2,977 (4,319) 21,272 (43,380)
U.S. Treasury Note Futures, Net        
Interest rate derivative (losses) gains, net $ (2,696) $ 8,691 $ (16,421) $ 27,171
[1] Represents the periodic net interest settlement incurred during the period (often referred to as “net interest carry”). Also includes “price alignment interest” income earned or expense incurred on cumulative variation margin paid or received, respectively, associated with centrally cleared interest rate swap agreements.
[2] Represents the price discount of forward-settling TBA purchases relative to a contemporaneously executed “spot” TBA sale, which economically equates to net interest income that is earned ratably over the period beginning on the settlement date of the sale and ending on the settlement date of the forward-settling purchase.
v3.19.3
Derivative Instruments - Fair Value of Derivative Instruments (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Derivative Assets $ 675 $ 438
Derivative Liabilities (724) (6,959)
Interest Rate Swap    
Derivative Assets 269 0
Derivative Liabilities (44) (5,709)
10-year U.S. Treasury Note Futures    
Derivative Assets 0 0
Derivative Liabilities 0 (1,250)
TBA Commitments    
Derivative Assets 406 438
Derivative Liabilities $ (680) $ 0
v3.19.3
Borrowings
9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Borrowings

Note 4. Borrowings

Repurchase Agreements

The Company finances the purchase of MBS through repurchase agreements, which are accounted for as collateralized borrowing arrangements. In a repurchase transaction, the Company sells MBS to a counterparty under a master repurchase agreement in exchange for cash and concurrently agrees to repurchase the same security at a future date in an amount equal to the cash initially exchanged plus an agreed-upon amount of interest. MBS sold under agreements to repurchase remain on the Company’s consolidated balance sheets because the Company maintains effective control over such securities throughout the duration of the arrangement. Throughout the contractual term of a repurchase agreement, the Company recognizes a “repurchase agreement” liability on its consolidated balance sheets to reflect the obligation to repay to the counterparty the proceeds received upon the initial transfer of the MBS. The difference between the proceeds received by the Company upon the initial transfer of the MBS and the contractually agreed-upon repurchase price is recognized as interest expense ratably over the term of the repurchase arrangement.

Amounts borrowed pursuant to repurchase agreements are equal in value to a specified percentage of the fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral throughout the term of the repurchase agreement. The counterparty to the repurchase agreements may require that the Company pledge additional securities or cash as additional collateral to secure borrowings when the value of the collateral declines.

As of September 30, 2019 and December 31, 2018, the Company had no amount at risk with a single repurchase agreement counterparty or lender greater than 10% of equity. The following table provides information regarding the Company’s outstanding repurchase agreement borrowings as of the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

Pledged with agency MBS:

 

 

 

 

 

 

 

 

Repurchase agreements outstanding

 

$

3,697,906

 

 

$

3,721,629

 

Agency MBS collateral, at fair value

 

 

3,891,308

 

 

 

3,931,232

 

Net amount (1)

 

 

193,402

 

 

 

209,603

 

Weighted-average rate

 

 

2.35

%

 

 

2.72

%

Weighted-average term to maturity

 

22.2 days

 

 

17.3 days

 

 

(1)

Net amount represents the value of collateral in excess of corresponding repurchase obligation. The amount of collateral at-risk is limited to the outstanding repurchase obligation and not the entire collateral balance.

 

The following table provides information regarding the Company’s outstanding repurchase agreement borrowings during the three and nine months ended September 30, 2019 and 2018:

 

 

 

September 30, 2019

 

 

September 30, 2018

 

Weighted-average outstanding balance during the three months ended

 

$

3,609,519

 

 

$

3,841,280

 

Weighted-average rate during the three months ended

 

 

2.46

%

 

 

2.17

%

Weighted-average outstanding balance during the nine months ended

 

$

3,672,844

 

 

$

3,730,460

 

Weighted-average rate during the nine months ended

 

 

2.59

%

 

 

1.93

%

Long-Term Unsecured Debt

As of September 30, 2019 and December 31, 2018, the Company had $74,272 and $74,104, respectively, of outstanding long-term unsecured debentures, net of unamortized debt issuance costs of $1,028 and $1,196, respectively. The Company’s long-term debentures consisted of the following as of the dates indicated:

 

 

 

September 30, 2019

 

 

December 31, 2018

 

 

 

Senior

Notes Due 2025

 

 

Senior

Notes Due 2023

 

 

Trust

Preferred Debt

 

 

Senior

Notes Due 2025

 

 

Senior

Notes Due 2023

 

 

Trust

Preferred Debt

 

Outstanding Principal

 

$

35,300

 

 

$

25,000

 

 

$

15,000

 

 

$

35,300

 

 

$

25,000

 

 

$

15,000

 

Annual Interest Rate

 

 

6.75

%

 

 

6.625

%

 

LIBOR+

2.25 - 3.00 %

 

 

 

6.75

%

 

 

6.625

%

 

LIBOR+

2.25 - 3.00 %

 

Interest Payment Frequency

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

 

Quarterly

 

Weighted-Average Interest Rate

 

 

6.75

%

 

 

6.625

%

 

 

5.05

%

 

 

6.75

%

 

 

6.625

%

 

 

5.19

%

Maturity

 

March 15, 2025

 

 

May 1, 2023

 

 

2033 - 2035

 

 

March 15, 2025

 

 

May 1, 2023

 

 

2033 - 2035

 

Early Redemption Date

 

March 15, 2018

 

 

May 1, 2016

 

 

2008 - 2010

 

 

March 15, 2018

 

 

May 1, 2016

 

 

2008 - 2010

 

 

The Senior Notes due 2023 and the Senior Notes due 2025 are publicly traded on the New York Stock Exchange under the ticker symbols “AIW” and “AIC,” respectively. The Senior Notes due 2023 and Senior Notes due 2025 may be redeemed in whole or in part at any time and from time to time at the Company’s option at a redemption price equal to the principal amount plus accrued and unpaid interest. The indenture governing these Senior Notes contains certain covenants, including limitations on the Company’s ability to merge or consolidate with other entities or sell or otherwise dispose of all or substantially all of the Company’s assets.

v3.19.3
Income Taxes
9 Months Ended
Sep. 30, 2019
Income Tax Disclosure [Abstract]  
Income Taxes

Note 8. Income Taxes

For its tax years ended December 31, 2018 and earlier, Arlington Asset was subject to taxation as a corporation under Subchapter C of the Internal Revenue Code. On December 27, 2018, the Company’s Board of Directors approved a plan for Arlington Asset to elect to be taxed and to operate in a manner that will allow it to qualify as a REIT under the Internal Revenue Code commencing with its taxable year ending December 31, 2019. As a REIT, the Company will be required to distribute annually 90% of its REIT taxable income. So long as the Company continues to qualify as a REIT, it will generally not be subject to U.S. Federal or state corporate income taxes on its taxable income to the extent that it distributes all of its annual taxable income to its shareholders on a timely basis. At present, it is the Company’s intention to distribute 100% of its taxable income, although the Company will not be required to do so. The Company intends to make distributions of its taxable income within the time limits prescribed by the Internal Revenue Code, which may extend into the subsequent taxable year.

As of September 30, 2019, the Company had estimated net operating loss (“NOL”) carryforwards of $14,588 that can be used to offset future taxable ordinary income. The Company’s NOL carryforwards begin to expire in 2028. As of September 30, 2019, the Company had estimated net capital loss (“NCL”) carryforwards of $394,447 that can be used to offset future net capital gains. The scheduled expirations of the Company’s NCL carryforwards are $111,177 in 2019, $102,322 in 2020, $66,862 in 2021, $3,763 in 2022 and $110,323 in 2023. If the Company were to use its NOL carryforwards to offset taxable ordinary income and/or use its NCL carryforwards to offset net capital gains, the Company’s required income distribution as a REIT would be reduced accordingly.

Through December 31, 2017, the Company was subject to federal alternative minimum tax (“AMT”) on its taxable income and gains that were not offset by its NOL and NCL carryforwards with any AMT credit carryforwards available to offset future regular tax liabilities. As part of the Tax Cuts and Jobs Act, the corporate AMT was repealed for tax years beginning after December 31, 2017 with any AMT credit carryforward after that date continuing to be available to offset a taxpayer’s future regular tax liability. In addition, for tax years beginning in 2018, 2019 and 2020, to the extent that AMT credit carryforwards exceed the regular tax liability, 50% of the excess AMT credit carryforwards would be refundable in that year with any remaining AMT credit carryforwards fully refundable in 2021. As a result, the realizability of the Company’s AMT credit carryforward is certain and will be realized as either a cash refund or as an offset to future regular tax liabilities or a combination of both. For the 2018 tax year, the Company claimed $4,566 of its AMT credit carryforward as a cash tax refund, which is included as a receivable in “other assets” as of September 30, 2019 on the accompanying consolidated balance sheets.  As of September 30, 2019 and December 31, 2018, the Company had an AMT credit carryforward of $4,566 and $9,132, respectively, included as a receivable in “other assets” on the accompanying consolidated balance sheets.

The Company recognizes uncertain tax positions in the financial statements only when it is more-likely-than-not that the position will be sustained upon examination by the relevant taxing authority based on the technical merits of the position. A position that meets this standard is measured at the largest amount of benefit that will more-likely-than-not be realized upon settlement. A liability is established for differences between positions taken in a tax return and the financial statements. As of September 30, 2019 and December 31, 2018, the Company assessed the need for recording a provision for any uncertain tax position and has made the determination that such provision is not necessary.

 

On May 29, 2018, the Company received an assessment of $9,380 from Arlington County, Virginia for a business, professional and occupation license (“BPOL”) tax for 2018.  The BPOL tax is a local privilege tax on a business’ gross receipts for conducting business activities subject to licensure within Arlington County.  The Company had not been assessed or paid any such BPOL tax prior to 2018.  On June 28, 2018, the Company filed an administrative appeal with Arlington County. On August 1, 2018, the Company received a denial of its administrative appeal from Arlington County and, subsequently, the Company filed an administrative appeal with the Tax Commissioner of Virginia (the “Tax Commissioner”) on September 27, 2018.  On June 21, 2019, the Company received a determination from the Tax Commissioner stating that he believes the Company is engaged in a licensable privilege subject to the BPOL tax. However, the Tax Commissioner determined that certain of the Company’s gross receipts are exempt from BPOL taxation.  The Tax Commissioner requested that Arlington County revise its initial BPOL tax assessment to exclude these certain gross receipts from its tax calculation.  On August 21, 2019 the Company received a revised 2019 BPOL tax assessment of $471 as well as a 2018 BPOL tax assessment of $488, including interest charges, from Arlington County both of which the Company paid on September 3, 2019.  In the third quarter of 2019, the Company recognized an expense of $842 in “other general and administrative expense” which represents the 2018 BPOL tax (and associated interest) and the 2019 BPOL tax incurred through September 30, 2019.  The Company retains the right to appeal the Tax Commissioner’s determination through June of 2020. BPOL tax years 2016 and 2017 remain subject to examination by Arlington County, although the county has previously informally indicated that it did not intend to pursue assessments for those years at such time.   

 

v3.19.3
Investments in Agency MBS (Tables)
9 Months Ended
Sep. 30, 2019
Agency MBS  
Additional Information Realized Gain Loss on Investments The following table provides additional information about the gains and losses recognized as a component of “investment gain (loss), net” in the Company’s consolidated statements of comprehensive income for the periods indicated with respect to investments in agency MBS classified as trading securities:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Net gains (losses) recognized in earnings for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency MBS still held at period end

 

$

12,576

 

 

$

(29,744

)

 

$

62,220

 

 

$

(103,536

)

Agency MBS sold during the period

 

 

4,315

 

 

 

(8,113

)

 

 

66,076

 

 

 

(43,547

)

Total

 

$

16,891

 

 

$

(37,857

)

 

$

128,296

 

 

$

(147,083

)